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V. ABSTRACT 
In this thesis is presented work carried out during the course of the last 42 
months. It concerns approaches towards total syntheses of the complanadine 
alkaloids. The main focus is the development of a model system to establish the 
viability of the key step in our proposed route to the complanadines. The thesis 
is divided into five chapters.  
Chapter 1 is an introduction to the complanadines, their biological activity and 
accomplished total syntheses to date. A brief introduction to the Diels–Alder 
reaction and selected examples of its application in the total syntheses of 
natural products are given. The Kondrat’eva oxazole–olefin hetero-Diels–Alder 
reaction as a method of pyridine formation is described and its application in the 
total synthesis of natural products is reviewed.  
Chapter 2 is the first part of the results and discussion section. It details our 
retrosynthetic analysis of complanadine A, outlines the corresponding proposed 
forward synthesis and presents a model system designed and synthesised to 
test the applicability of the Kondrat’eva oxazole–olefin hetero-Diels–Alder 
reaction in the context of our proposed total synthesis. 
Chapter 3 discusses work carried out in approaches to the total synthesis of 
complanadines and their monomeric subunit, lycodine, by means of the 
methodology developed in the previous chapter.  
Chapter 4 is the experimental section, which gives descriptions of the synthetic 
procedures employed and spectroscopic data for all compounds synthesised, 
both novel and previously reported, as discussed in Chapter 2 and Chapter 3. 
Supplementary information such as X-Ray data for synthesised compounds and 
selected NMR spectra are enclosed in the appendices. 
 xv 
 
VI. ABBREVIATIONS 
9-BBN  9-borabicyclo[3.3.1]nonane 
Å   angstrom 
AcOH   acetic acid 
AIBN   2,2’-azobis(2-methylpropionitrile) 
app   apparent 
aq   aqueous 
Ar   aromatic 
Boc   tert-butyloxycarbonyl 
Bn   benzyl 
b.pt.   boiling point 
BQ   1,4-benzoquinone 
br   broad 
BTSP   1,3-bis(trymethylsiloxy)propane 
Bu   butyl 
nBu   normal-butyl 
nBuLi   normal-butyl lithium 
°C   degrees celsius 
cat.   catalytic quantity 
CH2Cl2  dichloromethane 
CHCl3   chloroform 
CDCl3   chloroform-d 
conc.   concentrated 
COSY   correlation spectroscopy 
Cu(OTf)2  copper (II) triflate 
δ   chemical shift in parts per million 
∆   reflux 
d   doublet  
DCB   dichlorobenzene 
DBN   1,5-diazobicyclo[4.3.0]non-5-ene 
DBU   1,8-diazobicyclo[5.4.0]undecen-7-ene 
 xvi 
 
DCE   1,2-dichloroethane 
DCM   dichloromethane 
dd   doublet of doublets  
DEG   diethyleneglycol 
DIBAL-H  diisobutylaluminium hydride 
DIC   diisopropyl carbodiimide 
DIE   1,2-diiodoethane 
dil.   dilute 
DMAP   4-(dimethylamino)pyridine 
DME   1,2-dimethoxyethane 
DMF   N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
DNPH   2,4-dinitrophenylhydrazine 
dppf   diphenylphosphino ferrocene 
dt   doublet of triplets 
EBDPP  ethylenebis(diphenylphosphine) 
EDG electron donating group 
equiv.   equivalent(s) 
ES   electrospray 
Et   ethyl 
Et3N   triethylamine 
Et2O   diethyl ether 
EtOH   ethanol 
Eu(fod)3 Europium(III) tris(6,6,7,7,8,8,8,-heptafluoro-2,2-dimethyl-
3,5-octanedionate 
EWG electron withdrawing group 
FGI functional group interconversion  
g   gram 
h   hour(s) 
Hz   Hertz 
HWE   Horner–Wadsworth–Emmons reaction 
 xvii 
 
i
   iso 
IR   infrared 
IMDA   intramolecular Diels–Alder reaction 
J   coupling constant  
LA   Lewis acid 
LG   leaving group 
m   meta 
m   multiplet  
M   molar 
Me   methyl 
Mes   mesityl; 2,4,6-trimethylphenyl 
mg   milligram 
MHz   mega Hertz 
mmol   millimole 
min   minute(s) 
mL   millilitre 
µL   microlitre 
m.pt.   melting point 
Ms   methanesulfonyl; mesyl 
MS   molecular sieves, mass spectrometry 
MW   molecular weight 
µW   microwave 
m/z   mass to charge ratio 
NaBH4  sodium borohydride 
NMR   nuclear magnetic resonance 
NOESY  nuclear Overhauser effect spectroscopy 
o   ortho 
o   octet 
(P)   protecting group 
p   para 
Ph   phenyl 
 xviii 
 
PMA   phorbol myristyl acetate 
PMB   p-methoxybenzyl 
PNB   p-nitrobenzyl 
ppm   parts per million 
Pr   propyl 
p-TSA   p-toluenesulfonic acid 
q   quartet  
R   generic substituent 
rt   room temperature 
s   singlet  
sat.   saturated 
SET   single electron transfer 
sol.   solution 
t   triplet 
td   triplet of doublets 
TBAF   tetrabuthylammonium fluoride 
TBDMS  tert-butyldimethyl silyl 
TBDMSCl  tert-butyldimethyl silylchloride 
TCDI   1,1’-thiocarbonyldiimidazole 
Tf   trifluoromethanesulfonyl 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
TMS   trimethylsilyl 
Tol   toluene 
TPP tetraphenylporphyrin; 5,10,15,20-tetraphenyl-21H,23H-
porphine 
Ts   tosyl; para-toluenesulfonyl 
w/up   workup 
Yb(OTf)3  ytterbium (III) triflate 
v   wavenumber 
Chapter 1  Introduction 
1 
 
 
 
 
 
 
 
 
 
 
Introduction
Chapter 1  Introduction 
2 
1. INTRODUCTION 
1.1 Alkaloids 
Alkaloids are a class of secondary metabolites which contain one or more basic 
nitrogen functional group and which occur in plants, microorganisms, marine 
organisms, and animals. Plants are estimated to produce approximately 40,000 
different alkaloids, which can be organized into groups according to their carbon 
skeletal structures. The role of these compounds in plants is not always clear 
and can vary, however it is believed they play a part in plant defence against 
herbivores, to improve their growth, reproduction and survival.1 For example, 
liriodenine (1) shows antifungal activity protecting the plant from parasitic fungi 
(Figure 1.1).2 In contrast, alkaloid substances such as serotonin (2) play a vital 
role in neurotransmission in animals including humans.3  
 
Figure 1.1 Structures of liriodenine, serotonin and tropinone. 
As the number of alkaloids identified has increased, so has the number of 
alkaloid families into which they are classified. Like other natural products, 
biosynthesis of alkaloids in plants involves complicated multi-step pathways and 
is catalysed by enzymes. The identification and characterization of novel 
alkaloid biosynthetic enzymes has been the focus of much research over the 
past few decades. Although it is not always clear why certain alkaloids show 
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significant biological activity, they are often useful as drugs or as biological 
probes for physiological studies. Interest in the importance of biologically active 
alkaloids has increased due to their potential application in medical treatment of 
various conditions. Since the synthesis of tropinone (3) by Robinson4 in 1917, 
generations of chemists have been looking into the realisation and development 
of total syntheses of these challenging natural products .  
1.2 The Complanadines 
Lycopodium alkaloids5 represent a large family of plant substances obtained 
from club mosses belonging to the Lycopodiaceae family. These structurally 
diverse alkaloids often possess unusual skeletal connectivity. Many of them 
continue to be of interest from medicinal and biological points of view, as well as 
providing challenging targets for synthetic chemists. New natural compounds 
belonging to this group have been isolated in the last decade, including the 
complanadines (Figure 1.2).6-8 
Chapter 1  Introduction 
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Figure 1.2 Complanadines A-E, lycodine and huperzine A. 
The first, complanadine A (4)7, was reported by Kobayashi et. al. in 2000, and 
was followed by the isolation of complanadine B (5)8 in 2005, complanadines C 
(6)6 & D (7)6 in 2007 and complanadine E (8)9 in 2011. As shown in Figure 1.2, 
4, 5, 7 and 8 are dimeric derivatives of the known tetracyclic alkaloid lycodine 
(9)5, varying only in oxidation state, whereas derivative 6 has different skeletal 
connectivity. 
Intriguingly, 4, 5, 7 and 8 all possess a non-symmetric 2,3’-bipyridyl type 
linkage, a rare alkaloid structural motif. Complanadines A 4 and D 7 show 
moderate cytotoxicity towards murine leukemia L1210 cells6,7 whereas 
complanadine C 3 does not. Also, complanadines C 6 and D 7 show 
antimicrobial activity towards Cryptococcus neoformans and Aspergillus niger.6 
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Perhaps most significant, however, are the reported neurotrophic effects of 4, 5 
and 6.6,8 These have been studied in the most detail for complanadine A 4, 
which was reported to induce neurite outgrowth of PC-12 cells in a dose-
dependent manner (Figure 1.3). To date there are no available biological data 
for complanadine E 8. 
 
Figure 1.3 Glial cell-mediated morphological change of PC-12 cells by complanadine A, 
reproduced from reference 8. 
Compounds able to induce neuronal differentiation and neurite outgrowth are of 
medicinal interest as potential treatments for neurodegenerative conditions. 
Indeed, the related lycopodium alkaloid huperzine A (10)5 has been used for the 
treatment of Alzheimer’s disease in traditional chinese medicine for many years. 
1.3 The Lycopodium Alkaloids 
Complanadines belong to the lycopodium alkaloid family, a diverse group of 
natural products generally consisting of sixteen carbon and one or two nitrogen 
atoms, with various degrees of oxygenation. They are presumably derived from 
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two 2-propylpiperidine subunits (Figure 1.4). Ma and Gang5 recently reviewed 
the chemical, pharmacological, and clinical research being performed on this 
family of alkaloids, and several previous reviews exist as well.10,11
 
 
The lycopodium family is often divided into four classes based on their structural 
skeletons. These classes are the lycodines, the lycopodines, the fawcettimines, 
and a miscellaneous class.5 A typical example from each of these classes is 
shown in Figure 1.4, where phlegmarine (11) is the example of the 
miscellaneous class. Although the biosynthesis of the lycopodium alkaloids is 
not completely understood, it is thought that phlegmarine 11, in which the two 2-
propylpiperidine subunits (highlighted in red and purple) (Figure 1.4) are more 
obvious, is the common precursor to all classes of the lycopodium alkaloids. 
Thus, bond formation between C-4 and C-13 of phlegmarine yields the lycodine 
9 skeleton. From lycodine, disconnection of the C-1–N
α 
bond, and reconnection 
of C-1 to N
β 
gives the lycopodine structure (12). From there, migration of C-4 
from C-13 to C-12 reveals the fawcettimine (13) skeleton.  
 
Figure 1.4 Representative compounds of the major classes of lycopodium alkaloids. 
Many representatives of the lycopodium family are biologically active. For 
example, a feature of many compounds in the lycodine subclass is their ability 
to inhibit acetylcholinesterase.12
 
 Of these, huperzine A 10 is the most 
potent.13,14
 
It has been shown that due to its strong inhibition of 
acetylcholinesterase it increases memory and learning efficiency in 
mammals,13,14
 
and shows promise in the treatment of Alzheimer’s disease and 
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an autoimmune neuromuscular disease known as myasthenia gravis.15
 
Huperzine A and a Schiff base derivative of huperzine A named ZT-1 are 
currently in clinical trials for use as a treatment for Alzheimer’s disease.5
 
 
1.4  The Diels–Alder Reaction 
The most widely applied pericyclic reaction for the construction of six-
membered functionalised carbocyclic or heterocyclic compounds is the Diels–
Alder reaction. The usefulness of this [4+2] cycloaddition reaction is especially 
valuable in cases of structurally complex natural product targets. This arises 
from its high regio- and stereoselectivity and its versatility, as wide range of 
dienes and dienophiles can be used.  
This reaction was first documented in 1928 by Otto Paul Hermann Diels and his 
student Kurt Alder.16 In 1950, for their work on this reaction, Diels and Alder 
were awarded the Nobel prize in chemistry.17 
The reaction between a conjugated diene (14) and a substituted alkene (15), 
commonly termed the dienophile, occurs via single transition state (16) 
(Scheme 1.1), to form a cyclic adduct (17) with the formation of two new σ-
bonds at the expense of two π-bonds in the starting reagents. It is an 
associative type of reaction, and it is accelerated by high temperatures or 
pressures. 
 
Scheme 1.1 Simplified Diels–Alder reaction scheme. 
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The majority of these reactions involve electron-rich dienes possessing electron 
donation groups such as alkyl or alkoxy and electron-poor dienophiles activated 
by electron withdrawing groups (carbonyls, -CF3, -CN). The most commonly 
known activated dienes are Danishefsky’s diene (18) and the similar 
Danishefsky-Brassard (19) and Rawal’s dienes (20) (Figure 1.5). 
 
Figure 1.5 Electron-rich dienes. 
1.4.1 Frontier Molecular Orbitals and the Diels–Alder reaction 
According to frontier orbital theory, it is possible to determine if a pericyclic 
reaction is allowed or forbidden by simply considering the relationship of the 
frontier orbitals of the reactants. The frontier orbitals are the highest occupied 
molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO). 
The interaction between these orbitals, a so-called HOMO-LUMO interaction, is 
a concept that is similar to Lewis acid-Lewis base chemistry, which involves the 
interaction of a filled orbital of the base with an empty orbital of the acid. 
According to this theory, a pericyclic reaction is allowed when the HOMO of one 
reactant has the same symmetry as the LUMO of the other.  
Returning to the Diels-Alder reaction, 1,3-butadiene has four π orbitals, ψ1A, 
ψ2A, ψ3A and ψ4A, with ψ2A being the HOMO. Ethylene has two π orbitals which 
are labelled ψ1B and ψ2B, the latter being the LUMO (Figure 1.6). Figure 1.6 
shows an idealized geometry for the approach of these frontier orbitals in 
parallel planes. The black dashed lines highlight the initiative overlap of the 
terminal lobes of the 4π electron system of the diene and 2π electron system of 
Chapter 1  Introduction 
9 
the dienophiles. This is the origin of the “[4+2]” nomenclature for the 
cycloaddition. Since the HOMO-LUMO interaction shown in (Figure 1.6) 
involves orbitals of the same symmetry, the reaction is allowed; the interaction 
is suprafacial on both components.  
1A
2A
3A
4A
1
2HOMO
3
4
bonding
orbital
interaction
EWG
EDG
6 -electron overlap
Diene
MO
Dienophile
MO
1B
2B LUMO
A
B
 
Figure 1.6 Frontier molecular orbital diagram for diene and dienophile, and 6 π electron 
overlap. 
In an example of a Diels–Alder reaction of (21) with (22) we can see the 
reaction can proceed deriving the endo-product (23) and the exo-product (24) 
(Scheme 1.2).  
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Scheme 1.2 An example of Diels–Alder reaction. 
Endo and exo selectivity is an important consideration in certain Diels–Alder 
reactions. The exo approach would afford the thermodynamically favoured 
product, whereas the endo approach would afford the kinetically favoured 
product. The endo adducts are normally the observed products, which can be 
explained by secondary orbital interactions, shown as red dashed lines (Figure 
1.7). 
 
Figure 1.7 Bonding orbital interactions and secondary orbital interactions diagram. 
1.4.2 Applications Of The Diels–Alder Reaction In The Total Synthesis Of 
Natural Products 
Some significant total syntheses of natural products such as terpenoids, 
steroids, alkaloids and polyketide-derived natural products, have been achieved 
based on the IMDA reaction.18  
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1.4.3  The Diels–Alder Reaction In The Total Synthesis Of 
Isocyanopupukeanane Terpenoid 
2-Isocyanoallopupukeanane (25) belongs to a class of structurally unique 
marine sesquiterpenoids called isocyanopupukeananes. Ho et al.19 used the 
intramolecular hetero-Diels–Alder reaction as a key step in the total synthesis of 
(±)-25 (Scheme 1.3).  
Me
MeO2C
Me
O
O
Br
Me
Me
Me
Me
O
Me
Me
O
Me
H
Me Me
Me
Me
O
OAc
Me
H
Me Me
Me
O
Me
H
Me
Me
CN
CHBr3,
tBuNH2
KOH, C6H6
56%
Tol, 225 C
(sealed tube)
86%
O3, Me2S
-78 C, DCM
89%
2-Isocyanoallopupukeanane
25
26
30
2928
27
7 steps
7 steps
 
Scheme 1.3 Total synthesis of 2-isocyanoallopupukeanane. 
The addition of dibromocarbene to a 5-norbornene-2-carboxylic acid ester (26) 
induced a ring expansion to provide tricyclic lactone (27), which was elaborated 
to bicyclo[3.2.1]oct-2-ene (28), possessing an α,β-unsaturated ketone and a 2-
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methylbutenyl unit as a hetero-diene and a dienophile, respectively. When 28 
was heated, the intramolecular hetero-Diels–Alder reaction proceeded to afford 
cycloadduct (29) with the tricyclic framework required for the further steps in the 
synthesis of isocuanoallopupukeanane. Next, the alkene moiety in 29 was 
cleaved by ozonolysis to give (30). With seven more synthetic operations from 
30, including the introduction of an isocyano group, the total synthesis of (±)-25 
was successfully accomplished. 
1.4.4 The Diels–Alder Reaction In The Total Synthesis Of Batrachotoxin 
Steroid 
The batrachotoxins are a unique class of steroidal alkaloids, isolated in minute 
quantities from the skins of poison arrow frogs and they have been isolated 
from the feathers of a New Guinea bird. Kishi and co-workers20 have achieved 
the total synthesis of (±)-batrachotoxinin A (31) by using an intramolecular furan 
Diels–Alder reaction (Scheme 1.4). 
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Scheme 1.4 Total synthesis of batrachotoxinin A. 
The synthetic precursor (32) of the substrate (33) for the attempted IMDA 
reaction was prepared efficiently from (±)-Wieland–Miescher ketone.21 The 
allylic alcohol 32 was oxidized to terminal enal 33 with MnO2, which smoothly 
underwent an intramolecular [4+2] cycloaddition with the furan moiety. The 
resulting cycloadduct (34), obtained highly stereoselectively, was directly 
subjected to reductive amination and then acetylation, affording a single product 
(35) in good yield.  
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The stereoselectivity of the IMDA reaction was dramatically influenced by the 
C6 substituent (an OTBDMS group). In fact, a C6 deoxy analogue provided the 
corresponding cycloadduct in 3-4:1 diastereoselectivity, while the C6 β-OPMB 
derivative underwent [4+2] cycloaddition with poor (3:2) selectivity. The 
cycloadduct 35 was then transformed into (36) via an intramolecular oxy-
Michael reaction. After further functional group manipulations, (±)-31 was 
eventually synthesised. 
1.4.5  The Diels–Alder Reaction in the Total Synthesis Of Anhydrolycorin-
7-one 
Boger et al. reported the total synthesis of anhydrolycorin-7-one (37), by 
application of one-pot 2-fold IMDA reactions of 2-amino-1,3,4-oxadiazoles 
(Scheme 1.5). The Boger group22 developed the IMDA reactions of 2-amino-
1,3,4-oxadiazoles, tethering an alkenyl functionality, which serves as a 
dienophile. This elaborate strategy was effectively used for the total synthesis of 
37. Thus, the IMDA substrate was subjected to thermal conditions for the 
construction of an advanced intermediate (38) in a single step by heating an N-
functionalized 2-amino-1,3,4-oxadiazole-5-carboxylate (39). The initial [4+2] 
cycloaddition afforded heterocyclic adduct (40), which underwent the loss of 
nitrogen to generate a carbonyl ylide (41). This zwitterionic intermediate then 
aromatized through elimination of methanol, furnishing a furan intermediate 38. 
Then 2-amidofuran 38 underwent a similar IMDA reaction to give (42), followed 
by aromatization with the removal of water, eventually providing (43). The 
conversion of 43 into 37 was achieved by decarboxylation. The Boger group 
employed analogous sequential IMDA reactions of N-acyl-6-amino-1,2,4,5-
tetrazine in the total syntheses of anhydrolycorin-7-one23 and hippadine23. 
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Scheme 1.5 The total synthesis of anhydrolycorin-7-one. 
1.4.6 The Diels–Alder Reaction in the Total Synthesis Of Imerubrin 
Alkaloid 
Lee and Cha24 have used the IMDA reaction of an acetylene-containing 
isoquinoline-derived oxazole (44) in their total synthesis of imerubrine (45) 
(Scheme 1.6) which belongs to the tropoloisoquinoline alkaloid family. The 
IMDA reaction of the substrate 44, which is followed by a retro-Diels–Alder 
reaction with the elimination of hydrogen cyanide, provided a tetracyclic 
compound (46) after the simultaneous removal of the Boc group. Remarkably 
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this cyclization–elimination cascade proceeds smoothly in a one-pot operation 
under thermal conditions in good yield.  
The key [4+3] cycloaddition reaction was achieved by reaction of 46 with α-
methoxy trimethylsyloxyallyl cation (47) generated in situ from ((3,3-
dimethoxyprop-1-en-2-yl)oxy)trimethylsilane by reaction with TMSOTf in 
nitroethane to furnish cycloadduct (48). The same group has also reported the 
total synthesis of (–)-colchicine, a related tropolone alkaloid, using a similar 
strategy.25 
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Scheme 1.6 The total synthesis of imerubrine. 
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1.5  Kondrat’eva Oxazole-Olefin Diels–Alder Reaction 
The Diels–Alder reaction of oxazoles with alkenes is a valuable tool for the 
construction of highly substituted pyridines and it has been exploited for the 
synthesis of numerous compounds, from complex natural products to 
application in the synthesis of pharmaceuticals. 
Kondrat’eva was the first to report the use of an oxazole as an azadiene in a 
Diels–Alder reaction.26,27 The report presented seminal studies on a variety of 
alkyl-substituted oxazoles (49) and their reactions with maleic acid anhydride 22 
in either benzene or ether to provide the cycloaddition products (50) (Scheme 
1.7).  
 
Scheme 1.7 First application of oxazole as azadiene in Diels–Alder reaction by 
Kondrat’eva. 
Unlike the reaction of oxazole with alkynes, this reaction furnished highly 
substituted pyridines instead of furans. This reaction attracted the interest of 
many synthetic chemists and since the publication of Kondrat’eva in 1975 it has 
been applied in the syntheses of various pyridine-containing natural products. 
Chapter 1  Introduction 
18 
1.5.1  The Kondrat’eva Oxazole–Olefin Diels–Alder Reaction: 
Applications In Total Synthesis 
Despite an early recognition of practical value of the Kondrat’eva oxazole-olefin 
Diels–Alder reaction, there are few reports applying this cycloaddition in an 
intramolecular fashion to the synthesis of pyridine-containing natural products.  
The first report of an intramolecular Diels–Alder cycloaddition of an oxazole with 
an alkene in the context of total synthesis was from Weinreb and Levin28 at 
Pennsylvania State University. As a target to test the feasibility of the IMDA 
cycloaddition, they chose the unusual azaphenanthrene alkaloid eupolauramine 
(51). As starting materials, o-anisic acid (52) and ethanolamine were used. The 
oxazole intermediate (53) was achieved in 5 steps. Unsaturated ester 53 then 
was refluxed under nitrogen for 3 h at 0.014 M in DCB. Two tricyclic 
hydroxypyridines (54) and (55) were obtained in a 1:1.7 ratio in 67% total yield 
(Scheme 1.8).  
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Scheme 1.8 The total synthesis of eupolauramine. 
Compounds 54 and 55 probably arise via Diels–Alder adduct (56) which 
undergoes oxidative fragmentation through the hydride elimination pathway. 
Weinreb and Levin had an initial assumption that either traces of oxygen which 
were present during the IMDA reaction and/or the solvent itself were 
responsible for the oxidative fragmentation of the cycloadduct 56. Thus, 
cycloaddition reactions were performed using ethylbenzene, bromobenzene, 
and o-dichlorobenzene as a solvent after thoroughly degassing each with 
argon. In every case, however, the 3-hydroxypyridines 54 and 55 were the sole 
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products of the IMDA reactions. The only effect of changing solvent appeared to 
be a decrease in the relative amount of the decarboxylated pyridinol 55 
obtained when the reaction was run at a lower temperature. For example, the 
ratio of 54 to 55 changed to 4.4:1 (70% total yield) when bromobenzene was 
used as the reaction solvent. It would appear the oxygen is at least partly 
responsible for the oxidative decomposition of cycloadduct 56. In the absence 
of oxygen the Diels–Alder adduct must follow other degradative pathways, 
possibly involving disproportionation.  
In 1968 Colin patented a synthesis of isonicotinic acid esters and 
isonicotinonitriles via the Diels–Alder reaction of oxazoles with acrylic esters or 
acrylonitrile in the presence of triethylamine.28 It seemed reasonable that the 
triethylamine might function by accelerating the elimination of water from the 
initially formed Diels–Alder cycloadduct. Weinreb and Levin reasoned that the 
use of a non-nucleophilic base in the Diels–Alder reaction of compound (57) 
might increase the rate of the loss of water from cycloadduct 56 relative to that 
of the oxidative fragmentation, thereby providing the desired annelated pyridine 
57 instead of 3-hydroxypyridines. Indeed, when Diels–Alder precursor 53 was 
refluxed in o-dichlorobenzene for 16 h with 0.75 equivalents of 1,5-
diazabicyclo[4.3.0]non-5ene, only the desired tricyclic pyridine ester 57 was 
produced in 76% yield.  
Ohba and co-workers29 have achieved the total synthesis of the Rauwolfia 
alkaloids suaveoline (58) and norsuaveoline (59) using the Kondrat’eva reaction 
(Scheme 1.9). To achieve the synthesis of suaveoline and norsuaveoline, which 
have an ethyl group at the 20-position, the authors used a commercially 
available amino ester (60). Over 7 steps the aldehyde (61) was prepared and 
then a Wittig reaction was carried out using the phosphorane prepared from n-
propyltriphenylphosphonium bromide and t-BuOK, furnishing the (Z)-olefin (62) 
in a good yield. Addition of Cu(OTf)2 failed to give cyclisation product due to 
rapid decomposition, although the same group reported that this Lewis acid 
promoted a comparable cycloaddition leading to cyclopenta[c]pyridines.30 
However, treatment of the olefin 62 in DCB at 160 oC in the presence of 1.50 
Chapter 1  Introduction 
21 
equiv. of 1,5-diazabicyclo[4.3.0]non-5ene, an application of Weinreb’s 
procedure, improved slightly the yield of the product. Furthermore, alteration of 
the solvent from DCB to xylene raised the yield of cycloaddition product to 50%. 
By the use of 5.00 equiv. of 1,5-diazabicyclo[4.3.0]non-5ene, the pyridine (63) 
was obtained in 65% yield. Ultimately, treatment of the key intermediate 62 with 
20.00 equiv. of 1,5-diazabicyclo[4.3.0]non-5ene in refluxing xylene gave desired 
pyridine 63 in 69% yield as the best result. It is likely that 1,5-
diazabicyclo[4.3.0]non-5ene might serve as a scavenger of water and promote 
the conversion of the initially formed Diels–Alder cycloadduct into the pyridines.  
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Scheme 1.9 Total synthesis of suaveoline and norsuaveoline. 
Methylation of 63 with MeI was performed in the presence of NaH in DMF, 
affording the indole Nα-Me derivative and finally removal of the Boc protecting 
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group in trifluoroacetic acid gave target compound 58 in 82% yield and 
deprotection of 63 gave norsuaveoline in 88% yield. 
(–)-Normalindine (64) was reported for the first time as one of the many 
alkaloids isolated from the root bark of Strychnos johnsonii (Loganiaceae) by 
Massiot et al. in 1987.31 The initial step in its subsequent total synthesis by 
Ohba at al. was N-alkylation of L-alanine methyl ester (65) with 2-(3-indolyl)ethyl 
bromide (Scheme 1.10). The amino esters (66) and (67) were obtained as a 3:1 
diastereomeric mixture over 8 steps.32,33  
With a view to introducing an olefinic dienophile into the amino esters 66 and 
67, the above 3:1 mixture was treated with DIBAL-H at –78 °C in DCM, followed 
by the Wittig reaction with ethyl(triphenylphosphoranylidene)acetate in a one-
pot procedure. A 3:1 mixture of the (E)-esters (68) and (69) and a 3:1 mixture of 
(Z)-esters (70) and (71) were obtained in 59% and 26% overall yields.  
After successful syntheses of the oxazole-olefin derivatives, the group explored 
IMDA reactions. The best result was obtained by heating the 3:1 mixture of (E)-
isomers 68 and 69 in refluxing toluene for 24 h. Under these conditions, the 
adducts (72) and (73), both having α- configuration for the C(13b) proton, were 
produced in 53% and 5% yields, respectively. Addition of Lewis acids such as 
Eu(fod)3 and Yb(OTf)3, failed to improve the yields of the adducts 72 and 73. 
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Scheme 1.10 Key step in total synthesis of normalindine. 
Treatment of 68 and 69 in DCB at 150 °C in the presence of 1,5-
diazabicyclo[4.3.0]non-5ene, an application of Weinreb’s procedure, resulted in 
a retro-Michael reaction. In a similar fashion, the 3:1 mixture of the (Z)-isomers 
70 and 71 afforded the adduct (74) in 40% yield. No adducts arising from the 
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minor diastereomers 69 and 71 were obtained. Conversion of three adducts 72, 
73, and 74 into pyridine derivatives was then investigated (Scheme 1.11). 
 
Scheme 1.11 Final steps in total synthesis of normalindine. 
On treatment with 1,5-diazabicyclo[4.3.0]non-5ene in refluxing toluene for 10 h, 
the adduct 72 underwent a retro-Diels–Alder reaction and no product 
possessing the desired skeleton was obtained. However, the C(2)-O bond 
cleveage of 72 was found to be facile upon exposure to AcOH at room 
temperature for 1 h, affording the diol (75) in 77% yield with concomitant 
addition of water to the imino group. The desired ester (76) was eventually 
obtained in 18% yield, accompanied by recovered 75 (62%). Under these 
conditions, the adduct 74 gave results analogous to those obtained from 72. 
Alkaline hydrolysis of 76 with LiOH followed by the modified Curtius 
rearrangement34 using diphenyl phosphoroazide furnished the carbamate 
compound, which finally was converted to the target compound 63 by treatment 
with TFA and subsequent reductive deamination of the resulting arylamine with 
butyl nitrite in DMF.  
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1.6 Effect Of Copper (II) trifluoromethanesulfonate On The Intramolecular 
Diels–Alder Reaction Of Oxazole-Olefins 
Ohba and co-workers35 reported total syntheses of the monoterpene alkaloids 
(–)-plectrodorine (77) and (+)-oxerine (78) (Scheme 1.12), possessing a 
cyclopenta[c]-pyridine ring system. The yields of the IMDA reactions of the 
oxazole-olefins 79 and 80, exploited as a key step of the synthesis, were 
significantly low.  
 
Scheme 1.12 Total synthesis of monoterpene alkaloids (–)-plectrodorine and (+)-oxerine. 
This led the group towards investigation of the effect of Lewis acids on the 
corresponding cycloaddition of the dimethyl substituted derivatives (83) and (85) 
(Scheme 1.13).30 The requisite oxazole-olefins 83, (84), 85 and (86) were 
prepared from lactones (87) and (88) according to their previous procedure for 
79 and 80.35 With four model oxazole-olefins 83–86 in hand, Ohba and co-
workers firstly examined the IMDA reaction of 83 in detail. Heating a 0.05 M 
solution of 83 in DCB at 150 °C under argon for 24 h provided the cyclopenta[c]-
pyridine (89); the yield however was only 21%. Although Weinreb used 1,5-
diazabicyclo[4.3.0]non-5ene successfully in intramolecular oxazole-olefin Diels-
Alder reactions,28 no formation of 89 was observed in the presence of the 
amidine. As the first example of Lewis acid catalysis of oxazole-olefin 
cycloadditions, Levin recorded the results of investigation on the effect of 
europium salts.36 In the case of 83, however, addition of Eu(fod)3 failed to 
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improve the yield of 89. Fortunately, several metal trifluoromethanesulfonates, 
such as Yb (III), Sc (III) or Cu (II) proved to be effective promoters of the 
cycloaddition of 83. The best result was obtained by heating 83 in DCB in the 
presence of 2 mol% of copper (II) trifluoromethanesulfonate at 180 °C for 1 h; 
under these conditions 89 was produced in 55% yield. 
4 s
tep
s
4 steps
 
Scheme 1.13 Lewis acid effect on IMDA oxazole olefin cycloaddition reactions. 
A dramatic rate enhancement was observed for the cycloaddition of 85 
possessing an ester group on the terminal olefin when a catalytic amount of 
Cu(OTf)2 was employed. In the absence of the catalyst, (90) was obtained in 
only 15% yield together with unaltered 85 (73%) after 24 h at 150 °C, whereas 
smooth cycloaddition occurred in the presence of 2 mol% of Cu(OTf)2 giving 90 
in 95% yield after 30 min. Addition of Eu(OTf)3 again failed to effect any 
improvement. Under the influence of 10 mol% of Cu(OTf)2, the above reaction 
proceeded even at higher temperature, reflux in DCB.  
Finally, the Ohba group focused their attention on the IMDA reaction of the 
unsubstituted substrates 84 and 86. As compared with the dimethyl substituted 
compounds, the cycloaddition of 84 and 86 turned out to be apparently slow 
and less effective. Thus, heating a 0.05 M solution of 84 in o-DCB at 180 °C for 
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24 h produced (91) in a poor (6%) yield along with unaltered 84 (30%). Even in 
the presence of copper (II) trifluoromethanesulfonate (10 mol%), the yield of 91 
remained low after 8 h (24%). Although this cycloaddition was somewhat 
promoted by the introduction of the ester group on the terminal olefin of 86, the 
yield of (92) was moderate (42%). 
Ohba and co-workers clarified that the IMDA reaction of 83 and 85 are 
considerably accelerated in the presence of copper (II) 
trifluoromethanesulfonate to provide cycloaddition products in moderate to 
excellent yields. The large enhancement, namely a “gem-dimethyl effect” or 
Thorpe–Ingold effect37, observed for the dimethyl substituted substrates 83 and 
85 may be explained in terms of the “reactive rotamer effect” described by 
Jung.38 
1.7  Total Syntheses Of Complanadine A 
In 2010, two independent research groups simultaneously reported the first total 
syntheses of complanadine A. Fisher and Sarpong39 and Siegel and co-
workers40 employed entirely different approaches, which are discussed 
separately below. 
1.7.1 Fisher and Sarpong’s Total Synthesis of Complanidne A 
Fisher and Sarpong’s approach employed an iridium-catalysed pyridine C-H 
functionalisation41 as a key step. The authors envisaged that a powerful 
simplification of the synthesis would entail formation of (93) and (94) from an 
intermediate such enamide (95). The enamide was in turn envisaged to arise 
from acid-promoted formal cycloaddition of (96) and (97) following the 
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precedent of Schumann for the synthesis of racemic N-desmethyl-α-obscurine 
(Scheme 1.14).42 
 
Scheme 1.14 Retrosynthetic analysis of Complanadine A by Fisher and Sarpong. 
They commenced the synthesis with the preparation of the ketal (98) from (+)-
pulegone (99) using literature procedures over 7 steps (Scheme 1.15). 
 
Scheme 1.15 Preparation of the ketal 98. 
Chapter 1  Introduction 
29 
Enamide 97 was hydrolysed with perchloric acid to generate the reactive enol 
tautomer (101) (Scheme 1.16). The addition of the ketal 98, which is 
deprotected in situ, initiated the N-desmethyl-α-obscurine cascade (102) 
proceeding by a series of cyclisations (via 103 and 104).  
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Scheme 1.16 The N-desmethyl-α-obscurine cascade. 
Boc protection of 102 was followed by oxidation to the pyridone with lead 
tetraacetate. Subsequent triflation then furnished derivative 64, which was 
converted to Boc-protected lycodine (105) after removal of the triflate using Pd-
catalysed reducing conditions (Scheme 1.17). 
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Scheme 1.17 Suzuki cross-coupling of the boronic ester and the triflate. 
The conversion of 94 to 105 was achieved in a single step. The Ir(I)-catalysed 
borylation chemistry yielded the boronic ester 93. Finally Suzuki cross-
coupling43-45 of boronic ester 93 and triflate 94 followed by cleavage for the Boc 
protecting group the complanadine A 4 in 42% yield. 
1.7.2 Siegel’s total synthesis of the Complananidne A 
Siegel and co-workers took a markedly different approach to the synthesis of 
complanadine A. They envisaged the pseudosymmetry of the molecule could 
be accessed by implementation of a metal mediated [2+2+2] + [2+2+2] 
Chapter 1  Introduction 
31 
sequence using a substituted diyne (106) and two equivalents of the 
corresponding alkyne-nitrile (107) (Scheme 1.18). 
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Scheme 1.18 Synthetic disconnections of Complanadine A by Siegel. 
They began the synthesis of the required alkene-nitrile 107 from the enolate of 
thioether (109), reacting with 3-iodopropyl acetate (Scheme 1.19). Further 
oxidation with m-CPBA and a mild sulfoxide elimination derived enone (110). 
Treatment of the enone 110 with the anion of trimethylsilyl acetonitrile produced 
the Michael adduct as a mixture of diastereomers, but after desilylation with 
cerium fluoride, the desired diastereomer (111) was easily separated. 
Diastereoselective delivery of ethynylmagnesium chloride into the ketone 
cleanly provided the corresponding propargyl alcohol (112) as a single isomer. 
Activation of the alcohol 112 as the corresponding acetate provided a precursor 
for a copper mediated amination reaction. Further reaction of 112 with 
benzylamine and substoichiometric amount of CuCl delivered the propargyl 
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amine (113) in a high yield with complete diastereoselectivity. Transformation of 
the secondary amine 113 into the desired alkyne-nitrile 107 was accomplished 
over 2 steps (Scheme 1.19). 
 
Scheme 1.19 Synthesis of the alkyne-nitrile 107. 
The first [2+ 2+2] cycloaddition of the alkyne-nitrile 107 and bis(trimethylsilyl)-
butadiyne (114) proceeded smoothly, heating the mixture of the two in the 
presence of CpCo(CO)2, deriving the desired cyclisation product (115) as the 
main regioisomer (Scheme 1.20). However, after a series of trials and a variety 
of conditions, pyridyl-alkyne 115 did not undergo the second [2+2+2] 
cycloaddition with the alkyne-nitrile 107.  
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Scheme 1.20 [2+2+2] cycloaddition of the alkyne-nitrile and bis(trimethylsilyl)butadiyne. 
Removing both TMS groups produced a derivative that was too reactive and 
which led to decomposition upon attempted [2+2+2] cyclisation. The 
monosilylated alkyne (117) in a reaction with alkyne-nitrile 107 under the same 
conditions resulted a single compound, the symmetric 2,2’-bipyridyl (118) rather 
than the desired 2,3’-bipyridyl isomer (Scheme 1.21). 
 
Scheme 1.21 Synthesis of the 2,2’-bipyridinyl 118. 
The authors state that after ‘significant experimentations’ they found that using 
the formyl protecting group on the alkyne-nitrile (119) and in the presence of the 
PPh3, they achieved a remarkable switch in regioselectivity and accessed the 
desired compound (120) as the major isomer (1:3, 120/121) (Scheme 1.22). 
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The authors state that the ability of triphenylphosphine to alter the 
regioselectivity ‘warrants further study’. 
 
Scheme 1.22 Second [2+2+2] annulation of the formyl protected alkyne-nitrile 119 and the 
pyridyl-alkyne 117. 
Further fluoride mediated removal of the TMS group, debenzylation by 
hydrogenolysis and subsequent deformylation using hot acidic methanol 
solution generated (+)-complanadine A 4 (Scheme 1.23).  
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Scheme 1.23 Final steps to complanadine A. 
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2. RESULTS AND DISCUSSION I 
2.1  Retrosynthetic Analysis of Complanadine A 
The first total synthesis of racemic lycodine 9 was reported by Heathcock46,47 
based on an intramolecular Mannich condensation strategy, in which sequential 
construction of the three aliphatic rings preceded the final major event, 
formation of the pyridine from a 1,5-dicarbonyl. A different approach using a 
pyridine based starting material was published in 2010 by Tsukano and 
Hirama.48 Their stereoselective total synthesis of lycodine proceeded via use of 
Diels–Alder and intramolecular Mizoroki–Heck reactions, starting with methyl 3-
hydroxy-2-pyridinecarboxylate.  
The key reaction in our proposed synthesis is an intramolecular Kondrat’eva 
oxazole–olefin hetero-Diels–Alder reaction.26,27,49 This reaction furnishes 
substituted pyridines (122) via ring opening of adduct (123) and loss of water 
from (124) (Scheme 2.1). 
 
Scheme 2.1 Intramolecular Kondrat'eva oxazole–olefin hetero-Diels–Alder reaction 
mechanism. 
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In the context of lycopodium alkaloids this is a powerfully simplifying 
disconnection, as 9 may thus be accessed from a trans-fused azabicycle (127) 
to which is appended an oxazole and a vinyl group (Scheme 2.2).  
 
Scheme 2.2 Kondrat’eva reaction disconnection of lycodine. 
In the heterodimeric series, complanadine A 4 is proposed to be accessed from 
a precursor (128) containing a central bis(oxazole) core linked to two equivalent 
bicyclic fragments (129). This in turn is constructed by sequential alkylation of 
the mono-protected bis(oxazole) (130) core (Scheme 2.3). 
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Scheme 2.3 Initial disconnection of complanadine A by Kondrat’eva reaction. 
The desired 2,3'-bipyridyl linkage derives from the connectivity in the 
bis(oxazole) 130 core. The use of the Kondrat'eva pyridine formation in total 
synthesis is well-precedented; in the intramolecular mode, a four-atom linker 
between diene and dienophile has been determined to be optimal26-29,33,50 as in 
the case here. In 127 both diene and dienophile are required to be axial for 
pyridine formation – this corresponds to the trans-decalin chair-chair 
conformation (131) (Scheme 2.4). 
 
Scheme 2.4 Decalin conformers. 
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The use of this key transformation at such a late stage in the forward synthesis 
is potentially a high-risk strategy. Accordingly, we decided to mitigate this risk 
by carrying out a model study. To prove the viability of the intramolecular 
hetero-Diels–Alder cyclisation, we aimed to prepare a pyridine precursor in 
which the diene and dienophile would have the same spatial arrangement and 
electronic properties as in the real system. However, by omitting functionality 
which was not anticipated to affect directly the cyclisation, we would be able to 
access the pyridine precursor more rapidly. Accordingy, we aimed to retain the 
trans-decalin backbone, but to remove the endocyclic nitrogen and the methyl 
group. We also did not consider absolute stereochemistry, but targeted a 
racemate.  Model substrate (133) would be quickly accessible by means of 
Michael addition to α,β-unsaturated ketone (134) providing vinyl derivative 
(135); further functional group transformations would give oxazole (137), which 
when subjected to IMDA conditions would furnish the model pyridine 133 
(Scheme 2.5). The reaction highlighted in orange indicates our key 
intramolecular Kondrat’eva oxazole–olefin hetero-Diels–Alder reaction.  
 
Scheme 2.5 Proposed 1st generation approach. 
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2.2  Synthetic Results for Model System 
2.2.1  Enone Functionalisation Approaches 
To access ketone (138) from commercially available cis-decahydronaphthalen-
1-ol (139), the Swern oxidation51 was used, providing the product in high yield 
(Scheme 2.6). Halogenation of ketone 138 with sulfuryl chloride afforded 
desired product (140). Further thermal dehydrohalogenation of the chloroketone 
140 with collidine at 135 °C furnished desired ketone 134 in 23% yield.  
 
Scheme 2.6 Synthesis of α,β-unsaturated ketone 110. 
A test reaction of conjugate addition to a structurally similar 2-cyclohexen-1-one 
(141) suggested use of 2 equiv. of vinylmagnesium bromide and 0.5 equiv. of 
Cu (I) salt to give the highest percentage of desired Michael addition product. 
Using these conditions, the reaction of ketone 134 with vinylmagnesium 
bromide in the presence of copper bromide–dimethyl sulfide complex 
proceeded via 1,2 addition, providing the alcohol (143) as the sole product 
(Scheme 2.7). 
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Scheme 2.7 Michael addition of vinylmagnesium to α,β-unsaturated ketone 110. 
Acid catalysed isomerisation of vinyl alcohol 143 occurred during column 
purification, giving the (144) in 24% yield. A possible isomerisation mechanism 
is proposed below (Scheme 2.8). It was interesting to observe differences in the 
spectra of the crude and the product after column. Characteristic vinyl group 
proton resonances were observed in both cases. However, the isomerised 
compound has a conjugated diene system, which results in the vinyl CH2=CH- 
proton signal shifting downfield by approximately 1 ppm. 
 
Scheme 2.8 Possible isomerisation mechanism of 143. 
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The unsuccessful synthesis of ketone 135 via cuprate addition to the α,β-
unsaturated system led us to considerer of a radical vinylation, using 
methodology developed by Zard52, which required use of β-iodoketone (149) 
and ethylsulfonylethene (155) as vinyl radical source (Scheme 2.9). This was 
also unsuccessful. 
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Scheme 2.9 Possible radical vinylation of β-iodoketone 149 by Zard and the mechanism 
of the reaction. 
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We next considered other two-step procedures to form 135, by means of other 
enone β-functionalisation protocols. Attempts to synthesise ketone 149 using 
methodology reported by Marx53 wherein tetraalkyl ammonium iodides react 
with enones in trifluoroacetic acid at rt to give β-iodoketones were not 
successful and only starting material was recovered. A report from Miller and 
McKean54 on preparation of β-iodoketones, utilizes low temperature 1,4-addition 
of trimethylsilyliodide to enones to give the intermediate iodo TMS enol ethers, 
followed by hydrolysis of these to the β-iodoketones. Unfortunately in our case 
only starting material was recovered. Attempts accessing the β-bromoketone by 
bubbling HBr gas through a solution of 134 in DCM were fruitless as well. 
After the failure to synthesise the desired vinyl ketone 135, we examined the 
addition of allylmagnesium bromide in order to effect a 1,2 addition to the 
ketone 134. This would provide allyl alcohol (160) which should undergo an 
oxyanion-Cope rearrangement,55 so providing (161), which possesses the 
desired quaternary centre (truncation of the side chain would then be explored) 
The allylation of 134 gave alcohol 160 in 41% yield (Scheme 2.10). During 
column purification 150 underwent elimination of water deriving (162). Attempts 
to induce the rearrangement using KH and 18-crown-6 in THF failed. 
Surprisingly, some form of retro-allylation occurred and ketone 134 was 
recovered after column purification in 47% yield. Use of ortho-xylene as solvent 
and elevated temperature resulted in the same outcome. 
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Scheme 2.10 Allylation of ketone 134 and attempted oxyanion-Cope rearrangement. 
Concurrently with the reactions described above, approaches towards oxazole 
137 were examined.  
Known methods for synthesis of 2-substituted-4,5-unsubstituted oxazoles are 
either indirect, low yielding or require expensive reagents. Polniaszek et al.56 
have reported the synthesis of 2-substituted oxazoles (163) from acetamides 
(164) where bromine was changed to a substituted phenyl group, which is 
similar to the α-bromo derivative (165) required for our purposes. Cyclization 
using Eaton’s reagent57 (phosphorus pentoxide, 7.7 wt.% solution in 
methanesulfonic acid) afforded oxazoles in moderate yield (Scheme 2.11). 
 
Scheme 2.11 Polniaszek's synthesis of 2-substituted oxazoles. 
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In order to access 137, acetamide 136 was required. This should be accessible 
by means of an olefination of the ketone 135 with the phosphorus ylide derived 
from (166). Synthesis of triphenylphosphonium bromide 166 commenced with 
reaction of α-bromoacetic acid (167) with aminoacetaldehyde dimethyl acetal 
(168) to give 2-bromo-N-(2,2-dimethoxyethyl)acetamide 165 in 67% yield 
(Scheme 2.12). 
 
Scheme 2.12 Synthesis of triphenylphosphonium bromide 166. 
Acetamide 165 was then reacted with triphenylphosphine to form 
triphenylphosphonium bromide 166 in 54% yield. Attempted Wittig reactions58 of 
166 with cyclohexanone as a test reaction using different bases were not 
satisfactory. Only traces of the desired olefination product were observed by 1H-
NMR. Accordingly, the Horner–Wadsworth–Emmons reaction59,60 using 
phosphonoacetamide (169) was then explored. 
Synthesis of α,β-unsaturated amides from amide-containing phosphonates via 
Horner–Wadsworth–Emmons reactions has been reported by Ordóñez et al.61,62 
The viability of the reaction in the presence of a free amide N-H is illustrated 
(Scheme 2.13). They successfully accomplished syntheses of various α,β-
unsaturated amides employing the Masamune–Roush procedure63. 
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Scheme 2.13 Horner–Wadsworth–Emmons reaction of phosphonamides with free N-H, as 
reported by Ordóñez. 
The required phosphonoacetamide 169 was synthesized by the Michaelis–
Arbuzov reaction64,65 of 2-bromoacetamide 165 with trimethylphosphite under 
reflux (Scheme 2.14).  
 
Scheme 2.14 Synthesis of the phosphonoacetamide 169 through Michaelis–Arbuzov 
reaction. 
The viability of the reaction was tested using cyclohexanone (170) as substrate, 
employing the Masamune–Roush modification. The reaction furnished α,β-
unsaturated amide product (171) in moderate yield (Scheme 2.15). 
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Scheme 2.15 HWE reaction of the phosphonoacetamide 169 using the Masamune–Roush 
procedure. 
The viability of oxazole formation using Polniaszek’s conditions56 was tested 
using milder cyclisation conditions - treating acetamide 165 with trifluoroacetic 
acid (Scheme 2.16). All starting material was consumed within 30 min, but the 
reaction did not furnish the oxazole ring as desired. Instead, the starting 
material was hydrolysed to aldehyde (173). 
 
Scheme 2.16 Attempted synthesis of 2-(bromomethyl)oxazole 172. 
2.2.2  The Baddeley reaction 
The unsuccessful attempts at accessing the vinyl ketone 135 by means of 
conjugate addition or oxyanion-Cope rearrangement led us instead to examine 
the literature and identify compounds which possessed the required substitution 
at positions 1 and 4a of the decalin skeleton (174) (Figure 2.1):  
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Figure 2.1 Desired substitution pattern of the decalin system. 
The literature contains reports describing the interaction of decalin (175) and 
the Friedel–Crafts acetylating agent.66-70 Interaction of decalin and acetyl 
chloride at a temperature of 10 °C or lower, with an excess of the acid chloride 
and aluminium chloride furnishes 10β-vinyldecalin 1β,1'-oxide (176) in 35-40% 
yield (see Scheme 2.18). This attracted our interest as it possesses the 
requisite substituent pattern including a substituent at the ring junction (C4a), 
which we were not able to access before. 
Consideration of the synthetic utility of this “Baddeley reaction” led to the 
conception of a 2nd generation approach (Scheme 2.17). This approach 
commences with the use of commercially available and cheap starting 
materials: decalin, AlCl3 and acetyl chloride, to form the enol ether 176. 
Hydrolysis of 176 to access the hydroxy ketone (177) is reported. This would be 
followed by protection of the alcohol to form (178) and reduction to derive 
alcohol (179). Transformation of the alcohol to the tosylate (180) and a 
subsequent elimination would give alkene (181). Deprotection of vinyl derivative 
181 and oxidation of the alcohol (182) would lead to formation of the vinyl 
ketone 135 which then could be used in further steps as per the proposed 1st 
generation route. 
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Scheme 2.17 2nd Generation model system via decalin acylation. 
The synthesis of the vinyl ether 176 was repeated using the exact procedure 
given in the publication. The crude was distilled and additionally purified by 
refluxing the distillate with lithium aluminium hydride in dry ether to give pure 
vinyl ether in 25% yield (Scheme 2.18). In the original paper the reaction was 
performed on 712 g scale; we reproduced it up to 176 g of substrate. At the time 
of the original publications, all structural assignments were made by means of 
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IR, elemental analysis and degradation/chemical correlation, as no NMR was 
available. We were able to confirm the structure using NMR and mass 
spectrometry data. 
 
Scheme 2.18 Baddeley acylation of decalin. 
The mechanism we propose for this unusual Friedel–Crafts ‘aliphatic acylation’ 
is shown in Scheme 2.19. The reaction would begin with formation of an 
acylium cation, which would then act as a hydride abstractor on decalin 175, 
forming tertiary decalin cation (183) and liberating acetaldehyde. Through loss 
of a proton, cation 183 would form ∆9,10-octalin (184). Alkene 184 would then 
react with a second equivalent of acylium cation, forming Friedel–Crafts 
acylation intermediate (185). We next propose a [1,2] hydride shift transforming 
intermediate 185 from a tertiary to a secondary cation (186), which then would 
cyclise to form oxonium intermediate (187). Finally, loss of proton would afford 
the observed vinyl ether 176.  
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Scheme 2.19 Proposed acylation mechanism of decalin. 
Acid hydrolysis of the vinyl ether 176 can give two ring opening products. The 
action of dilute sulfuric acid to 176 in diethyl ether gives the required product 
177 in which the C1 hydroxyl and C4a methyl ketone are cis.  
 
Scheme 2.20 Synthesis of the hydroxyl-ketone 177, via acidic ring opening of 176. 
The ring opening reaction in the presence of diethyl ether gave crystalline 
desired hydroxyl-ketone 176 in 51% yield (Scheme 2.20). The relative 
stereochemistry of the cis- product was determined by X-ray crystallography 
(Figure 2.2).  
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Figure 2.2 ORTEP diagram of 177, ellipsoids at 50% probability. Selected H atoms are 
shown as spheres of arbitrary radius. 
Gentle reflux of the vinyl ether in dilute sulfuric acid, in presence of diethyl ether, 
undergoes ring opening reaction via a typical enol ether hydrolysis mechanism 
(Scheme 2.21). However ring opening by refluxing in a dilute aqueous acid in 
absence of organic solvent (and hence at a higher temperature) goes via an 
SN2 mechanism giving the trans- product.  
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Scheme 2.21 Ring opening mechanism of the vinyl ether 176 under mild conditions. 
Interestingly, the ring opening reaction could never be induced to go to 
completion and yields were never higher than 51%. The idea of a reversible 
process was then considered. Pure hydroxyl ketone 177 was resubjected to the 
same reaction conditions as for the enol ether hydrolysis. After refluxing it for 
several hours, characteristic peaks of vinyl ether 176 were detected by proton 
NMR. This confirmed the ring opening reaction of the 176 is reversible.  
In order to effect conversion of the functionality in 177 to the desired vinyl 
ketone 135, alcohol protection as a silyl ether was required. The desired 
OTBDMS product (191) was formed in excellent yield (Scheme 2.22). Further 
reduction with DIBAL-H furnished (192) as a single diastereomer in 70% yield. 
In order to assign the relative configuration of newly formed stereocentre, silyl 
ether 191 was reduced with LiAlH4 followed by an acidic workup, resulting a 
mixture of two diastereoisomeric diols (193) and (194). The major diol 193 was 
formed in a ratio of 12.6:1 to the 194 and was identical to the material produced 
by deprotecting silyl ether 192 with TBAF in 81% yield. 
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Scheme 2.22 Synthesis of the diols 193 and 194. 
The relative stereochemistry of 193 was established by X-ray crystallography 
(Figure 2.3). 
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Figure 2.3 ORTEP diagram of 193, ellipsoids at 50% probability. Selected H atoms are 
shown as spheres of arbitrary radius. 
Attempts to sulfonylate the alcohol 192 in order to effect elimination to the 
desired vinyl derivative were not successful (Scheme 2.23), most likely due to 
the poor accessibility of the neopentylic hydroxy group.  
 
Scheme 2.23 Attempts to sulfonylate the alcohol 192. 
2.2.3  Shapiro reaction 
An alternative approach to access the vinyl moiety in the target system was 
required, which led us to modify the 2nd generation approach. The 3rd 
generation approach (Scheme 2.24) uses the same hydroxy ketone 177 to 
access a sulfonylhydrazone (197), which could be transformed to the target 
vinyl alcohol 182 by means of a Shapiro reaction.71 The alcohol 182 could then 
be oxidised to the corresponding ketone 135 and be used in further steps as 
envisaged for the 1st and 2nd generation approaches. Steps highlighted in blue 
indicate reactions previously accomplished.  
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Scheme 2.24 3rd generation approach via Shapiro reaction. 
Treatment of hydroxy ketone 177 with mesitylenesulfonylhydrazide in the 
presence of a catalytic amount of p-TSA afforded hydrazone (199) in 86% yield 
(Scheme 2.25). Reaction of 177 with p-toluenesulfonylhydrazide under the 
same conditions yielded the corresponding hydrazone (200) in good yield, 
however separation of this product from the reaction mixture proved to be more 
challenging due to the solubility of the product. 
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Scheme 2.25 Formation of hydrazones 189 and 190. 
As vinyl ether 176 undergoes a ring opening reaction under acidic conditions 
producing hydroxy ketone 177, and hydrazone formation also involves acidic 
catalysis, the idea of a one pot synthesis of 199 from 176 occurred. It was found 
that the reaction indeed proceeded smoothly, using 10 mol% of p-TSA, giving 
hydrazone 199 in 66% yield (Scheme 2.26). Successful formation of 
hydrazones provided substrates for the Shapiro reactions. The first attempt at 
the reaction of 199 in THF involved exposing it to three equiv. of n-butyllithium, 
followed by protic quench and dilution of the reaction mixture with EtOAc, which 
led to inadvertent acetylation of the formed vinyl alcohol to give (201) in 66% 
yield as the sole product (Scheme 2.26). Repeating the reaction using water-
immiscible diethyl ether as reaction solvent in place of THF, followed by protic 
workup, produced vinyl alcohol 182 in excellent 99% yield. Three equivalents of 
base were needed due to the presence of a free hydroxy group. Hydrazone 200 
yielded the alcohol 182 in lower yield due to the presence of impurities 
(unreacted tosylsulfonylhydrazide) in the substrate. From vinyl alcohol 182, vinyl 
ketone 135 was accessed by Swern oxidation, delivering the product in 99% 
yield. 
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Scheme 2.26 Synthesis of vinyl ketone 135 via Shapiro reaction. 
Access to the vinyl ketone 135 provided the opportunity to realize the olefination 
step envisaged in the 1st and 2nd generation approaches. To access olefin 
(202), ketone 135 was employed in HWE conditions with phosphonoacetamide 
169. None of the attempted conditions gave the desired α,β-unsaturated amide 
202. Changing the temperature, reaction time, or base, or use of DBU and LiCl 
as per the Masamune–Roush modification63 did not produce the olefination 
product. When butyllithium was used, an undesired 1,2 addition of the butyl 
fragment occurred, generating (203) (Scheme 2.27). Use of non-nucleophilic 
NaH did not afford any product. 
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Scheme 2.27 HWE reaction of the phosphonoacetamide 169. 
It was decided to employ a less functionalised phosphonate in the Horner–
Wadsworth–Emmons reaction, with the intention of introducing an oxazole 
precursor in additional, subsequent steps. Thus, the phosphonoacetamide 169 
was changed to methyl 2-(dimethoxyphosphoryl)acetate (204). After 
deprotonation with n-BuLi and reflux for 64 h, the reaction afforded the desired 
product, alongside formation of the epimerised material (205). During the reflux 
under basic conditions, decalinone ring isomerisation occurred whereby the 
trans-decalin ring epimerised to cis-decalin (210) (Scheme 2.28) which then 
underwent reaction with the phosphonate nucleophile to form the epimerised 
product. 
 
Scheme 2.28 Trans- to cis- epimerisation of vinyl ketone 135. 
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As the separation of α,β-unsaturated esters was not possible by means of 
chromatography, it was decided to carry the mixture forward to the reduction 
step and separate the products later in the synthesis. Common reducing agents 
such as NaBH4 and L-selectride did not effect conjugate reduction of the 
unsaturated ester 205 (Scheme 2.29). LiAlH4 reduction did not favour 1,4 
addition of the hydride and instead derived the alcohols 206 as anticipated. 
 
Scheme 2.29 HWE reaction of methyl 2-(dimethoxyphosphoryl)acetate 204. 
Hudlicky et al.72 published the successful reduction of α,β-unsaturated esters 
using single electron transfer (SET) employing Mg in MeOH. The reaction with 
unsaturated ketone 205 was successful. However, using starting material as a 
mixture of 2 epimers, the reaction produces all four possible diastereoisomeric 
products (207) (Scheme 2.29). The separation of these proved to be 
impossible. NMR data of the mixture were very complex; we could not 
unambiguously assign each of the products and the ratios between each 
diastereomer.  
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2.2.4  Attempts at oxazole introduction not employing an aldehyde 
There is not much literature precedent for the synthesis of 2-substituted 4,5-
unsubstituted oxazoles, as mentioned above. Therefore, we gave consideration 
to an alternative approach, namely that of introducing an intact oxazole to the 
decalin skeleton 
Rickborn et al. reported formation of (211), with yields increasing from 35% to 
75% upon the reaction time of oxazoles (212) with benzaldehyde being 
increased from 0.25 h to 24 h (Scheme 2.30).73  
 
Scheme 2.30 Reaction of oxazoles 212 with benzaldehyde. 
On attempts to trap 2-lithiooxazoles with electrophiles, a complication arises 
due to an equilibrium between the lithiated oxazole product (214) and the ring-
opened isocyanide (215) (Scheme 2.31).73-76 Prolonged reaction time allows 
adducts derived from the acyclic tautomer 215 to form, as this is in equilibrium 
with the precursor of cyclic C-2 product (216). In a similar manner, Hodges et al. 
found that after 24 h, reaction of lithiated oxazole with benzaldehyde gave only 
2% of 216, alongside 20% of the 4-substituted oxazole (217) which arises from 
transformation of (218) to (219) followed by cyclisation.74  
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Scheme 2.31 Metalation at C-2 of oxazole and reactivity with benzaldehide. 
Anderson et al. further investigated acylation of 5-phenyloxazole (220) at the C-
2 position in reactions with acid chlorides.77 Deprotonation of 5-phenyloxazole 
220 and reaction with benzoyl chloride gave a sole reaction product (221) 
(Scheme 2.32).73 According to the authors, addition of zinc (II) chloride solution 
to the resulting lithiated oxazole yields the corresponding zinc species, which 
are unreactive towards benzoyl chloride even at elevated temperatures. 
Addition of 1 equiv. of copper (I) iodide to the organozinc derivative leads to the 
generation of bimetallic species (222), which reacts rapidly at room temperature 
to furnish the ketone 221 in 70% yield. The authors also state that careful 
monitoring of the reaction mixture provided no evidence of formation of products 
arising from the ring-opened tautomer. Direct transmetallation of lithiooxazole 
with copper (I) iodide only, led to the generation of species which failed to 
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deliver either the ketone 221 or the opened ring product when reacted with 
benzoyl chloride.77 
 
Scheme 2.32 Improved synthesis of 221 using bimetallic oxazole intermediate. 
These findings were considered to be useful in the context of a reaction of 
aldehyde (223) with metallated oxazole 214 as planned in our 4th generation 
approach (Scheme 2.33). To access aldehyde 223, use of a Wittig reaction with 
(methoxymethyl)triphenylphosphonium chloride (224) was considered. 
Subsequent hydrolysis of the resultant olefination product (225) would give a 
mixture of aldehydes from which the desired epimer 223 should be isolable; 
epimerisation with 1,5-diazabicyclo[4.3.0]none-5-ene would allow recycling of 
the undesired epimer.  
 
Scheme 2.33 4th Generation approach via coupling of aldehyde 223 with 2-oxazolyl 
cuprate. 
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Attempts at one-carbon homologation via Wittig reaction were fruitless. After 
stirring a reaction mixture of ketone 135 and in situ generated ylide overnight, 
the reaction failed to occur. Most of the unreacted starting material was 
recovered. 
In order to effect the one-carbon homologation, a new approach was envisaged. 
This 5th generation approach would involve protection of the hydroxy ketone 
175 to give ketal (227) (Scheme 2.34). Subsequent oxidation of 227 to the 
corresponding ketone would provide a substrate for an olefination reaction to 
access alkene (228). Then hydroboration of 228, furnishing alcohol, followed by 
ketal deprotection, would furnish homologated hydroxy ketone (229). Next we 
proposed formation of a hydrazone (230) followed by a Shapiro reaction, which 
was successful in previous reactions to introduce the vinyl moiety. Introduction 
of oxazole would occur via displacement of tosylate (231). Successful formation 
of 137 would provide the substrate for IMDA as anticipated in previous 
approaches to access compound 133.  
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Scheme 2.34 5th Generation approach via hydroboration of 228 and coupling of tosylate 
231 with lithiated oxazole. 
On the basis of the approach outlined, to avoid double olefination, the ketone 
must be protected. A direct approach to ketal formation from vinyl ether 176 
was attempted. As the enolate undergoes the ring opening step forming 
hydroxy ketone 17778,79 catalysed by acid, subsequent further ketal synthesis 
was performed using standard procedure80 (Scheme 2.35). Reaction mixture 
was vigorously stirred at rt for 2 days in DCM. A partial reaction was observed; 
formation of product was detected by mass spectrometry and characteristic 
proton peaks were observed by NMR. However the amount of ketal formed was 
small.  
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Scheme 2.35 Attempted formation of the acetal 227. 
The reaction mixture was then refluxed for an additional 15 h, but the increase 
in temperature had no effect. When the reaction mixture was refluxed in 
benzene using a Dean–Stark apparatus81, only elimination product (232) was 
formed, in good yield (Scheme 2.35). Various modifications of classical ketal 
formation were attemped. Addition of 5 mol% of molecular iodine82 had no effect 
on synthesising (233). Use of 1,3-bis(trimethylsiloxy)propane (234) and 
TMSOTf83, iodine84, or NBS85 were equally unsuccessful. Examining the 
structure of the targeted ketals 227 and 233, it can be seen that there are two 
adjacent quaternary carbons. The resultant steric hindrance likely explains such 
poor reactivity. 
In light of the failure of the ketalisation, a modified 6th generation approach was 
conceived (Scheme 2.36). 
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Scheme 2.36 6th Generation approach via second Shapiro reaction. 
The Shapiro reaction had proven useful in previous approaches and the idea of 
forming the tosylate (231) via second Shapiro reaction arose. Formation of 
hydrazone (235) from vinyl ketone 135 would provide the precursor for a 
second Shapiro reaction. The carbanionic intermediate (236) of this reaction 
would then be trapped with methyl chloroformate to furnish an α,β-usaturated 
system (237). Further reduction would give (238), which could be converted to 
vinyl tosylate 231. Introduction of the oxazole moiety to compound 231 would 
afford the desired IMDA precursor 137 which would be employed in further 
steps as per the previous plans.  However, attempts to react vinyl ketone 135 
with 2,4,6-trimethylbenzenesulfonohydrazide were unsuccessful, plausibly due 
to steric hindrance of the ketone.  
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2.2.5  Regioselective hydroboration 
A new strategy was designed in order to access IMDA precursor 137 (Scheme 
2.37). The new 7th generation approach involved hydroboration of vinyl ketone 
135 with 9-BBN to access alcohol (239), which would be protected with a 
silicon-based protecting group providing the ketone. Olefination to the 
corresponding alkene (240) followed by a second hydroboration would afford 
the 1-carbon homologated alcohol. Subsequent derivatisation of (241) and 
displacement with metallated oxazole would introduce the desired oxazole 
moiety, giving (242). Then deprotection of 242 followed by transformation of the 
alcohol to the corresponding tosylate followed by treatment with base would 
give elimination product 137. Successful formation of substrate for IMDA will 
provide access to precursor for the key reaction of our approach as anticipated 
to access compound 133.  
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Scheme 2.37 7th Generation approach via double hydroboration. 
A previously prepared vinyl ketone 135 was introduced to the hydroboration 
reaction using 9-BBN. After the reaction was completed (as indicated by the 
absence of starting material on TLC) and product purified by chromatography, 
we observed characteristic vinylic proton peaks in the 1H-NMR spectrum. To 
our surprise, the vinyl group is inert to hydroboration with 9-BBN. In fact this 
reagent acted as a reducing agent yielding a mixture of two alcohols 182 and its 
epimer (248) in a total of 46% yield (Scheme 2.38). The ratio of the two 
products was 3:1.  
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Scheme 2.38 Hydroboration of vinyl ketone 135. 
The serendipitous discovery of the inertness of the vinyl group with respect to 
hydroboration permitted us to modify the 7th generation approach and propose 
accessing the homologated vinyl alcohol (249) via a simple two-step sequence 
as envisaged in the 8th generation approach (Scheme 2.39). 
This approach employs hydroboration of a bis(alkene) (250), which can be 
accessed from vinyl ketone 135 by means of olefination. Subsequent 
hydroboration of 250 would yield the mixture of diastereomeric alcohols (251). 
Finally isolation of the desired diastereomer, followed by tosylation would form 
the precursor for two further steps exactly as envisaged in the 6th and 7th 
generation model systems.  
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Scheme 2.39 8th Generation approach via hydroboration of the bis(alkene) 250. 
The Wittig methylenation of ketone 135 to synthesize bis(alkene) 250 was 
tested. Reaction with ylide (252), generated in situ from 
methyltriphenylphosphonium bromide, yielded the desired product in good yield 
(Scheme 2.40).  
 
Scheme 2.40 Synthesis of homologated vinyl alcohol 249. 
The best results for this olefination reaction were achieved when using 
potassium tert-butoxide as a base. Reactions using n-BuLi gave lower yields of 
the alkene 250 alongside formation of the product derived from epimerisation at 
the ring junction. 
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Hydroboration of the olefin 250 with 9-BBN proceeded smoothly giving a single 
product of the reaction in 85% yield. This remarkable transformation proved to 
be totally regio- and diastereoselective, providing us with the desired 
diastereomer 249 (Scheme 2.40). To confirm the relative stereochemistry of the 
hydroboration product, the esterification of the vinyl alcohol 249 was undertaken 
to obtain the p-nitrobenzoate ester (253) in 58%, with the intention of obtaining 
crystals of suitable quality for x-ray diffraction.  
 
Scheme 2.41 Formation of PNB ester 253. 
Unfortunately, no such crystals were obtained; the relative configuration was 
subsequently supported by the basis of NOESY NMR data of an aldehyde 
derivative (vide infra). 
Vinyl alcohol 249 was submitted to tosylation to give derivative 231 in 68% yield 
(Scheme 2.42). To test the oxazole displacement reaction, tosylate 231 was 
introduced to the lithiated oxazole 214. Unfortunately only starting material was 
recovered. Attempted oxazole alkylation at C-2 position using a copper-
mediated reaction, applying methodology developed by Anderson,77 did not 
work either.  
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Scheme 2.42 Attempted synthesis of the vinyl oxazole 137 by displacement of tosylate 
231. 
In the literature, Vedejs and Monahan86 and Boger et al.87 report accessing 2-
alkylated oxazoles using lithiated oxazole complexed to borane (254), by 
displacement of triflates. Vedejs described metallation of oxazole-borane 
complexes as a practical solution to the problem of ring opening of 2-
lithiooxazoles (Scheme 2.43).88  
 
Scheme 2.43 Use of borane complexation to prevent oxazole ring opening, as reported 
by Vedejs. 
Treatment of lithiated oxazole-borane complexes (255) with alkyl triflates 
reportedly affords alkylated products (256) and (257) in good yields after 
purification (Scheme 2.44). 
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Scheme 2.44 Metallation of oxazole-borane complexes and their alkylation, as reported 
by Vedejs. 
Attempts at the reactions of our corresponding tosylate 231 and triflate (259) 
under the same displacement conditions were unsuccessful, resulting only in 
elimination to the bis(alkene) 250 in both cases (Scheme 2.45).  
 
Scheme 2.45 Synthesis of triflate 259 and attempted displacement with lithiated oxazole-
borane complex. 
Despite the leaving group being on a primary carbon, steric hindrance of the 
molecule will most likely explain these results. SN2 displacement requires 
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approach of the nucleophile at 180º angle; there is a high probability this 
requirement cannot be fulfilled in the case at hand.  
Negative results for the displacement of tosylate 231 and triflate 259 left us with 
a last option envisaged in this series of reactions. A slight modification of the 
previous approach would allow formation of the iodide (260), which should be 
easily accessible from alcohol 249. A successful reaction of this iodide with 
metallated oxazole would provide the desired substrate for IMDA as envisaged 
in previous approaches (Scheme 2.46).  
 
Scheme 2.46 9th Generation approach via displacement of iodide 260. 
The initial attempt to access iodide from alcohol 249 commenced with the use 
of a classical Appel reaction89 to access corresponding bromide which would 
undergo a Finkelstein reaction90 to give the corresponding iodide (Scheme 
2.47). In the event, the substrate undergoes elimination, providing elimination 
product (261) alongside recovery of unreacted starting material. This may have 
arisen via formation of the bis(alkene) 250 which then rearranged to the tetra-
substituted alkene 261. The same results were observed when tosylate 231 
was treated with NaI in acetone in order to perform functional group 
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displacement to access iodide 260. This isomerisation was not observed in 
other cases of elimination.  
 
Scheme 2.47 Formation of tetrasubstituted alkene elimination product 261. 
Functional group interconversion by displacement of hydroxy group with iodide 
eventually proved to be possible. However, the synthesis of the required iodide 
did not prove to be easy due to poor stability of the product and difficulty in 
separating it from triphenylphosphine and its oxide. Column chromatography 
cannot be used as immediate elimination occurrs to the bis(alkene) 250. Use of 
ethylenebis(diphenylphosphine) instead of triphenylphospine was found to be 
advantageous due to easier separation of the product from the phosphorus-
containing byproducts.91,92 Reaction of reactive iodide species with the alcohol 
provided desired iodo derivative 260 in 61% yield (Scheme 2.48). In this case 
consumption of all iodine sources to form the reactive iodophosphonium 
species is crucial - a side reaction occurs due to formation of an iodonium 
species by attack of free iodine on the vinyl group. This is followed by attack of 
the hydroxyl to form a 6-exo-tet cyclisation product, the tetrahydropyran (262). 
Whilst obviously the formation of tetrahydropyran side product 262 is not 
desired, this reaction provided the first evidence that both the vinyl and 
hydroxymethyl substituents on the decalin are indeed axially disposed as was 
thought. 
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Scheme 2.48 Formation of iodide 260 and tetrahydropyran 262. 
Attempts to access desired oxazole 137 by means of displacement reactions of 
260 were unsuccessful. Under the same conditions as applied in the tosylate or 
triflate cases, the iodide undergoes elimination to the bis(alkene) 250, with 
recovery of some starting material.  
Having formed the iodide 260 we envisaged that the use of an oxazole Grignard 
coupling with (263) to access oxazole derivative 137 would be our next attempt 
(Scheme 2.49). This 10th generation approach necessitates formation of 2-
iodooxazole (264), which should be accessible from the parent oxazole 213. 
Generation of the corresponding oxazole Grignard regent and coupling with 
iodide 260 would provide desired substrate for IMDA as envisaged in previous 
approaches.  
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Scheme 2.49 10th Generation approach via Grignard coupling of iodide 260. 
Copper (I) catalysed cross-coupling between Grignard reagents and alkyl 
bromides as reported by Kochi and Tamura93 was the main literature precedent 
which inspired the above approach. Interesting results on the deprotonation of 
oxazoles and their reactivity towards electrophiles were reported by Mongin et 
al.94,95 The deprotonation of the oxazole using 1/3 equiv. of a magnesiated 
species (Bu3MgLi) generated in situ can be achieved by reaction of n-BuLi and 
magnesium bromide, then trapping the metallated oxazole with molecular iodine 
was reported to give 2-ioodooxazole 264 in 70% yield (Scheme 2.50). Putting 
this methodology in to practice we found the product formed in a yield as low as 
8%. Precomplexation of oxazole with borane86 before deprotonation and 
quench with the electrophile gave iodide 261 in low yields also.  
Greaney et al. used 1,2-diiodoethane and LHMDS to access 2-iodo-4,5-
disubstitured oxazoles.96 Application of this methodology exactly as reported 
was not successful, but a change of base to n-BuLi gave 261 in moderate 47% 
yield (Scheme 2.50). 
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Scheme 2.50 Formation of 2-iodooxazole 264. 
Following a procedure from the patent literature97 procedure, lithiated oxazole 
was transmetalated with zinc before adding iodine to the reaction mixture. Our 
best results gave 57% of the iodo product in comparison to the literature 
reported yield of 69%. Reaction using borane–THF complex did not offer any 
improvement, yielding the iodooxazole in a lower 19% yield. 
With 2-iodooxazole in hand, we attempted the copper (I) catalysed cross-
coupling between oxazolemagnesium iodide (263) and iodide 260. In every 
instance, no desired product was obtained. As the stability of 2-iodooxazole was 
marginal, we employed protocols wherein this reagent was used immediately 
upon generation. These were equally fruitless, however.  
Returning to the hydroboration of the alkene 250 in order to access the one-
carbon homologated alcohol 249, this two-step procedure initially involves 
formation of the borane (265), which is subsequently oxidised with base and 
hydrogen peroxide. The possibility was entertained that a palladium mediated 
cross-coupling employing the borane 265 with the iodooxazole 214 might allow 
access to the desired IMDA substrate 137. This 11th generation approach is 
detailed in Scheme 2.51.  
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Scheme 2.51 11th Generation approach via Pd mediated cross coupling of borane 265. 
The reaction of alkylborane derivatives with halides is a useful tool when it 
comes to alkene substrates. Typically 9-BBN is used in cases of terminal 
alkenes. This procedure has been used widely in synthesis of steroids98,99 or 
other natural products.100-103 Suzuki coupling of borane 265 with 2-iodooxazole 
was tested (Scheme 2.52). 
 
Scheme 2.52 Formation of borane 265 and attempted Suzuki coupling. 
Pd(dppf) (II) chloride and Cs2CO3 as base are the most commonly used 
conditions for this type of reaction. When borane 265 was treated in situ with 
these reagents, no formation of the desired product was observed. Use of other 
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bases or additives such as triphenylarsine did not make any difference to the 
course of the reaction. In all cases bis(alkene) 250 was recovered. It is most 
likely that β-hydride elimination occurred after oxidative insertion of palladium 
into the carbon-boron bond. We sought to examine briefly the use of other 
boranes, but bis(alkene) 250 was inert to hydroboration with catecholborane.  
2.2.6  Reaction of lithiated oxazole-borane complex with aldehyde 
The borane oxazole complexation methodology described above allowed us to 
consider new synthetic strategies. We conceived a new approach, which was to 
proceed by oxidation of the alcohol 249 to the corresponding aldehyde 223. 
Then the aldehyde would react with the lithiated oxazole-borane complex 254 in 
accordance with Vedejs’ protocol.86 Successful formation the 2-oxazolyl alcohol 
226 followed by deoxygenation would derive the desired IMDA precursor 137 
(Scheme 2.53).  
 
Scheme 2.53 12th Generation approach via oxazole reaction with the aldehyde 223. 
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To access the aldehyde, a Swern oxidation was very successful, giving the 
aldehyde 223 in 87% yield as a single diastereomer, i.e. with negligible 
epimerisation at the aldehyde α-position (Scheme 2.54).  
 
Scheme 2.54 Swern oxidation of the alcohol 249. 
The relative configuration of the vinyl aldehyde 223 was elucidated based on a 
NOESY correlation between the aldehyde proton and the vinyl -CH=CH2 proton 
(Figure 7), which indicated that the vinyl and aldehyde groups are located on 
the same face of the trans-decalin skeleton (i.e. both are oriented axially, Figure 
2.4). This provided compelling evidence that the configuration we had inferred 
for the new stereocentre in hydroboration product 249 was correct. 
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Figure 2.4 NOESY correlations for vinyl aldehyde 223. 
Treatment of oxazole 213 with borane, followed by lithiation and addition to 
aldehyde 223 using Vedejs’ protocol afforded the desired product as a mixture 
of two diastereomers (266) and (267) in 53% yield (Scheme 2.55).  
 
Scheme 2.55 Reaction of the aldehyde 223 with an oxazole using Vedejs protocol. 
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No substrate control of stereochemistry was observed; the ratio of the 
diastereomeric products was 1:1. These proved to be separable by careful 
column chromatography. The configuration of the newly formed stereocentre 
was deemed unimportant, since after deoxygenation a single isomer would 
once again be obtained. 
The relative configuration of one of the diastereomers, 266, was determined by 
X-ray crystallography (Figure 2.5).  
 
Figure 2.5 Crystal structure for 266, showing two discrete molecules in the unit cell. 
Ellipsoids at 50% probability. Selected H atoms are shown as spheres of arbitrary radius 
and a disordered molecule of chloroform solvent has been omitted for clarity. 
The low yield of the reaction is due in part to the competing action of borane as 
reductant, reducing the aldehyde to the corresponding alcohol 249. This was 
observed in every instance, with 249 being isolated in an average yield of 45%. 
Other boron Lewis acids were used to avoid the reduction occurring. Intriguingly 
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none of these were useful in terms of improvement of reaction yield. 
Triethylborane provided some of the product alongside some of the starting 
material and other degradation products. Use of boron trifluoride etherate was 
even less successful; no desired product formation was observed, nor was 
starting material recovered.  
2.2.7  Attempts at deoxygenation 
The next step towards completion of the proposed model system would involve 
deoxygenation of the alcohols 226.  
There is only sparse literature precedent for dehydroxylation at the α-position of 
a heterocyclic fragment. In our initial attempts to reduce the 2-oxazolyl alcohols 
226, we employed the procedure of Nutaitis and Swartz for the reduction of 
heterocyclic secondary α-carbinols.104 The procedure is a modification of that 
developed by Gribble et al.105 – reduction with sodium borohydride and TFA is 
reportedly effective for the synthesis of diaryl or hetaryl-aryl methanes. We 
subjected a mixture of diastereomeric alcohols 226 to the reported conditions. 
The reaction went to the completion after 3 h, but afforded unexpected products 
(Scheme 2.56). 
 
Scheme 2.56 Attempted reduction of 2-oxazolyl alcohol 226 using Gribble and Nutaitis’ 
conditions. 
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The formation of the observed diastereomeric mixture of tricyclic 
tetrahydropyrans (268) is easily rationalised. TFA effected protonation of the 
vinyl group and the resultant carbocation was attacked by the hydroxyl oxygen 
to yield the cyclisation product 268 after loss of a proton. The reaction did not 
furnish the desired deoxygenated product 137, but formation of byproduct 268 
allowed the relative configuration of 249 to be inferred: for 268 to form requires 
a particular stereochemistry in the starting molecule 226, that shown in Scheme 
2.56. As alcohol substrate 226 was used as a mixture of 2 diastereomers, the 
product 268 was formed as all four possible diastereomers. We successfully 
separated and assigned the configurations of two of these diastereomeric 
tetrahydropyrans. The relative configuration of the two products was established 
by COSY and NOESY correlations (Scheme 2.57). See appendix for NMR 
spectra.  
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Scheme 2.57 Correlations of COSY and NOESY for identified products 269 and 270. 
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An alternative dehydroxylation methodology is that reported by Barenjee et al., 
who successfully deoxygenated aromatic secondary α-carbinols by reduction of 
the corresponding tosylate with sodium iodide and elemental zinc.106 The 
application of this methodology required mesylate (271), which was accessed 
from alcohol 266 in 93% yield (Scheme 2.58). 
 
Scheme 2.58 Mesylation of alcohol 266 and attempts at reduction. 
Attempts to reduce mesylate 271 did not give the desired deoxygenated 
compound; rather, they afforded the elimination product (272) as a single 
isomer (Scheme 2.59) 
 
Scheme 2.59 Mesylation of alcohol 267. 
The question of whether the elimination occurred from mesylate 266 or from the 
iodide formed in situ is not clear. Possibly relevant to this question is the 
observation that the other diastereomeric mesylate (273) is less stable and 
undergoes elimination under the conditions of its formation. Thus, it is plausible 
that mesylate 271 can undergo direct elimination under harsher conditions 
without the intermediacy of the corresponding iodide. 
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In order to obtain higher quality x-ray diffraction data for the products of lithiated 
oxazole-borane complex addition to aldehyde 223, formation of a derivative was 
carried out. Thus, the esterification of the vinyl alcohol 266 gave the p-
nitrobenzoate ester 274 with the intention of obtaining crystals of suitable quality 
for x-ray diffraction, but no such crystals were ultimately obtained (Scheme 
2.60). 
 
Scheme 2.60 Formation of the PNB ester 274. 
Next we attempted to employ a two-step approach comprising oxidation to the 
ketone and subsequent Wolff–Kishner reduction107,108. Additionally, the 
possibility of reduced product (137) undergoing the IMDA reaction in situ was 
considered.  
Swern oxidation of the mixture of two diastereomers alcohols 226 provided the 
ketone 275 in good yield, with no epimerisation occurring (Scheme 2.61). When 
this was subjected to reduction conditions, the reaction was unsuccessful, 
leading to complete decomposition of the starting ketone; no hydrazone 
intermediate was observed either. 
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Scheme 2.61 Attempted Wolff–Kishner and Clemmensen reductions of ketone 270. 
Having ketone 270 in hand, we attempted a Clemmensen reduction109-111. This 
reaction afforded products seen previously. Tetrahydropyrans 269 and 270 
formed in 66% yield and in a 1:8 ratio. 
Our next approach involved an attempted Barton–McCombie radical 
dehydroxylation.112 The required imidazole-1-carbothioate substrates (276) and 
(277) were easily accessed from corresponding alcohols 266 and 267 in 83% 
and 51% yield respectively (Scheme 2.62).  
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Scheme 2.62 Formation of imidazole-1-carbothioate substrates 276 and 277. 
Whilst the Barton–McCombie procedure is typically performed with a sub-
stoichiometric amount of AIBN or another radical initiator, there are many 
literature reports of this reaction succeeding without addition of any radical 
initiator.113-115  
In practice, when we attempted this reaction on the substrate 276 at hand, the 
desired deoxygenated product 137 was not observed. Instead, a byproduct was 
formed, both in the presence and absence of AIBN (Scheme 2.63). 
 
Scheme 2.63 Barton-McCombie reactions on imidazole-1-carbothioate 276. 
Although the deoxygenation had occurred to produce (279), a radical 
intermediate appeared to have incorporated a butyl group to give (278) 
(Scheme 2.64). Formation of this product was confirmed by mass spectrometry. 
Analysis of NMR data showed the butyl -CH3 triplet peak at (δ = 0.91 ppm) in 1H 
NMR. There were no vinylic protons present. The 13C-NMR spectrum confirmed 
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the correct number of carbons were present for the proposed butyl-containing 
product. Combination of DEPT-135 and DEPT-90 spectroscopic data showed 
presence of two primary carbons at (δ = 13.5 ppm) and (δ = 11.4 ppm) in the 
13C-NMR spectrum. 
Our initial mechanistic proposal for this reaction can be seen in (Scheme 2.64). 
As in a normal Barton–McCombie radical dehydroxylation, a tributyltin radical 
abstracted the carbothioate group from 276 leaving an alkyl radical 279. It was 
then expected that radical 279 would abstract a hydrogen atom from a molecule 
of tributyltin hydride to give the desired deoxygenation product. However, the 
presence of an alkene in the molecule and an alignment of reactive groups 
allowed a 5-exo-trig cyclization to occur. Subsequent 1,5 radical hydrogen 
abstraction, again facilitated by the alignment of reactive groups induced by the 
trans-decalin skeleton, would give alkyl radical (281). Whilst such a mechanistic 
proposal accounts for formation of the tricyclic skeleton, it must necessarily 
include a radical-mediated butyl transfer from tributyltin hydride as the 
propagation step. 
 
Scheme 2.64 Possible radical mechanism for formation of butyl incorporation product 
278. 
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To our knowledge, such a radical-mediated butyl transfer from tributyltin hydride 
is unprecedented in the literature and we therefore formulated an alternative 
mechanistic hypothesis, proceeding not by radical intermediates, but by a Prins-
type pathway. Thus, at elevated temperature, loss of the carbothioate group 
would lead to formation of a stabilised benzylic cation (282). The cation would 
then undergo a Prins-type cyclisation with concomitant hydride shift to give a 
cation on the decalin skeleton (283). Incorporation of the butyl group would then 
be by addition of an organometallic nucleophile as opposed to a radical transfer. 
 
Scheme 2.65 Possible ionic mechanism for formation of butyl incorporation product 278. 
An interesting anisotropic effect was observed in the 1H-NMR spectrum of 276. 
The oxazole α-methine resonance was exceedingly deshielded, so much so (δ 
= 7.07 ppm) that its unambiguous assignment required a COSY spectrum. The 
relevant COSY correlations can be seen in (Figure 2.6). 
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Figure 2.6 COSY correlations for imidazole-1-carbothioate 276. 
We considered tactics to avoid the unwanted 5-exo-trig radical cyclisation onto 
the alkene and opted temporarily to mask the alkene by functional group 
interconversion. Attempts to oxidise the vinyl group to the corresponding 
aldehyde were not successful. Reactions such as ozonolysis did not give 
product, but completely destroyed the imidazole-1-carbothioate 276 in 15 min. 
Lemieux–Johnson oxidation116 with OsO4 and NaIO4 following Danishefsky’s 
procedure117 or Upjohn118 dihydroxylation-oxidation with OsO4, NMO, PhI(OAc)2 
following Nicolaou’s119 procedure for oxidative cleavage of olefins were not 
effective in our case. Some formation of the product was observed by 1H-NMR 
monitoring of reaction mixtures; however the amounts were very small and did 
not change when reaction times were increased. When reactions were 
performed at elevated temperatures, no vinyl imidazole-1-carbothioate 276 
survived. 
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2.2.8  Kondrat'eva oxazole-olefin hetero- Diels–Alder reaction 
Fruitless attempts to accesses the dehydroxylated Kondrat'eva oxazole-olefin 
hetero Diels–Alder reaction precursor 137 led to our attempting the reaction on 
the hydroxy derivative 226 using 1,5-diazabicyclo[4.3.0]none-5-ene as per the 
reports of Ohba.29,33,50,120,121 It should be stressed that far from being a 
redundant functional group, a hydroxyl group α- to the pyridine ring in the 
desired product would provide a functional handle for the synthesis of the 
western hemisphere of complanadine B 5 (which possesses a ketone at this 
position); alternatively the hydroxyl group could simply be removed subsequent 
to the pyridine formation. 
The first attempts at the reaction, refluxing reaction mixtures in o-xylene at 145 
ºC with 20 equivalents of 1,5-diazabicyclo[4.3.0]none-5-ene were fruitless. Only 
starting material was recovered. When the reaction temperature was increased 
to 180 ºC in 1,2-dichlorobenzene and prolonged reaction time, a small degree 
of product formation could be observed by NMR.  
Accordingly, microwave acceleration was considered. After 90 min of 
microwave irradiation in toluene at 200 ºC, all starting material was consumed. 
Purification of the crude reaction mixture afforded five identifiable products of 
the reaction (284), (285), (286) (287) and (288) (Scheme 2.66). 
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Scheme 2.66 Microwave assisted IMDA reaction of the 2-oxazolyl alcohols 226. 
Success in production of these pyridines proves the viability of this key reaction. 
It is clear that all five products arise from IMDA reaction of the oxazole and vinyl 
moieties. However, the precise mechanisms by which these particular products 
formed was not clear in the first instance. The corresponding PNB derivatives 
(289), (290) and (291) were synthesised from 284, 286 and 287 in the hope of 
synthesising crystalline materials which would be suitable for X-ray analysis, but 
in the event no suitable crystals were obtained (Figure 2.7). 
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Figure 2.7 PNB derivatives 289, 290, 291. 
We propose that pyridyl ketone 285 is formed by oxidation of the corresponding 
alcohol (the expected product of the reaction) (292) and not by oxidation of the 
reaction substrate 226 (Scheme 2.67). The initial [4+2] cycloaddition provides 
oxygen bridged adduct (293), which undergoes ring opening to give 
intermediates (294) and/ or (295). Then these intermediates lose water to 
furnish the pyridine product 292 and further oxidation gave corresponding 
ketone 285. 
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Scheme 2.67 Mechanism for formation of 285 via IMDA of 226. 
It is generally the case that electron-withdrawing groups render dienes 
unreactive towards [4+2] cycloadditions (with the exception of inverse electron 
demand Diels–Alder reactions). Therefore, an oxazolyl ketone such as 275 
would not be expected to be a viable substrate for the direct formation of pyridyl 
ketone 285. In practice when ketone 275 was refluxed in ortho-xylene with 1,5-
diazabicyclo[4.3.0]none-5-ene additive, no cyclization product was observed. 
Instead the epimerised ketone (296) was isolated in 59% yield (Scheme 2.68). 
 
Scheme 2.68 Epimerisation of 275. 
We assigned the stereochemsity of the initial cycloadduct on the basis of 
molecular modelling (MM2 minimisation). On this basis we propose that the 
initially formed cycloadduct is (297) and not (298) (Figure 2.8). 297 is lower in 
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energy than 298 by 25.9 kJ mol-1. It can be seen that for 297, both decalin rings 
are able to adopt chair-like conformations, but in 298 one of the decalin rings is 
appreciably distorted away from the ideal chair geometry due to steric clash 
with the nitrogen. 
 
N
O
H
298
 
 
 
Figure 2.8 Possible cycloadducts and their MM2 minimised structures. 
Whereas formation of 284 proceeds via a net oxidation reaction, we suggest 
that products 284, 286, 287 and 288 are derived from the oxygen bridged 
cyclisation adduct 293 via net redox neutral reactions, as would be expected 
given the reaction conditions employed. 
In the case of 284, after formation of the oxygen bridged intermediate 293, ring 
opening gave 294. Subsequently, we propose that in contrast with the 
transformation of 294 or 295 to 292 (as per formation of 285), in this instance an 
elimination of water occurred via the residual aldehyde-derived hydroxyl group 
to give the intermediate (299) (Scheme 2.69). Finally tautomerisation gave the 
3-hydroxy pyridine 284 product. We propose the term “diverted Kondrat’eva 
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reaction” for this transformation; to our knowledge such a formation of a 3-
hydroxypyridine is unprecedented in the literature. 
 
Scheme 2.69 Proposed mechanism for formation of 284. 
A mechanism for the formation of 286 is proposed in (Scheme 2.70). We 
suggest the same cycloadduct 293 is the first intermediate. In this instance, the 
oxazabicyclo[2.2.1]heptene cycloadduct is proposed to fragment by means of 
the DBN-mediated abstraction of an exocyclic proton, the hydroxyl α-proton, 
giving the ring-opened intermediate (300) and protonated DBN (301). Then 
protonation of the resultant azadienol 300 by 301 provides the intermediate 
(302) which tautomerises to product 286. 
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Scheme 2.70 Proposed mechanism for formation of 286. 
Finally, for formation of 287 and 288 we propose a more involved mechanism. 
Starting with the same cycloadduct intermediate 293, nucleophilic attack of DBN 
molecule followed by ring opening fragmentation gave (304). Water, present in 
the reaction mixture, attacks the amidinium intermediates xx1 to form an amide 
and give ring opened fragment (305). Then, elimination of water gives 
vinylogous alcohol intermediate (306). At this instance the two different 
diastereomers had reacted differently. In the case of S* alcohol (in the mixture 
of two in 306) subsequent elimination of a second water molecule gave (307), 
followed by final tautomerisation to give product 287. Formation of the minor 
product must have occurred by oxidation of the R* alcohol (in the mixture of two 
in 306) resulting in direct aromatisation to give the hydroxy product 288.  
We assign the configuration of 288 as R* alcohol isomer on the basis of the 
Karplus relationship. We examined molecular models of the two possible 
diastereomers at the alcohol bearing stereocentre and considered the coupling 
of the alcohol α-H proton with H in 288 (>CH-CH(OH)<). In the R* isomer, the 
dihedral angle between these two protons is ≈ 30° which would imply a coupling 
constant of J ≈ 7.0 Hz, which is indeed observed. In contrast, the same protons 
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in the S* diastereomer, would have a dihedral angle ≈ 90°, which would give 
rise to a coupling constant of J ≈ 0 Hz. 
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Scheme 2.71 Proposed mechanism for formation of 287 and 288. 
It was noted that dehydration of 286 would represent an alternative route to the 
expected pyridine 292. Attempts at dehydration of 286 with Burgess’ reagent122 
(304) in order to access the expected product 292 were not successful (Scheme 
2.72). 
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Scheme 2.72 Attemted dehydration reaction of 286 with Burgess’ reagent. 
Very recently, Mendez et al. published the results of theoretical calculations on 
oxazole cycloadditions with ethylene, facilitated by the addition of an alkyl 
group, Lewis acid or Brønsted acid to the oxazole nitrogen atom.123 They found 
that formation of the oxazolium cation accelerates the reaction rates, making 
the process more exothermic. Conversely, an oxazole anion has a greater 
activation energy and renders the reaction endothermic (Figure 2.9). In 
comparison with neutral oxazole, the cation has a decreased the HOMO–LUMO 
gap and a more stabilised transition state.  
 
Figure 2.9 Activation energy graphs for neutral oxazole, oxazolium cation and oxazolium 
anion with ethylene computed at the B3LYP/6-311+G(2d, 2p) level of theory, reproduced 
from reference 123. 
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So far, there are no reports in the literature of these theoretical predictions 
being reduced to practice. In order to ascertain the ability of an oxazolium cation 
to accelerate the IMDA, we tested reactions of the alcohol 226 with boron 
trifluoride diethyl etherate as our choice of Lewis acid and acetic acid as our 
choice of Brønsted acid respectively. Reaction with Lewis acid went to 
completion after 20 min of irradiation in a microwave reactor at 145 ºC. 
However, the reaction gave as cyclisation products the tetrahydropyrans (311) 
observed previously when oxazolyl alcohols 226 were treated with Brønsted 
acid (Scheme 2.73). In this case the product was obtained as all four possible 
diastereomers in 90% yield; this was a surprising result and is difficult to 
rationalise mechanistically. A possible explanation could be the presence of 
trace amounts of hydrofluoric acid in the boron trifluoride diethyl etherate.  
 
Scheme 2.73 Attempted IMDA of 2-oxazolyl alcohol 226 promoted by BF3·Et2O. 
In an attempt to prevent this transannular reaction occurring, we thought 
derivatisation of the hydroxy derivative 266 as the corresponding methyl ether 
(312) might be a solution (Scheme 2.74). 
 
Scheme 2.74 Methylation of alcohol 266. 
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IMDA on ether 312 using Brønsted acid under microwave conditions were 
fruitless, furnishing only unreacted starting material. In a reaction of 312 with 
boron trifluoride diethyl etherate, some pyridine formation was observed by 
1H-NMR, however prolonged reaction time lead to decomposition and column 
purification did not afford any identifiable products. 
No further attempts were made to optimise the Kondrat’eva reaction of oxazolyl 
alcohols 226. The model system was deemed to have served its primary 
purpose, namely to demonstrate that the key intramolecular Kondrat’eva 
reaction is indeed viable. Whilst the unoptimised yields are low, it was not 
considered worthwhile to attempt to improve on them, since conditions 
established as being optimal for the model system would not necessarily be 
applicable in the real system. Efforts towards reaction optimisation would be 
better directed towards the real system. 
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3. RESULTS AND DISCUSSION II 
3.1 Synthetic Results for real system 
To access the ‘monomeric unit’ of complanadine A, we envisaged accessing 
lycodine 9 via intramolecular Kondrat’eva oxazole-olefin Diels–Alder reaction of 
(313) followed by deoxygenation and deprotection of the cycloaddition product 
(314) (Scheme 3.1)  
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Scheme 3.1 Retrosyntheis of lycodine via oxazole-olefin IMDA from starting diketone 316. 
1st Generation approach. 
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In the synthesis of IMDA precursor 313 we envisaged employing many steps/ 
methodologies developed in the model system. We planned to access 313 by 
reaction of lithiated oxazole-borane complex with aldehyde (320). The aldehyde 
could be accessed by means of an olefination of ketone (319), followed by 
selective hydroboration of the bis(alkene). Subsequent oxidation would produce 
the one-carbon homologated aldehyde 320, analogously with the model system. 
Thus, the precedent established in the model system allows us confidently to 
disconnect lycodine to a much simpler precursor, azabicyclic vinyl ketone 319. 
The early steps employed in the model system would not be applicable to the 
synthesis of 319, so a de novo route was required. We conceived a route to 
azabicyclic vinyl ketone 319 that employs methodology developed by Wiesner 
(vide infra). Specifically, 319 should be accessible by means of addition of 
vinylmagnesium bromide to the salt (318) formed by O-alkylation of vinylogous 
amide (317). Amide 317 would be protected as the N-benzyl derivative and 
should be readily accessible by reaction of commercially available 3-
bromopropylamine hydrobromide (315) and 5-methyl-1,3-cyclohexadione (316) 
as reported in the literature.124 
Wiesner et al. attempted to synthesise various lycopodium alkaloids using this 
strategy of Grignard reagent addition to the salts formed from vinylogous 
amides.125-128 In the original publication dating to 1965, Wiesner synthesised 
vinylogous amide 317 by reaction of diketone 316 and 3-amino-1-propanol 
(321) at reflux in benzene to derive (322) (Scheme 3.2).126  
Chapter 3  Results and discussion 2 
109 
 
Scheme 3.2 Synthesis of vinylogous amide 323 and addition of allylmagnesium bromide 
to the salts, as reported by Wiesner126. 
Further cyclisation of 322 in pyridine hydrochloride furnished cyclised 
vinylogous amide 317 and subsequent alkylation with NaH and MeI gave N-
methyl derivative (323). Further transformations to the corresponding salts were 
achieved by reacting 323 with PCl5 to give (324), PBr3 to give (325) or reflux 
with 2-iodopropane in benzene to access (326). Reactions of salts 324, 325 and 
326 with an excess of allylmagnesium bromide gave the corresponding addition 
products (327), (328) and (329) in 80%, 65% and 50% yield respectively 
(Scheme 3.2). Crucially, the relative configuration of allyl and methyl groups 
was assigned as trans- (by inference from subsequent chemical 
transformations) and formation of the cis-product was observed in a low yield of 
3-5% only in the case of 324. The observed relative stereochemistry is that 
required for our proposed synthesis. 
Much more recently, Snider successfully applied this methodology in the total 
synthesis of another lycopodium alkaloid, (±)-7-hydroxylycopodine (330), 
providing additional confirmation of the stereoselectivity of the Grignard addition 
step (Scheme 3.3).124 Snider used the vinylogous amide 317 in a reaction with 
(331) to give N-alkylated product (332) which was converted to the salt (333) 
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when heated with 2-iodopropane (336). The intermediate salt 333 was treated 
with propargylmagnesium bromide to derive corresponding addition product 
(334). Further Prins cyclisation followed by hydrolysis afforded the tricyclic 
compound (335) which was further elaborated to give the desired alkaloid 330. 
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Scheme 3.3 Syntheis of (±)-7-hydroxylycopodine 330 as reported by Snider. 
This stereoselective addition of the propargyl moiety suggested the possibility of 
addition of vinylmagnesium bromide to the salt derived from the N-Bn analogue 
in order to access 319. We envisaged using benzyl protection as this could be 
easily cleaved by hydrogenation later in the synthesis. 
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The forward synthesis began with the formation of the vinylogous amide 317 
using microwave assisted conditions as per the reaction conditions reported in 
Snider’s publication.124 Indeed, this alkylation/annelation reaction between 3-
bromopropylamine 315 and dione 316 afforded the vinylogous amide 317 in 
excellent yield after 20 min of microwave irradiation (Scheme 3.4) 
 
Scheme 3.4 Synthesis of N-Bn protected vinylogous amide 337. 
In the protection step the crude vinylogous amide (337) was used, affording the 
corresponding N-Bn product in 73% yield (Scheme 3.4). Reaction of N-
benzylated product 337 with 2-iodopropane at 65 ºC for 4 days in a sealed 
pressure tube formed salt 318 in quantitative yield (Scheme 3.5). The salt 318 
was then immediately dissolved in anhydrous THF and treated with 
vinylmagnesium bromide at –78 ºC. Unfortunately after workup only the starting 
N-Bn protected vinylogous amide was recovered. A change in the reaction 
temperature of Grignard reagent addition from –78 ºC to room temperature and 
even addition to the refluxing solution of the salt in THF did not make any 
difference, each time unreacted 337 was returned. Neither addition of multiple 
batches of freshly prepared vinylmagnesium bromide, nor use of vinyllithium 
was successful.  
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Scheme 3.5 Salt 318 formation and addition of vinylmagnesium bromide. 
Addition of ethynylmagnesium bromide then was considered. In the event of a 
successful addition, reduction of the alkyne to the corresponding alkene was 
envisaged to give us the desired vinyl ketone 319 as targeted previously. 
However, addition of ethynylmagnesium bromide was not successful either, 
giving only the product of salt hydrolysis, the starting vinylogous amide 337, as 
in the previous case. 
In order to ascertain whether the problem lay in the choice of protecting group 
or organometallic species, addition of allylmagnesium bromide was tested. 
Reaction of the salt 318 with excess allyl Grignard reagent led to formation of 
two double addition products (339) and (340) in low yield (Scheme 3.6). 
 
Scheme 3.6 Addition of allylmagnesium bromide to the salt 318. 
1,4-addition to with respect to nitrogen seems to be favoured, probably due to 
the steric hindrance caused by the benzyl group rendering access to the 
desired reactive site α- to nitrogen more difficult. In view of these results, we 
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revised the protecting group strategy: next, formation of the ‘unprotected’ salt 
(341) using Meerwein’s salt129,130 (342) was attempted. Reaction with oxophilic 
trimethyloxonium tetrafluoroborate was performed, which derivered the 
corresponding salt in 98% yield (Scheme 3.7). Immediate reaction with 
allylmagnesium bromide in dry THF at 0 ºC gave only the product of salt 
hydrolysis, the starting vinylogous amide 317. Most likely, the reason for the 
unsuccessful addition of the allyl nucleophile to this salt is that the first 
equivalent of Grignard reagent gave a neutral imine intermediate which is much 
less reactive towards addition than an imimium species.  
 
Scheme 3.7 Formation of salt 341 with Meerwein's salt and addition of allyl Grignard. 
Given that the addition of allylmagnesium bromide to the corresponding N-Me 
salt is reportedly high-yielding124 we decided to adopt this approach and change 
our route to N-Me protection instead of N-Bn. Whilst N-methylation is not a 
common amine protection strategy, we expected that the comparatively 
unfunctionalised structures of lycodine/complanadine would allow for clean N-
demethylation post-Kondrat’eva reaction. In a slight modification of our original 
approach, we envisaged transformation of allyl to vinyl by means of an olefin 
isomerisation of (344), followed by cross-metathesis using Grubbs 2nd 
generation catalyst131-133 and ethylene. Successful formation of the vinyl 
derivative (345) would be followed by olefination and hydroboration steps to 
access (346). Further hydroboration step followed by subsequent oxidation to 
the corresponding aldehyde (347) and addition of the lithiated oxazole-borane 
complex 254 would afford the IMDA precursor (348). After a successful [4+2] 
cycloaddition reaction, (349) would then undergo deoxygenation and finally 
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deprotection would derive the target lycodine 9 as planned (Scheme 3.8). 
Transformations highlighted in blue indicate reactions previously accomplished 
by Wiesner and Snider.124 Transformations highlighted in orange indicate our 
key intramolecular Kondrat’eva oxazole-olefin hetero-Diels–Alder reaction. 
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Scheme 3.8 2nd Generation approach via addition of allylmagnesium bromide to the N-Me 
compound. 
Previously prepared vinylogous amide 317 was deprotonated and alkylated with 
methyl iodide to produce N-methylated product 323 in 66% yield (Scheme 3.9). 
In comparison with the N-benzylation, this reaction has proven to be much more 
challenging to work up and purify due to formation of by-products from 
impurities from the previous reaction and from undesired O-methylation. In 
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order to obtain a better yield for this reaction, the starting vinylogous amide 
must instead be purified by column chromatography. After deprotonation with 
sodium hydride, the alkylating agent must be added very slowly, dropwise to the 
cooled reaction mixture, to prevent side reactions occurring.  
 
Scheme 3.9 Synthesis of N-Me protected vinylogous amide 317 and addition of allyl 
Grignard to the salt 326. 
Having formed the N-Me derivative, formation of salt 326 was carried out, giving 
the product in quantitative yield. Reaction with allylmagnesium bromide yielded 
the desired addition product in 66% yield from 329 as a single diastereomer 
(Scheme 3.9) as per the literature procedure of Snider;124 this is an improved 
yield with respect to the literature value of the 48%. Hydrolysis of the enol ether 
329 with 1 M sulfuric acid in diethyl ether resulted in a mixture of two products 
(350) and (351) in total of 17% yield and a diastereomeric ratio of 1:1.4 in favour 
of the undesired epimer. Unfortunately we were not able to reproduce the yield 
of 77% and ratio of diastereomers 1:1.7 as published by Snider. Attempts of 
epimerisation of 351 with 1,5-diazabicyclo[4.3.0]none-5-ene in order to access 
the desired trans-fused azadecalin system were unsuccessful.  
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At this point a more direct approach which has not been attempted previously 
was explored: reaction of the salt 326 with vinylmagnesium bromide proceeded 
to give the desired azabicyclic vinyl ketone, but with no stereoselectivity, 
resulting in a mixture of two enol ethers, which after hydrolysis afforded an 
inseparable mixture of 4 diastereomers (352) in 9% yield over two steps 
(Scheme 3.10).  
 
Scheme 3.10 Addition of vinymagnesium bromide to the salt 326. 
Attempted addition of ethynylmagnesium bromide to the N-Me substrate was 
also fruitless.  
Successful formation of allyl ketone 350 (albeit in low yield) allowed us to 
explore isomerisation of the allyl moiety and to attempt access to the 
corresponding vinyl derivative by means of alkene isomerisation.  
Probably the most common such isomerisation of alkenes involves the use of 
RhCl3. In a publication from Nolan, Prunet et al., they employed this reagent to 
successfully isomerize an allyl fragment appended to a quaternary carbon (353) 
to give the corresponding propenyl derivative (354) (Scheme 3.11).134 Attempts 
to apply this transformation in our system failed, with only unreacted starting 
material being recovered. 
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Scheme 3.11 Isomerisation of 353 using RhCl3.134 
Hanessian and co-workers published a paper describing isomerisation of 
unsubstituted terminal C-allyl groups to the corresponding 2-propenyl 
derivatives using Grubbs 2nd generation catalyst (356).135 In this work they 
demonstrated that a wide range of substrates isomerised in high yields of 75-
95% using 10 mol% of the catalyst at reflux in MeOH. An example in Scheme 
3.12 shows isomerisation of (355) to (357), which proceeded smoothly in 90% 
yield producing the product in a ratio >10:1 E/Z. 
 
Scheme 3.12 Allyl isomerisation with Grubbs 2nd generation catalyst.135 
Such methodology appeared attractive in the context of our system, as it raised 
the possibility of a one-pot isomerisation/ cross metathesis procedure. However, 
our attempts at this reaction were fruitless. Only unreacted starting material was 
recovered.  
White and co-workers reported methodology to access allylic acetates from 
monosubstituted olefins.136-139 This Pd(OAc)2 catalysed allylic C–H oxidation 
promoted by DMSO or bis(sulfoxide) ligands in acetic acid provides either linear 
or branched products depending on the reaction conditions. An example of this 
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methodology can be seen in (Scheme 3.13). This methodology would allow us 
to access a double bond migration product. 
 
Scheme 3.13 Allylic oxidation of terminal alkene to allylic acetate by White.136 
Unfortunately application of this methodology was not successful in the reaction 
with 350. Le Bras reported an improvement of this reaction by addition of 
base,140 but in our case this was equally unsuccessful.  
Olefin migration by means of a Schenk ene reaction141 was considered next 
(Scheme 3.14). To access peroxide (360), oxygen was bubbled through a 
mixture of a substrate 351 and photosensitiser (TPP) in MeOH under 
photoirradiation 2 × 150 W halogen lamps. After 2 h of irradiation, all starting 
material was consumed as indicated by TLC. Surprisingly, NMR data indicated 
that the allylic fragment was still present. Of even greater surprise, however, 
was the absence of the expected N-Me singlet peak. After comprehensive 
characterisation, the product was unambiguously assigned as N-demethylated 
species (361), obtained in in 57% yield after column purification. 
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Scheme 3.14 Attempted ene reaction of 351 with singlet oxygen and N-Me deprotection. 
It is not clear what the mechanism for this transformation is. One proposal is 
shown in Scheme 3.15. Although the intended reaction pathway involved singlet 
oxygen, it is conceivable that instead triplet oxygen mediates a radical hydrogen 
abstraction from 351 providing (362), which then reacts with peroxide radical to 
give (363). This “perhemiaminal” would be expected to collape to the iminium 
species, (364) which could be hydrolysed during workup to give the deprotected 
product 361. 
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Scheme 3.15 Proposed N-Me deprotection mechanism via formation and hydrolysis of a 
“perhemiaminal”. 
The approaches detailed above constitute the total of our efforts to effect 
isomerisation of the allyl group; this aim has not been achieved to date.  
One further variation on the theme of additions to salt 326 was also considered. 
The reaction of a lithiated dithiane (366) with salt intermediate 326 was explored 
in order to introduce indirectly the vinyl moiety into the system (Scheme 3.16). If 
the nucleophile can be successfully added to give the enol ether (367), 
subsequent hydrolysis and deprotection would lead to the formation of 
dicarbonyl 345. This could be transformed to the desired bis(alkene) 346 by 
means of a double olefination. Successful formation of the bis(alkene) would 
allow us to explore further the synthetic route as envisaged in previous 
approaches to lycodine.  
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Scheme 3.16 Approach to the synthesis of the bis(alkene) 346 via addition of lithiated 
dithiane. 
In the event, addition of the lithiated dithiane was unsuccessful; only the 
vinylogous amide 323 was recovered. 
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3.2 Conclusions  
 
Formation of the pyridine moiety in our model system validates the 
intramolecular Kondrat’eva oxazole–olefin hetero-Diels–Alder reaction as a 
strategy for late-stage assembly of the pyridine ring in a synthesis of lycodine 
and/or the complanadines. In addition, much of the methodology developed for 
the assembly of our model system will be of use in the realisation of such a total 
synthesis.  
We have determined that the presence of a hydroxyl group at the α-position of a 
2-substituted oxazole has the potential to alter significantly the outcome of the 
Kondrat’eva reaction. This substituent has been shown to be “non-innocent”, 
participating in the cyclisation reaction, e.g. as a leaving group. We anticipate 
that these findings may be of utility in contexts other than the total synthesis of 
the complanadines. 
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3.3 Future work 
 
Work towards synthesis of lycodine and the complanadines could be continued 
from azabicylic intermediate 350 by attempting alternative approached to effect 
alkene migration (Scheme 3.17). 
 
Scheme 3.17 Proposed synthesis of 345 via Johnson–Claisen rearrangement. 
Selenium dioxide mediated oxidation should provide alcohol (368) followed by 
O-alkylation with triethyl orthoacetate (369) to give (370). Then Johnson–
Claisen rearrangement would provide (371). Next Grubbs’ cross metathesis 
with ethylene should finally derive vinyl ketone 345 which could be used in 
further steps as previously envisaged, applying methodology developed in 
model system.  
Alternatively, given the low yields in which 350 has been accessed, as well as 
the fact that the N-methyl substituent and the allyl side chain are not ideal for 
our approach, routes to 345 other than Wiesner’s and Snider’s should perhaps 
be considered. One possible approach would be an intramolecular Tsuji-Trost 
Chapter 3  Results and discussion 2 
124 
allylation of (372) (Scheme 3.18). Formation of a π-allyl palladium species (373) 
would be followed by intramolecular nucleophilic attack to access vinyl fragment 
in 345. 
 
Scheme 3.18 Proposed synthesis of 345 via intramolecular Tsuji–Trost allylation. 
Another possible way to access vinyl ketone 345 involves nitrene insertion to 
the C–H bond in (377) (Scheme 3.19). We envisage that 376 should be easily 
accessible from (374) by means of conjugate addition of a vinyl cuprate, 
followed by α-alkylation to derive (376). When heated, azide 376 should 
generate reactive nitrene species 377 and undergo C–H insertion to provide 
345. 
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Scheme 3.19 Proposed synthesis of 345 via nitrene insertion. 
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4. EXPERIMENTAL 
4.1 General Methods 
Reactions which required the use of anhydrous, inert atmosphere 
techniques were carried out under an atmosphere of nitrogen. In most cases, 
solvents were obtained by passing through anhydrous alumina columns using 
an Innovative Technology Inc. PS-400-7 solvent purification system.142 All other 
solvents were purchased anhydrous from Fisher Scientifics or Sigma–Aldrich. 
TLC using aluminium backed plates precoated with Alugram®SIL G/UV 254 nm. 
Visualisation was accomplished by UV light, KMnO4, DNPH, vanillin, ceric 
ammonium molybdate followed by gentle warming. Organic layers were 
routinely dried with anhydrous MgSO4 and evaporated using a Büchi rotary 
evaporator. When necessary, further drying was facilitated by high vacuum. 
Flash column chromatography was carried out using Davisil LC 60 A silica gel 
(35-70 micron) purchased from Fisher Scientifics or high purity silica gel (60 Å, 
200-400 mesh) and Celite® 545 from Sigma–Aldrich. 
IR spectra were recorded on Perkin-Elmer 1600 FT IR spectrometer with 
only selected absorbances quoted as νmax in cm-1. NMR spectra were run in 
CDCl3 or CD3CN on either a Brüker Avance 250 (250 MHz), Brüker Avance 300 
(300 MHz), Brüker Avance 400 (400 MHz) or Brüker Avance 500 (500 MHz) 
instrument and recorded at the following frequencies: proton (1H – 250/500 
MHz), carbon (13C – 62.5/125 MHz). The following abbreviations are used: s, 
singlet; d, doublet; t, triplet; q, quartet; pent, pentet; hept, heptet; dd, doublet of 
doublets; m, multiplet and br, broad.  
A micrOTOF electrospray time-of-flight (ESI-TOF) mass spectrometer 
(Brüker Daltonik GmbH, Bremen, Germany) was used; this was coupled to an 
Agilent 1200 LC system (Agilent Technologies, Waldbronn, Germany). The LC 
system was used as an autosampler only. 10µl of sample was injected into a 
30:70 flow of water:acetonitrile at 0.6mL/min to the mass spectrometer. For 
each acquisition 10µL of calibrant of 5mM sodium formate was injected after the 
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sample. The observed mass and isotope pattern matched the corresponding 
theoretical values as calculated from the expected elemental formula. Some 
samples for mass spectroscopy were sent to EPSRC NMSSC Swansea and 
analysed to obtain accurate mass using a Thermofisher LTQ Orbitrap XL ESI 
full-scan machine. 
All capillary melting points were recorded using a Büchi 535 melting point 
apparatus. The readings were taken from a mercury-in-glass thermomether and 
were reported uncorrected as the meniscus point. All reactions were carried out 
at room temperature and under and under an atmosphere of N2, unless 
otherwise stated. 
Microwave assisted reactions were carried out in a Biotage Initiator 2.0 
Eight (0-300W at 2.45 GHz). 
 
4.2 Synthetic procedures for model system 
cis-1-Decalone (138)143 
 
This was performed by adaptation of a literature procedure144. To a stirred 
solution of oxalyl chloride (3.06 mL, 35.6 mmol, 1.10 equiv) in DCM (20 mL) at –
78 °C was added dimethyl sulfoxide (4.95 mL, 69.6 mmol, 2.15 equiv). The 
solution was stirred for 5 min and then decahydronaphthalen-1-ol 139 (5.00 g, 
32.4 mmol, 1.00 equiv) in dry THF (20 mL) was added. The reaction mixture 
was stirred for 90 min at –78 °C under nitrogen, and then Et3N (22.5 mL, 162 
mmol, 5.00 equiv) was added. After 5 min the solution was warmed to rt during 
20 min, then water (20 mL) was added and the reaction mixture was transferred 
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to a separating funnel. The mixture was extracted with DCM (2 × 100 mL). The 
combined organic extracts were washed with brine (2 × 100 mL) and dried over 
MgSO4, then filtered. The filtrate was concentrated under reduced pressure and 
purified by column chromatography (25% EtOAc in petroleum ether) to give the 
title product 138 (4.42 g, 90%) as a pale yellow oil: Rf 0.70 (25% EtOAc in 
petroleum ether). Analytical data were consistent with those previously 
reported:145,146 δH (300 MHz, CDCl3) 2.46-2.20 (3 H, m), 2.15-1.67 (6H, m), 
1.67-1.15 (7H, m); δC (125 MHz, CDCl3); 213.1 (>C=O), 50.6 (CH2-CH-CO-), 
40.4 (2°), 39.1 (2°), 29.1 (2°), 27.7 (2°), 25.1 (2°), 24.5 (2°), 23.5 (2°), 23.1 (2°). 
 
8a-Chloro-trans-1-decalone (140)147 
 
This was performed by adaptation of a literature procedure.148 To a stirred 
solution of 138 (4.42 g, 29.0 mmol, 1.00 equiv) in carbon tetrachloride (35 mL) 
at rt was added sulfuryl chloride (4.50 g, 33.4 mmol, 1.15 equiv) dropwise over 
a period of 20 min. The reaction mixture was stirred for 3 h, then transferred to 
a separating funnel and washed with water (2 × 50 mL), aq. sodium bicarbonate 
(2 × 50 mL) and aq. sodium chloride (2 × 50 mL). The organic phase was dried 
over MgSO4 and filtered. The filtrate was concentrated under reduced pressure. 
Purification by distillation under reduced pressure gave desired title ketone 140 
(3.52 g, 70%) as a colourless oil; b.pt. 90–93°C (2.3 mbar). Analytical data were 
consistent with those previously reported:147 δH (300 MHz, CDCl3) 3.23-2.98 
(2H, m), 2.64-2.57 (1H, m), 2.46-2.37 (4H, m), 2.36-1.21 (8H, m); δC (75 MHz, 
CDCl3); 205.6 (>C=O), 76.6 (-CH2-CCl-), 47.3 (2°), 36.5 (2°), 36.3 (2°), 29.2 
(3°), 27.6 (2°), 25.5 (2°), 24.4 (2°), 21.7 (2°). 
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1,2,3,4,5,6,7,8-Octahydronaphthalen-1-one (134)149 
 
This was performed by adaptation of a literature procedure.148 To neat 140 
(3.52 g, 20.5 mmol, 1.00 equiv) was added collidine (3.01 mL, 22.6 mmol, 1.10 
equiv), then stirred and heated to 135 °C for 90 min. The reaction mixture was 
diluted with petroleum ether (25 mL) and filtered to separate solid collidine 
hydrochloride. The filtrate was washed with aq. hydrochloric acid (1.00 M, 2 × 
25 mL), sat. aq. sodium bicarbonate (2 × 25 mL) and water (2 × 25 mL). The 
combined organic extracts were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified by chromatography (5% 
EtOAc in petroleum ether) to give the title ketone 134 as a pale yellow oil (0.72 
g, 23%): Rf 0.52 (25% EtOAc-petrol ether). Analytical data were consistent with 
those previously reported:149,150 δH (250 MHz) 2.40-2.37 (2H, -CH2-CO-), 2.23-
2.17 (6H, m), 1.96-1.92 (2H, m), 1.61-1.59 (4H, m); δC (75 MHz, CDCl3); 199.3 
(>C=O), 157.0 (>C=C<), 132.2 (>C=C<), 37.8 (2°), 31.7 (2°), 31.4 (2°), 22.3 
(2°), 22.1 (2°), 22.0 (2°), 21.9 (2°). 
 
3-Vinylcyclohexanone (142)151 
 
This was performed by adaptation of a literature procedure.152 Copper (I) 
bromide-dimethyl sulphide complex (106 mg, 0.515 mmol, 10 mol%) was added 
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to a stirred solution of vinylmagnesium bromide (0.660 M, 15.6 mL, 10.4 mmol, 
2.00 equiv) in THF at 0°C, then stirred for 15 min. A solution of cyclohex-2-
enone 141 (500 mg, 5.20 mmol, 1.00 equiv) in dry THF (15 mL) was slowly 
added dropwise over 10 min. The resulting solution was stirred at 4–5°C for 90 
min. The reaction mixture then was added to a cold aq. solution of NH4Cl (40 
mL). The organic layer was separated and the aq. layer extracted with ether. 
The combined organic extracts were dried over MgSO4, and then filtered. The 
filtrate was concentrated under reduced pressure and purified by column 
chromatography (5 to 10% EtOAc in petroleum ether) to give the title vinyl 
ketone 142 (323 mg, 50%) as a colourless oil; Rf 0.35 (10% EtOAc in petroleum 
ether). Analytical data were consistent with those previously reported151,153: δH 
(250 MHz, CDCl3) 5.63-5.50 (1H, m, CH2-CH-), 4.93-4.86 (2H, m, CH2-CH-), 
2.30-1.20 (11H, m); δC (75 MHz, CDCl3); 200.2 (>C=O), 151.1 (CH2-CH-), 130.3 
(CH2-CH-), 38.5 (2°), 26.0 (2°), 23.1 (2°). 
 
1-Vinyl-,2,3,4,4a,5,6,7,8-octahydronaphthalen-4a-ol (144) 
 
This was performed by adaptation of a literature procedure.152 Copper (I) 
bromide-dimethyl sulfide complex (67.0 mg, 0.325 mmol, 0.500 equiv) was 
added to a stirred solution of vinylmagnesium bromide (1.40 M, 0.942 mL, 1.32 
mmol, 2.00 equiv) in THF at 0°C, then stirred for 15 min. A solution of 
3,4,5,6,7,8-hexahydronaphthalen-1(2H)-one 134 (100 mg, 0.665 mmol, 1.00 
equiv) in dry THF (5 mL) was slowly added dropwise over 10 min period. The 
resulting solution was stirred at 0–5°C for 2 h. The reaction mixture then was 
added to a cooled to 0 ºC aq. solution of NH4Cl (3 × 10 mL). The organic layer 
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was separated and the aqueous layer extracted with Et2O (2 × 15 mL). The 
combined organic extracts were dried over MgSO4, and then filtered. The filtrate 
was concentrated under reduced pressure and purified by column 
chromatography (5 to 50% EtOAc in petroleum ether) to give the title alcohol 
144 (27.8 mg, 24%) as a colourless oil; Rf 0.66 (25% EtOAc in petroleum ether); 
δH (300 MHz, CDCl3) 6.84 (1H, dd, J 17.0, 11.0 Hz, CH2-CH-), 5.26 (1H, dd, 
Jtrans 17.0, 1.0 Hz, CH2-CH-), 5.07 (1H, d, Jcis 11.0 Hz, CH2-CH-), 2.83-2.78 (1H, 
m, -OH), 2.49-0.70 (14 H, m); δC (75 MHz, CDCl3) 138.9 (CH2=CH-), 134.5 
(CH2=CH-C<), 129.3 (4°), 113.4 (CH2=CH-), 70.0 (>C-OH), 40.9 (2°), 39.6 (2°), 
27.3 (2°), 26.1 (2°), 25.0 (2°), 21.7 (2°), 18.4 (2°); νmax (film), 3426, 2922, 2852, 
1460, 1377, 1179, 907, 733 cm-1; TOF-ESI+ m/z calculated for (C12H18O - H2O 
+ H)+ 161.1325, found, 161.1322. 
1-vinyl-1,2,3,4,5,6,7,8-octahydronaphthalen-1-ol (143) 
δH (300 MHz, CDCl3) 5.81 (1H, dd, J 17.0, 10.5 Hz, CH2-CH-), 5.20 (1H, dd, 
Jtrans 17.0, 1.5 Hz, CH2-CH-), 5.10 (1H, dd, Jcis 10.5, 1.5 Hz, CH2-CH-), 2.41-
1.18 (15 H, m); δC (75 MHz, CDCl3) 143.6 (CH2=CH-), 133.0 (>C(-CH2-)=C<), 
128.7 (>C=C-(C4°)<), 112.7 (CH2=CH-), 68.1 (>C-OH), 37.8 (2°), 30.7 (2°), 30.6 
(2°), 24.0 (2°), 23.1 (2°), 22.8 (2°), 18.8 (2°); TOF-ESI+ m/z calculated for 
(C12H18O - H2O + H)+ 161.1325, found, 161.1327. 
 
1-Allyl-1,2,3,4,5,6,7,8-octahydronaphthalen-1-ol (160) 
 
This was performed by adaptation of a literature procedure.152 To a freshly 
prepared allylmagnesium bromide solution (0.640 M, 1.70 mL, 2.66 mmol, 2.00 
equiv) ketone 134 (200 mg, 1.33 mmol, 1.00 equiv) in THF (10 mL) was added 
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and stirred at –78 °C for 30 min. The reaction mixture then was quenched with 
NH4Cl (2 × 20 mL) cooled to 0 ºC aq. and extracted with Et2O (2 × 15 ml). The 
organic layer was dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure then purified by column chromatography (2.5 to 20% 
EtOAc in petroleum ether and 1% Et3N) to give the title alcohol 160 (104 mg, 
41%) as colourless oil; Rf 0.59 (25% EtOAc in petrol ether); δH (500 MHz, 
CDCl3) 5.72 (1H, ddt, J 16.5, 10.5, 7.0 Hz, allyl CH2=CH-), 5.06 (1H, d, Jtrans 
16.5 Hz, allyl -CH=CH2), 5.05 (1H, d, Jcis 10.0 Hz, allyl -CH=CH2), 2.37-2.30 
(2H, dd, J 7.0, 1.0 Hz, -CH2-CH=CH2), 2.21-2.17 (1H, m), 1.98-1.82 (5H, m), 
1.74-1.56 (7H, m), 1.49-1.36 (2H, m); δC (125 MHz, CDCl3) 134.5 (-CH=CH2), 
133.1 (>C=C<), 131.2 (>C=C<), 117.7 (-CH=CH2), 71.6 (>C(OH)-), 43.5 (-CH2-
CH=CH2), 35.9 (2°), 30.9 (2°), 30.8 (2°), 23.3 (2°), 23.2 (2°), 22.7 (2°), 18.6 (2°); 
νmax (film) 3380, 2927, 2858, 2828, 1436, 1365, 1168, 1089, 974 cm-1; TOF-
ESI+ m/z calculated for (C13H20O + Na)+, 215.1411; found, 215.1404. 
 
(E)-1-Allylidene-1,2,3,4,5,6,7,8-octahydronaphthalene (162) 
 
To a freshly prepared allylmagnesium bromide solution (0.120 M, 4.87 mL, 
0.585 mmol, 2.00 equiv) ketone 134 (44.0 mg, 0.292 mmol, 1.00 equiv) in THF 
(2 mL) was added and stirred at rt for 90 min. The reaction mixture was washed 
with cooled to 0 ºC aq. NH4Cl solution (2 × 20 mL) and extracted with Et2O (2 × 
15 ml). The organic layer was dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure then purified by column chromatography 
(eluents used: 2.5 to 10% EtOAc in petroleum ether and 1% Et3N) to give the 
title compound 162 (23.0 mg, 45%); Rf 0.59 (25% EtOAc in petrol ether); δH 
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(300 MHz, CDCl3) 6.72 (1H, ddd, J 16.5, 11.0, 10.0 Hz, CH2=CH-), 6.02 (1H, d, 
J 11.0 Hz, >C=CH-), 5.17 (1H, dd, Jtrans 16.5, 1.5 Hz, -CH=CH2), 5.02 (1H, dd, 
Jcis 10.0, 1.5 Hz, -CH=CH2), 2.46 (2H, t, J 6.0 Hz), 2.21-2.14 (2H, m), 2.09-2.01 
(4H, m), 1.71-1.53 (6H, m); δC (75 MHz, CDCl3) 138.9 (>C=C<), 137.8 (>C=CH-
), 134.1 (>C=C<), 128.7 (-CH=CH2), 120.5 (>C=CH-), 115.9 (-CH=CH2), 32.4 
(2°), 32.3 (2°), 30.1 (2°), 26.8 (2°), 25.4 (2°), 23.6 (2°), 22.9 (2°); νmax (film) 
2922, 2854, 1513, 1454, 1377, 1363, 1259, 1043, 984, 889 cm-1. TOF-ESI+ m/z 
calculated for (C13H18 + H)+, 175.1481; found, 175.1477. 
 
2-Bromo-N-(2,2-dimethoxyethyl)acetamide (165) 
Br
N
H
O
OMe
OMe
Br
O
OH
167
165
 
To a solution of bromoacetic acid 167 (2.77 g, 20.0 mmol, 1.00 equiv) and 
DMAP (122 mg, 1.00 mmol, 5 mol%) in DCM (100 mL), aminoacetaldehyde 
dimethyl acetal (2.11 g, 20.0 mmol, 1.00 equiv) was added dropwise followed 
by addition of N, N’-diisopropylcarbodiimide (3.09 mL, 2.52 g, 20.0 mmol, 1.00 
equiv). The reaction mixture was stirred at rt for 14 h. Precipitated urea was 
filtered and washed with DCM (2 × 25 mL). The filtrate then was concentrated 
under reduced pressure and purified by column chromatography (40% EtOAc in 
petroleum ether) to give the title acetamide 165 (3.04 g, 67%) as a pale yellow 
oil; Rf 0.31 (50% EtOAc in petrol ether); δH (250 MHz, CDCl3) 6.67 (1H, br, NH), 
4.38 (1H, t, J 5.0 Hz, -CH-(OCH3)2), 3.86 (2H, s, -CH2Br), 3.42 (2H, d, J 5.5 Hz -
NH-CH2-), 3.39 (6H, s, -OCH3); δC (62.5 MHz, CDCl3) 165.6 (>C=O), 102.2 (-
CH(OCH3)2), 54.4 (-OCH3), 41.5 (-NH-CH2-), 28.9 (-CH2Br); νmax (film) 3292, 
3084, 2941, 2835, 1654, 1539, 1430, 1387, 1366, 1193, 1125, 1072, 1053, 973, 
932, 885, 819 cm-1; TOF-ESI+ m/z calculated for (C6H12BrNO3 + Na)+, 
247.9898; found, 247.9889. 
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 (2-(2,2-Dimethoxyethylamino)-2-oxoethyl)triphenylphosphonium bromide 
(166) 
 
This was performed by adaptation of a literature procedure.154 The acetamide 
165 (800 mg, 5.53 mmol, 1.00 equiv) was dissolved in a 1:3 ratio mixture of 
THF and Et2O (60 mL), and to this solution, triphenylphosphine (1.85 g, 7.07 
mmol, 2.00 equiv) was added in one portion and left to stir at rt. After 45 min the 
clear reaction solution became turbid. After stirring for 15 h at rt, white 
precipitate of the phosphoniumsalt was collected by filtration and rinsed with 
Et2O (50 mL) and hexanes (50 mL) to remove residual triphenylphosphine. The 
crude was dissolved in DCM (1 mL) and precipitated with hexane (10 mL), 
separated from solvents and dried under high vacuum to give the title salt 166 
(1.15 g, 67%) as a white solid; m.pt. 143–145 °C; δH (300 MHz, CDCl3) 9.34 
(1H, t, J 5.5 Hz, -NH-CH2-), 7.85-7.74 9H, m, Aryl C-H), 7.68-7.60 (6H, m, Aryl 
C-H), 5.07 (2H, d, J 14.0 Hz, Ph3P+-CH2-CO-), 4.42 (1H, t, J 6.0 Hz, -NH-
CH(OCH3)2), 3.27 (6H, s, -CH(OCH3)2), 3.23 (2H, d, J 5.5 Hz-NH-CH2-
CH(OCH3)2); δC (75 MHz, CDCl3) 162.6 (1C, d, 1JCP 5.0 Hz, Ph3P+-CH2-CO-NH-
), 134.9 (1C, d, 1JCP 3.0 Hz, Ph3P+-CH2-CO-), 133.9 (1C, d, 1JCP 10.5 Hz, 
Ph3P+-CH2-CO-), 130.0 (1C, d, 1JCP 12.5 Hz, Ph3P+-CH2-CO-), 118.3 (1C, d, 
1JCP 87.5 Hz, Ph3P+-CH2-CO-), 101.0 (-CH2-CH(OCH3)2), 53.2 (-CH(OCH3)2), 
41.1 (-CH2-CH(OCH3)2), 32.3 (1C, d, 1JCP 59.0 Hz,Ph3P+-CH2-CO-); νmax (film), 
3054, 2899, 1668, 1550, 1458, 1336, 1110, 916, 719 cm-1; TOF-ESI+ m/z 
calculated for (C24H27NO3P)+, 408.1723, found, 408.1718. 
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Dimethyl 2-(2,2-dimethoxyethylamino)-2-oxoethylphosphonate (169) 
 
This was performed by adaptation of a literature procedure.62 A mixture of 2-
bromo-N-(2,2-dimethoxyethyl)acetamide 165 (1.59 g, 7.03 mmol, 1.00 equiv) 
and trimethyl phoshpite (2.48 mL, 21.1 mmol, 3.00 equiv) was heated neat for 
16 h at 105–110 °C. The reaction mixture was cooled, volatile materials were 
removed by vacuum distillation, after which the crude product was purified by 
column chromatography (5% MeOH in DCM) to give the title phosphonate 169 
(774 mg, 43%) as a colourless oil; Rf 0.11 (5% MeOH in DCM); δH (300 MHz, 
CDCl3) 6.82 (1H, br, -CO-NH-), 4.35 (1H, t, J 5.5 Hz, -CH2-CH(OCH3)2), 3.74 
(6H, d, 3JPH 11.0 Hz, -CH2-PO(OCH3)2), 3.36 (2H, d, J 5.5 Hz, -NH-CH2-
CH(OCH3)2), 3.33 (6H, s, -NH-CH2-CH(OCH3)2), 2.84 (2H, d, 2JPH 21.0 Hz, -CO-
CH2-PO(OCH3)2); δC (75 MHz, CDCl3) 163.9 (1C, d, 2JCP 18 Hz, (OCH3)2P-CH2-
CO-), 102.5 (-CH(OCH3)2), 54.0 (-CH(OCH3)2), 53.0 (2C, d, 2JCP 27 Hz, 
(OCH3)2P-CH2-CO-), 41.1 (-NH-CH2-CH(OCH3)2), 34.1 (1C, d, 1JCP 131.0 Hz, 
(OCH3)2P-CH2-CO-); νmax (film), 3447, 3289, 3084, 2997, 2955, 1655, 1552, 
1449, 1241, 1207, 1127, 1026, 926, 873 cm-1; TOF-ESI+ m/z calculated for 
(C8H18NO6P + H)+, 256.0949, found, 256.0926; calculated for (C8H18NO6P + 
Na)+, 278.0769, found, 278.0749. 
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2-Cyclohexylidene-N-(2,2-dimethoxyethyl)acetamide (171) 
 
This was performed by adaptation of a literature procedure.62 A stirred solution 
of phosphonoacetamide 169 (0.936 g, 0.366 mmol, 1.00 equiv) in dry THF (15 
mL) was treated with DBU (0.135 mL, 1.09 mmol, 3.00 equiv) and lithium 
chloride (46.2 mg, 1.09 mmol, 3.00 equiv) at rt. After stirring for 10 min, 170 
(0.037 mL, 0.366 mmol, 1.00 equiv) was added and the reaction mixture was 
stirred for 1.5 h at rt. The reaction mixture was then quenched by addition of a 
sat. NH4Cl solution (3 × 10 mL) and then extracted with EtOAc (3 × 10 mL). The 
combined organic extracts were washed with water (2 × 10 mL) followed by 
brine (20 mL), then were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(50% EtOAc in petroleum ether) to give the title amide 171 (22.2 mg, 27%) as 
colourless oil; Rf 0.60 (50% EtOAc in petrol ether); δH (300 MHz, CDCl3) 5.58 
(1H, br, -CO-NH-CH2-), 5.49 (1H, s, >C=CH-CONH-), 4.38 (1H, t, J 5.0 Hz, -
CH2-CH(OCH3)2), 3.42 (2H, d, J 5.5 Hz, -CO-NH-CH2-CH(OCH3)2), 3.38 (6H, s, 
-CH2-CH(OCH3)2), 2.82-2.77 (2H, m, -CH2-C(4º)-CH2-), 2.15-2.11 (2H, m, -CH2-
C(4º)-CH2-), 1.64-1.54 (6H, m, -CH2-CH2-CH2-CH2-CH2-); δC (75 MHz, CDCl3) 
167.1 (=CH-CO-NH-), 158.2 (>C=CH-CO-NH-), 115.3 (>C=CH-CONH-), 102.8 
(-CH2-CH(OCH3)2), 54.4 (-CH2-CH(OCH3)2), 40.5 (-CO-NH-CH2-), 37.7 (2°), 
29.6 (2°), 28.5 (2°), 27.7 (2°), 26.3 (2°); νmax (film), 3302, 2993, 2928, 2854, 
2834, 1658, 1632, 1535, 1447, 1246, 1226, 1187, 1128, 1056, 973, 851, 781, 
652 cm-1; TOF-ESI+ m/z calculated for (C12H21NO3 + H)+, 228.1599, found, 
228.1582; calculated for (C12H21NO3 + Na)+, 250.1419, found, 250.1401. 
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2-Bromo-N-(2-oxoethyl)acetamide (173) 
 
To a solution of acetamide 165 (0.057 g, 0.252 mmol, 1.00 equiv) in DCM (5 
mL) TFA (0.500 mL, 6.52 mmol, 25.8 equiv) was added dropwise and stirred 
under N2 at rt for 1 h. The reaction mixture was concentrated under reduced 
pressure and purified by column chromatography (25 to 75% EtOAc in 
petroleum ether) to give the title compound 173 (0.006 g, 13%) as a colourless 
oil; Rf 0.13 (50% EtOAc in petrol ether); δH (500 MHz, CDCl3) 9.65 (1H, s, >NH-
CH2-CHO), 7.23 (1H, br s, >NH-CH2-CHO), 4.22 (2H, d, J 5.0 Hz, >NH-CH2-
CHO), 3.91 (2H, s, -NH-CO-CH2Br); δC (125 MHz, CDCl3) 195.4 (>NH-CH2-
CHO), 166.0 (-NH-CO-CH2Br), 50.5 (>NH-CH2-CHO), 28.3 (-NH-CO-CH2Br); 
νmax (film) 3330, 2963, 1636, 1541, 1443, 1417, 1384, 1278, 1224, 1121, 1014, 
923, 885, 864, 715, 694 cm-1; TOF-ESI+ m/z calculated for (C4H6NO2Br + H)+, 
179.9660; found, 179.9679. 
 
(1R*,4aS*,8aS*)-9-Methylenedecahydro-1,4a-(epoxymethano)naphthalene 
(176) 
 
This was performed in accordance with a literature procedure.67 Acetyl chloride 
(89.4 mL, 1.25 mol, 2.40 equiv) was gradually added with stirring over 15 min. 
to a cooled (<25 °C) mixture of aluminium chloride (104 g, 0.786 mol, 1.50 
equiv) in DCM (225 mL). The resulting yellow-brown solution was decanted into 
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a flask, cooled to <10 °C, and decalin 175 (80.9 mL, 0.524 mol, 1.00 equiv) was 
gradually added over 30 min with stirring and cooling to keep the temperature of 
the reaction mixture below 10 °C. After a further 2 h at 10–15 °C, the mixture 
was gradually added to vigorously stirred slurry of crushed ice (1 kg) and water. 
The lower organic layer was separated and, together with DCM extracts of the 
aqueous layer, washed several times with ice-cold water and dried over MgSO4, 
then filtered. The filtrate was concentrated under reduced pressure. Fractional 
distillation of the residual brown oil gave crude product (b.p. 82–85 °C at 5.8 
Torr) which was then further purified by refluxing with LiAlH4 (0.5 g) in dry Et2O 
(30 mL) for 30 min. Excess of hydride was destroyed by cautious addition of 
EtOAc (5 mL), and ice-cold dilute sulfuric acid (50 mL, 0.5 N) was gradually 
added to the cooled mixture. The ethereal layer was separated and, with further 
ethereal extracts of aqueous layer, was washed with water (2 × 50 mL) and 
dried over MgSO4, then filtered. The filtrate was concentrated under reduced 
pressure. Further distillation afforded the pure title enol ether 176 (22.8 g, 25%) 
as a pale yellow oil; b.pt. 65 °C at 1.5 Torr; δH (250 MHz, CDCl3) 4.22 (1H, dt, J 
1.0, 0.5 Hz, >CH-O-), 4.03 (1H, d, J 4.5 Hz, =CH2), 3.66 (1H, d, J 1.5 Hz, 
=CH2), 0.86-1.07 (15H, m); δC (75 MHz, CDCl3) 166.0 (>C=CH2), 80.5 (>CH-O-
), 76.9 (=CH2), 50.0 (3°), 46.2 (4°), 39.5 (2°), 31.3 (2°), 30.2 (2°), 26.5 (2°), 24.9 
(2°), 22.1 (2°), 18.9 (2°); νmax (film) 2927, 2860, 1679, 1455, 1369, 1198, 1106, 
cm-1; TOF-ESI+ m/z calculated for (C12H18O + H)+, 179.1435, found, 179.1422. 
 
1-((1R*,4aS*,8aS*)-1-Hydroxydecahydronaphthalen-4a-yl)ethanone (177) 
 
This was performed in accordance with a literature procedure.68 A mixture of 
vinyl ether 176 (20.1 g, 113 mmol, 1.00 equiv) in Et2O (150 mL) and dilute 
Chapter 4  Experimental 
139 
sulfuric acid (1.00 N, 290 mL) was stirred and refluxed for 2.5 h. The ether layer 
was separated and, aqueous layed was washed with ether (2 × 100 mL) and 
combined organic extracts was dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure. The residue was washed with cold light 
petroleum to give the title product 177 (11.2 g, 51%), which crystallised from 
light petrol; m.pt. 60–61 °C; Rf 0.54 (50% EtOAc in petroleum ether). Crystals of 
177 suitable for X-ray diffraction were grown by slow diffusion of petrol ether 
vapour into a solution of 177 in MeOH; δH (300 MHz, CDCl3) 5.46 (1H, dd, J 8.5, 
0.5 Hz, -OH), 3.70 (1H, dq, J 8.5, 3.0 Hz, >CH-OH), 2.17 (1H, s, -CO-CH3), 
1.96-1.64 (6H, m), 1.53-1.16 (8H, m), 1.21-0.99 (1H, m); δC (75 MHz, CDCl3) 
217.5 (>CO-CH3), 68.9 (>CH-OH), 56.1 (3°), 48.8 (4°), 39.5 (2°), 36.9 (2°), 35.0 
(2°), 26.9 (>CO-CH3), 26.4 (2°), 25.7 (2°), 24.2 (2°), 17.2 (2°); νmax (film), 3751, 
3649, 3351, 2927, 2860, 2554, 2350, 2159, 2032, 1977, 1679, 1455, 1369, 
1253, 1198, 1177, 1137, 1106, 1066, 1041, 1009, 981, 947, 915, 884, 778, 720, 
644, 618 cm-1; TOF-ESI+ m/z calculated for (C12H20O2 + H)+, 197.1541, found, 
197.1514; calculated for (C12H20O2 + Na)+, 219.1361, found, 219.1327. 
 
1-((1R*,4aS*,8aS*)-1-((tert-Butyldimethylsilyl)oxy)decahydronaphthalen-4a-
yl)ethanone (191) 
 
tert-Butyldimethylsilyl chloride (0.370 g, 2.46 mmol, 1.25 equiv) was slowly 
added to a solution of hydroxyketone 177 (0.387 g, 1.97 mmol, 1.00 equiv) and 
imidazole (0.537 g, 7.89 mmol, 4.00 equiv) in dry DMF (6 mL) with stirring at 0 
°C. The reaction mixture was allowed to warm to rt, stirred for 17 h, and poured 
into an ice cold aq. solution of LiCl (20 mL). The aqueous mixture was extracted 
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with EtOAc (3 × 15 mL), and then the organic layer was washed with brine (3 × 
10 mL), dried over MgSO4 and filtered. The filtrate was concentrated under 
reduced pressure to furnish the crude product which was purified by column 
chromatography (1% to 5% EtOAc in petroleum ether) to give the title ketone 
191 (0.58 g, 95%) as a colourless oil; Rf 0.53 (5% EtOAc in pertroleum ether); 
δH (300 MHz, CDCl3) 3.74 (1H, br s, >CH-OSi(CH3)2-), 2.16 (3H, s, -CO-CH3), 
1.86-1.68 (14H, m), 1.57-1.02 (11H, m), 0.85 (9H, s, -Si(CH3)2-C(CH3)3), 0.01 
(3H, s, -Si(CH3)2-C(CH3)3), -0.02 (3H, s, -Si(CH3)2-C(CH3)3); δC (75 MHz, CDCl3) 
210.5 (>CO-CH3), 71.8 (>CH-OSi(CH3)2-), 52.2 (3°), 48.7 (4°), 38.9 (2°), 38.1 
(2°), 35.1 (2°), 28.2 (>Si(CH3)2-C(CH3)3), 27.1 (2°), 26.5 (>CO-CH3), 25.7 
(>Si(CH3)2-C(CH3)3), 21.3 (2°), 18.8 (2°), 18.0 (2°), -4.8 (>Si(CH3)2-C(CH3)3), -
4.8 (>Si(CH3)2-C(CH3)3); νmax (film), 2929, 2855, 1702, 1461, 1445, 1361, 1344, 
1251, 1202, 1158, 1069, 1049, 1017, 983, 954, 925, 900, 866, 837, 807, 774, 
650 cm-1; TOF-ESI+ m/z calculated for (C18H34O2Si + H)+, 311.2406, found, 
311.2406; calculated for (C18H34O2Si + Na)+, 333.2225, found, 333.2236. 
 
(1R*,4aS*,8aS*)-4a-((R*)-1-Hydroxyethyl)decahydronaphthalen-1-ol (193) 
(1R*,4aS*,8aS*)-4a-((S*)-1-Hydroxyethyl)decahydronaphthalen-1-ol (194) 
 
Procedure A 
 
A solution of silyl ether 191 (550 mg, 1.77 mmol, 1.00 equiv) in dry ether (10 
mL) was added to a suspension of LiAlH4 (100 mg, 2.65 mmol, 1.50 equiv) in 
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dry ether (10 mL). The mixture was stirred at rt for 17 h. Water was added until 
effervescence ceased, followed by aq. HCl (1.0 M) until all unreacted LiAlH4 
was consumed. After extraction with ether (3 × 15 mL), the combined organic 
extracts were dried over MgSO4 and filtered. The filtrate was purified by column 
chromatography (25% to 50% EtOAc in petroleum ether) to give two 
diastereomers 193 and 194:  
Diol 193 (270 mg, 77%) white solid; m.pt. 120–121 °C. Crystals of 193 suitable 
for X-ray diffraction were grown by slow diffusion of petrol ether vapour into a 
solution of 193 in chloroform. Rf 0.14 (25% EtOAc in petroleum ether); δH (300 
MHz, CDCl3) 5.64 (2H, s, -OH), 4.28 (1H, q, J 6.0 Hz, -CH(CH3)OH), 3.69-3.66 
(1H, m, >CH-OH), 2.16-1.76 (5H, m), 1.56-1.28 (8H, m), 1.14 (3H, d, J 6.0 Hz, -
C(OH)-CH3), 0.94-0.72 (2H, m); δC (75 MHz, CDCl3) 69.9 (-CH(CH3)-OH), 66.3 
(>CH-OH), 50.4 (HO-CH(CH3)-C(4°)-CH<), 41.5 (HO-CH(CH3)-C(4°)-CH<), 
39.5 (2°), 34.4 (2°), 33.9 (2°), 27.1 (2°), 25.2 (2°), 21.8 (2°), 18.9 (2°), 17.1 (-
C(OH)-CH3); νmax (film), 3152, 2921, 2867, 1456, 16374, 1319, 1261, 1196, 
1155, 1123, 1088, 1051, 1013, 987, 956, 934, 903, 885, 866, 843, 798, 774, 
731, 667 cm-1; TOF-ESI+ m/z calculated for (C12H22O2 + H)+, 199.1698, found, 
199.1684; calculated for (C12H22O2 + Na)+, 221.1517, found, 221.1507. 
Diol 194 (22 mg, 6%) as a white solid; Rf 0.37 (25% EtOAc in pertroleum ether); 
δH (250 MHz, CDCl3) 4.45 (1H, q, J 6.5 Hz, -CH(CH3)OH), 3.92-3.88 (1H, m, 
(>CH-OH), 2.72 (2H, s, -OH), 2.36-2.17 (1H, m, HO-CH(CH3)-C(4°)-CH<), 1.98-
1.24 (12H, m), 1.17 (3H, d, J 6.5 Hz, -CH(CH3)OH), 0.97-0.70 (2H, m); δC (75 
MHz, CDCl3) 72.2 (-CH(CH3)OH), 71.8 (>CH-OH), 50.7 (HO-CH(CH3)-C(4°)-
CH<), 39.1 (HO-CH(CH3)-C(4°)-CH<), 38.3 (2°), 37.6 (2°), 34.6 (2°), 28.5 (2°), 
27.4 (2°), 22.9 (2°), 18.4 (2°), 17.2 (CH3); νmax (film), 3298, 2924, 2850, 1452, 
1370, 1335, 1307, 1261, 1195, 1152, 1126, 1092, 1068, 1042, 1030, 1008, 
9889, 976, 953, 928, 903, 881, 845, 803, 779, 731, 674, 631 cm-1; TOF-ESI+ 
m/z calculated for (C12H22O2 + H)+, 199.1698, found, 199.1683; calculated for 
(C12H22O2 + Na)+, 221.1517, found, 221.1499. 
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Procedure B 
 
To a solution of silyl ether 192 (288 mg, 0.921 mmol, 1.00 equiv) in dry THF (5 
mL) TBAF solution in THF (1.00 M, 1.01 mL, 1.01 mmol, 1.10 equiv) was added 
at º0 C. The mixture was stirred at rt for 16 h before being diluted it with DCM 
(20 mL), washed with water (2 × 15 mL), brine (20 mL), the combined organic 
extracts were dried over MgSO4 and filtered. The filtrate was purified by column 
chromatography (25% to 50% EtOAc in petroleum ether) to give the title diol 
193 (0.147 g, 81%) as a white solid. Spectroscopic data correspond to those 
reported in procedure A. 
 
(R*)-1-((1R*,4aS*,8aS*)-1-((tert-
Butyldimethylsilyl)oxy)decahydronaphthalen-4a-yl)ethanol (192) 
 
To a solution of ketone 191 (1.65 g, 5.31 mmol, 1.00 equiv) in dry DCM (20 mL) 
at –78 °C was added DIBAL-H (1.00 M in DCM; 7.97 mL, 7.97 mmol, 1.50 
equiv). The reaction mixture was stirred at –78 °C for 5 min, then at rt for 1.5 h. 
The reaction mixture was diluted with EtOAc (150 mL) and poured into sat. aq. 
sodium potassium tartrate (150 mL) and water (150 mL). The reaction mixture 
was stirred vigorously for 30 min. The aqueous phase was washed with EtOAc 
Chapter 4  Experimental 
143 
(2 × 50 mL). The combined organic layers were washed with brine (2 × 50 mL), 
dried over MgSO4 and filtered. The filtrate was concentrated under reduced 
pressure and purified by chromatography (25% EtOAc-petroleum ether) to give 
the title product 192 (1.15 g, 70%) as an colourless oil; Rf 0.88 (25% EtOAc in 
petroleum ether); δH (300 MHz, CDCl3) 5.38 (1H, app s, OH), 4.26 (1H, q, J 6.0 
Hz, -CH(CH3)-OH), 3.81 (1H, q, J 3.0 Hz >CH-OH), 2.29-2.13 (1H, m), 2.08-
1.94 (1H, m), 1.86-1.70 (3H, m), 1.59-1.21 (8H, m), 1.12 (3H, dd, J 6.0, 1.0 Hz, 
-CH(CH3)-OH), 0.89 (9H, s, >Si(CH3)2-C(CH3)3), 0.86-0.68 (2H, m), 0.08 (6H, s, 
>Si(CH3)2-C(CH3)3); δC (75 MHz, CDCl3) 72.6 (>CH-O- Si(CH3)2-C(CH3)3), 65.7 
(-CH(CH3)-OH), 50.7 (HO-CHCH3-C(4°)-CH<), 41.8 (2°), 39.6 (HO-CHCH3-
C(4°)-CH<), 34.1 (2°), 33.8 (2°), 27.1 (>Si(CH3)2-C(CH3)3), 25.88 (2°), 25.82 
(>Si(CH3)2-C(CH3)3), 21.3 (2°), 19.0 (2°), 18.5 (2°), 16.4 (CH3), -4.76 
(>Si(CH3)2-C(CH3)3), -4.92 (>Si(CH3)2-C(CH3)3); νmax (film), 3402, 2928, 2857, 
1462, 1385, 1364, 1199, 1163, 1094, 1071, 981, 939, 822 cm-1; TOF-ESI+ m/z 
calculated for (C18H36O2Si + H)+, 313.2562, found, 313.2547; calculated for 
(C18H36O2Si + Na)+, 335.2382, found, 335.2374. 
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1-((1R*,4aS*,8aS*)-1-Hydroxydecahydronaphthalen-4a-yl)ethanone N-
(2,4,6-trimethylbenzenesulfonyl)hydrazone (199) 
 
Procedure A 
To a solution of hydroxyketone 177 (5.00 g, 25.4 mmol, 1.00 equiv) in ethanol 
(125 mL) was added 2,4,6-trimethylbenzenesulfonohydrazide (5.46 g, 25.4 
mmol, 1.00 equiv), p-TSA (5 mol%) and 4Å molecular sieves. The reaction 
mixture was refluxed for 3 h. The reaction mixture was left to cool over 16 h, 
during which time the product crystallised. The precipitate was then filtered and 
washed with cold ethanol (2 × 50 mL), to give the desired hydrazone 199 (8.58 
g, 86%) as a single isomer and a white solid; m.pt. 173–175 °C; Rf 0.47 (40% 
EtOAc in petroleum ether); δH (300 MHz, CDCl3) 6.97 (2H, s, Ar-H), 5.33 (1H, br 
s, -NH-), 3.60 (1H, s br, -OH), 2.69 (6H, s, Ar-o-CH3), 2.29 (3H, s, Ar-p-CH3), 
1.79 (3H, s, -CH3), 1.82-1.76 (3H, m), 1.43-0.99 (12H, m) 0.65-0.52 (1H, m); δC 
(75 MHz, CDCl3) 161.2 (CH3-C=N-), 143.0 (Ar-C), 139.8 (Ar-C), 132.4 (Ar-C), 
131.9 (Ar-C), 69.4 (>C-OH), 49.6 (3°), 49.0 (4°), 39.4 (2°), 37.5 (2°), 35.4 (2°), 
27.3 (2°), 25.2 (2°), 23.0 (2°), 22.6 (-C(CH3)=N-), 20.9 (2°), 17.2 (1°), 12.6 (1°); 
νmax (film) 3360, 3261, 2938, 2857, 1636, 1604, 1446, 1380, 1338, 1161, 1110, 
950, 891 cm-1; TOF-ESI+ m/z calculated for (C21H32N2O3S + H)+, 393.2211, 
found, 393.2205; calculated for (C21H32N2O3S + Na)+, 415.2031, found, 
415.2018. 
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Procedure B 
To a solution of enol ether 176 (6.93 g, 38.9 mmol, 1.00 equiv) in ethanol (125 
mL) was added 2,4,6-trimethylbenzenesulfonohydrazide (8.33 g, 38.9 mmol, 
1.00 equiv) and p-TSA (10 mol%). The reaction mixture was refluxed for 4 h. 
The reaction mixture was left to cool over 16 h, during which time the product 
crystallised. The precipitate was then filtered and washed with cold ethanol (3 × 
30 mL), to give the desired hydrazone 199 (10.0 g, 66%) as a white solid. 
Spectroscopic data correspond to those reported in procedure A. 
 
1-((1R*,4aS*,8aS*)-1-Hydroxydecahydronaphthalen-4a-yl)ethanone N-(4-
trimethylbenzenesulfonyl)hydrazone (200) 
 
Procedure A 
To a solution of hydroxyketone 177 (550 mg, 2.80 mmol, 1.00 equiv) in ethanol 
(15 mL) was added p-toluenesulfonyl hydrazide (520 mg, 2.80 mmol, 1.00 
equiv), p-TSA (5.3 mg, 10 mol%) and 4Å molecular sieves. The reaction mixture 
was refluxed for 3 h. The reaction mixture was left to cool overnight, during 
which time the product crystallised. The precipitate was then filtered and 
washed with cold ethanol (2 × 10 mL), to give the desired hydrazone 200 (820 
mg, 80%) as a single isomer and a white solid; m.pt. 174–176 °C; Rf 0.36 (30% 
EtOAc in petroleum ether); δH (300 MHz, CDCl3) 8.26 (1H, br s, -NH-) 7.93 (2H, 
d, J 8.0 Hz, Ar-H), 7.32 (2H, d, J 8.0 Hz, Ar-H), 5.70 (1H, br s, -OH), 3.66-3.64 
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(1H, m, >CH-CH(OH)-), 2.41 (3H, s, Ar-CH3), 1.84-1.70 (3H, m), 1.75 (3H, s, -
C(CH3)=N-), 1.49-1.00 (11H, m) 0.68-0.55 (1H, m); δC (75 MHz, CDCl3) 162.5 (-
C(CH3)=N-), 144.2 (Ar-C), 135.4 (Ar-C), 129.7 (Ar-C), 128.1 (Ar-C), 69.3 (>C-
OH), 49.6 (>CH-CH(OH)-), 49.1 (4°), 39.7 (2°), 37.2 (2°), 35.4 (2°), 27.1 (2°), 
25.5 (2°), 23.0 (2°), 21.5 (-C(CH3)=N-), 17.0 (2°), 13.2 (1°); νmax (film) 3658, 
3270, 2981, 2919, 2855, 1599, 1456, 1342, 1241, 1167, 1094, 994, 951, 812 
cm-1; TOF-ESI+ m/z calculated for (C19H28N2O3S + Na)+, 387,1777, found, 
387,1777. 
Procedure B 
To a solution of enol ether 176 (13.9 g, 77.8 mmol, 1.00 equiv) in ethanol (175 
mL) was added p-toluenesulfonyl hydrazide (14.5 g, 77.8 mmol, 1.00 equiv) and 
p-TSA (147 mg, 10 mol%). The reaction mixture was refluxed for 3 h. The 
reaction mixture was left to cool to rt. The precipitated product was then filtered 
and washed with cold ethanol (3 × 50 mL), to give the desired hydrazone 200 
(15.7 g, 55%) as a white solid. Spectroscopic data correspond to those reported 
in procedure A. 
 
(1R*,4aR*,8aS*)-4a-Vinyldecahydronaphthalen-1-yl acetate (201) 
 
This was performed by adaptation of a literature procedure.155 To a solution of 
hydrazide 199 (206 mg, 0.525 mmol, 1.00 equiv) in THF (10 mL), n-BuLi (0.740 
M, 2.12 mL, 1.62 mmol, 3.05 equiv), was added dropwise within 5 min at –78 
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°C. Bright yellow reaction mixture was warmed up to rt and stirred for 1.5 h. The 
reaction mixture then was diluted with EtOAc (20 mL), washed with aqueous 
NH4Cl solution (3 × 10 mL), brine (2 × 15 mL), water (15mL). The combined 
organic extracts were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure to give the crude. Purification by column 
chromatography (2.5 to 10% EtOAc in petroleum ether) gave the title acetate 
201 (76.6 mg, 66%) as a colourless oil; Rf 0.77 (25% EtOAc in petroleum ether); 
δH (300 MHz, CDCl3) 6.51 (1H, dd, J 17.5, 11.0 Hz, -CH=CH2), 5.09 (1H, dd, Jcis 
11.0, 1.5 Hz, -CH=CH2), 4.99 (1H, dd, Jtrans 17.5, 1.5 Hz, -CH=CH2), 4.93 (1H, 
q, J 2.5 Hz, >CH(OCOCH3)-), 2.03 (3H, s, -OCH3), 1.89-1.62 (6H, m), 1.58-1.10 
(8H, m), 0.90-0.82 (1H, m); δC (75 MHz, CDCl3) 170.7 (-OCOCH3), 143.4 (-
CH=CH2), 111.7 (-CH=CH2), 73.7 (>CH(OCOCH3)-), 48.1 (>CH-CH(OH)-), 42.4 
(4°), 40.3 (2°), 40.2 (2°), 31.1 (2°), 26.9 (2°), 25.9 (2°), 21.9 (2°), 21.2 (2°), 17.4 
(1°); νmax (film) 2929, 2929, 2853, 1735, 1633, 1451, 1377, 1243, 1229, 1152, 
1021, 907 cm-1; TOF-ESI+ m/z calculated for (C14H22O2 + Na)+, 245.1517, 
found, 245.1508. 
 
(1R*,4aR*,8aS*)-4a-Vinyldecahydronaphthalen-1-ol (182) 
 
Procedure A 
This was performed by adaptation of a literature procedure.155 To a solution of 
mesityl hydrazone 199 (2.42 g, 6.17 mmol, 1.00 equiv) in Et2O (40 mL) was 
added n-BuLi in hexanes (1.74 M, 10.8 mL, 18.8 mmol, 3.09 equiv), dropwise 
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over 10 min at –78 °C. Then bright yellow reaction mixture was warmed up to rt 
and the resulting orange solution then stirred for 1.5 h. The reaction mixture 
then was washed with aq. NH4Cl solution (3 × 20 mL), brine (2 × 20mL). The 
combined organic extracts were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure to give the crude. Purification by column 
chromatography (10 to 20% EtOAc in petroleum ether) gave the title product 
182 (1.10 g, 99%) as a colourless oil; Rf 0.50 (25% EtOAc in petroleum ether); 
δH (300 MHz, CDCl3) 6.55 (1H, dd, J 18.0, 11.0 Hz, -CH=CH2), 5.07 (1H, dd, Jcis 
11.0, 1.5 Hz, -CH=CH2), 5.01 (1H, dd, Jtrans 18.0, 1.5 Hz, -CH=CH2), 3.65 (1H, 
q, J 2.5 Hz, -O-CH), 1.83-1.68 (6H, m), 1.52-1.19 (8H, m), 1.15-1.03 (2H, m); δC 
(75 MHz, CDCl3) 142.8 (-CH=CH2), 112.2 (-CH=CH2), 72.0 (>CH-OH), 49.6 
(2°), 43.1 (>CH-CH(OH)-), 39.5 (4°), 38.3 (2°), 33.9 (2°), 26.9 (2°), 25.6 (2°), 
21.7 (2°), 16.6 (2°); νmax (film) 3416, 2925, 2849, 1629, 1450, 12.43, 1153, 927, 
903 cm-1; TOF-ESI+ m/z calculated for (C12H20O + H)+, 181.1592, found, 
181.1583; (C12H20O + Na)+, 203.1411, found, 203.1398. 
 
Procedure B 
To a solution of tosyl hydrazone 200 (0.720 g, 1.99 mmol, 1.00 equiv) in a 
mixture of Et2O (20 mL) and THF (5mL) was added n-BuLi in hexanes (1.39 M, 
4.42 mL, 6.15 mmol, 3.09 equiv), dropwise within 5 min at –78 °C. Then bright 
yellow reaction mixture was left to warm up to rt and the resulting orange 
solution then stirred under nitrogen atmosphere for 3.5 h. The reaction mixture 
then was washed with aq. NH4Cl solution (3 × 20 mL), brine (20mL). The 
combined organic extracts were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure to give the crude. Purification by column 
chromatography (10 to 20% EtOAc in petroleum ether) gave the title product 
182 (0.25 g, 70%) as a colourless oil. Spectroscopic data correspond to those 
reported in procedure A. 
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(4aR*,8aS*)-4a-Vinyldecahydronaphthalen-1-one (135) 
 
This was performed by adaptation of a literature procedure.156 To a stirred 
solution of oxalyl chloride (1.59 mL, 18.5 mmol, 1.10 equiv) in DCM (80 mL) at –
78 °C under nitrogen was added dimethyl sulfoxide (2.57 mL, 36.2 mmol, 2.15 
equiv). The solution was stirred for 10 min, and then vinyl alcohol 182 (3.04 mg, 
16.8 mmol, 1.00 equiv) in dry DCM (20 mL) was added. The reaction mixture 
was stirred for 90 min at –78 °C, and then Et3N (11.83 mL, 84.31 mmol, 5.00 
equiv) was added. After 15 min the solution was allowed to warm to rt over 30 
min, then water (100 mL) was added and the reaction mixture was transferred 
to a separating funnel. The mixture extracted with DCM (3 × 50 mL). The 
combined organic extracts were washed with brine (2 × 50 mL) and dried over 
MgSO4, then filtered. The filtrate was concentrated under reduced pressure and 
purified by column chromatography (10% EtOAc in petroleum ether) to give the 
title ketone 135 (2.98 g, 99%) as a pale yellow oil; Rf 0.58 (25% EtOAc-
petroleum ether); δH (300 MHz, CDCl3) 5.48 (1H, dd, J 18.0, 11.0 Hz, -
CH=CH2), 5.12 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 4.93 (1H, dd, Jtrans 18.0, 
1.0 Hz, -CH=CH2), 2.29-2.23 (2H, m), 2.15 (1H, dd, J 12.0, 3.0 Hz) 1.87-1.59 
(7H, m), 1.47-1.25 (4H, m), 1.25-1.05 (1H, m); δC (75 MHz, CDCl3) 212.3 
(>C=O), 140.6 (-CH=CH2), 116.1 (-CH=CH2), 57.0 (>CH-CO-), 46.1 (4°), 41.2 
(2°), 39.9 (2°), 39.8 (2°), 25.5 (2°), 22.1 (2°), 21.4 (2°), 21.0 (2°); νmax (film) 
2931, 2851, 1708, 1638, 1449, 1366, 1311, 1206, 1089, 999, 918, 838 cm-1; 
TOF-ESI+ m/z calculated for (C12H18O + H)+, 179.1435, found, 179.1428; 
(C12H18O + Na)+, 201.1255, found, 201.1246. 
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(4aR*,8aS*)-1-Butyl-4a-vinyldecahydronaphthalen-1-ol (203) 
 
A stirred solution of phosphonoacetamide 169 (79.3 mg, 0.352 mmol, 1.00 
equiv) in dry THF (10 mL) was treated with n-BuLi in hexanes (1.00 mL, 0.704 
mmol, 2.00 equiv) at –78 °C and stirred for 10 min. Then ketone 135 (62.8 mg, 
0.352 mmol, 1.00 equiv) in THF (10 mL) was added within 10 min and the 
resulting mixture was stirred for 1 h at –78 °C, then warmed up to rt and stirred 
for additional hour. The reaction mixture was then quenched by addition of a 
sat. NH4Cl solution (20 mL), extracted with DCM (2 × 15 mL). The combined 
organic extracts were washed with water (2 × 10 mL) followed by brine (20 mL), 
then was dried over MgSO4 and filtered. The filtrate was concentrated under 
reduced pressure and purified by column chromatography (5 to 20% EtOAc in 
petroleum ether) to give the title product 203 (0.714 g, 86%) single isomer as a 
colourless oil; Rf 0.58 (25% EtOAc-petroleum ether); δH (300 MHz, CDCl3) 6.58 
(1H, dd, J 18.0, 11.0 Hz, CH2=CH-), 5.16 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 
5.09 (1H, dd, Jtrans 18.0, 1.5 Hz, -CH=CH2), 1.93-1.04 (22H, m), 0.89 (3H, t, J 
14.0 Hz, -CH2-CH3); δC (75 MHz, CDCl3) 142.6 (-CH=CH2), 112.7 (-CH=CH2), 
73.9 (>C(OH)-CH2-CH2-), 51.2 (>CH-C(OH)-CH2-CH2-), 44.5 (4°), 40.1 (2°), 
39.9 (2°), 37.8 (2°), 37.2 (2°), 27.1 (2°), 25.9 (2°), 23.3 (2°), 21.7 (2°), 19.9 (2°), 
17.6 (2°), 14.0 (1°); νmax (film) 3474, 2924, 2852, 1454, 1378, 1282, 1147, 1005, 
900 cm-1; TOF-ESI+ m/z calculated for (C16H28O + Na)+, 259.2037, found, 
259.2014. 
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Methyl 2-(4a-vinyldecahydronaphthalen-1-ylidene)acetate (205) 
 
This was performed by adaptation of a literature procedure.157 A solution n-BuLi 
in THF (1.81 M, 5.65 mmol, 1.68 equiv) was added to a solution of methyl 2-
(dimethoxyphosphoryl)acetate 204 (0.990 mL, 6.93 mmol, 2.06 equiv) in dry 
THF (20 mL) at –78 °C and stirred for 30 min while temperature was left to rise 
to –10 °C. Then it was re-cooled to –78 °C and a solution of vinyl ketone 135 in 
THF was added dropwise. The resulting warmed up to rt within 1 h, then 
refluxed for 64 h. The reaction mixture was then quenched by careful addition of 
a sat. NH4Cl solution and then extracted with EtOAc (3 × 15 mL). The combined 
organic extracts were washed with brine (2 × 15 mL), then was dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure then 
purified by column chromatography (5% EtOAc in petroleum ether) to give the 
title product as inseparable mixture of two epimers 205 (62.5 mg, 19%) as pale 
yellow oil; Rf 0.59 (10% EtOAc-petroleum ether): 
Major epimer: δH (500 MHz, CDCl3) 5.74 (1H, dd, J 18.0, 11.0 Hz CH2=CH-), 
5.48 (1H, s, >C=CH-CO2CH3), 5.12 (1H, d, Jcis 11.0 Hz, -CH=CH2), 5.00 (1H, d, 
Jtrans 18.0 Hz, -CH=CH2), 3.95-3.91 (1H, m, >CH-C(4º)<), 3.68 (3H, s, =CH-
CO2CH3), 1.99-1.95 (1H, m), 1.86-1.73 (3H, m), 1.66-1.21 (10H, m); δC (125 
MHz, CDCl3) 167.3 (>C=CH-CO2CH3), 164.5 >C=CH-CO2CH3), 141.0 (-
CH=CH2), 114.4 (-CH=CH2), 112.0 (>C=CH-CO2CH3), 52.1 (1°), 50.8 (>CH-
C4°<), 44.6 (4°), 42.3 (2°), 40.0 (2°), 30.7 (2°), 26.4 (2°), 24.8 (2°), 23.4 (2°), 
21.6 (2°); νmax (film) 2927, 2857, 1716, 1638, 1433, 1385, 1208, 1165, 1137, 
1025, 999, 913, 856, 732 cm-1; TOF-ESI+ m/z calculated for (C15H22O2 + H)+, 
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235.1698, found, 235.1677; calculated for (C15H22O2 + Na)+, 257.1517, found, 
257.1506. 
Minor epimer: δH (500 MHz, CDCl3) 5.71 (1H, dd, J 17.0, 10.5 Hz CH2=CH-), 
5.65 (1H, s, >C=CH-CO2CH3), 4.96 (1H, d, Jcis 10.5 Hz, -CH=CH2), 4.94 (1H, d, 
Jtrans 17.0 Hz, -CH=CH2), 3.67-3.66 (1H, m, >CH-C(4º)<), 3.65 (3H, s, =CH-
CO2CH3), 2.12 (1H, dd, J 12.0, 4.0 Hz), 2.04 (2H, dq, J 13.5, 4.0 Hz), 1.82-1.19 
(11H, m); δC (125 MHz, CDCl3) 167.1 (>C=CH-CO2CH3), 166.0 >C=CH-
CO2CH3), 147.6 (-CH=CH2), 114.2 (-CH=CH2), 112.1 (>C=CH-CO2CH3), 52.2 
(1°), 50.7 (>CH-C4°<), 41.1 (4°), 38.7 (2°), 38.0 (2°), 28.9 (2°), 25.9 (2°), 24.5 
(2°), 22.3 (2°), 21.5 (2°); νmax (film) 2927, 2857, 1716, 1638, 1433, 1385, 1208, 
1165, 1137, 1025, 999, 913, 856, 732 cm-1; TOF-ESI+ m/z calculated for 
(C15H22O2 + H)+, 235.1698, found, 235.1677; calculated for (C15H22O2 + Na)+, 
257.1517, found, 257.1506. 
 
(E)-2-((4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-ylidene)ethanol (206) 
 
This was performed by adaptation of a literature procedure.158 A solution of 
acetate 205 (45.0 mg, 0.192 mmol, 1.00 equiv) in THF (10 mL) was added to a 
suspension of LiAlH4 in THF (7.28 mg, 0.192 mmol, 1.00 equiv) at –78 °C. The 
mixture was stirred for 1 h, then gradually warmed up to rt within 2 h and 
refluxed for 1.5 h. An extra equivalent of LiAlH4 was added and refluxed for 
additional 30 min. Water was added with care until effervescence ceased, 
followed by aq. HCl (1.0 M) until all unreacted LiAlH4 was dissolved. After 
extraction with ether (2 × 15 mL), the combined organic layers were dried with 
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MgSO4 and filtered. The filtrate was concentrated under reduced pressure Then 
purified by column chromatography (5 to 10% EtOAc in petroleum ether) to give 
the title product 206 (22.6 mg, 57%) as a pale yellow oil; Rf 0.19 (10% EtOAc-
petroleum ether); δH (250 MHz, CDCl3) 5.81 (1H, dd, J 18.0, 11.0 Hz, CH2=CH-
), 5.24 (1H, m, =CH-CH2-OH), 5.08 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 4.99 
(1H, dd, Jtrans 18.0, 1.5 Hz, -CH=CH2), 4.20 (2H, d, J 7.0 Hz, =CH-CH2-OH), 
2.71-2.64 (1H, m -CH2-CH2-CH<), 2.48-0.67 (19H, m); δC (62.5 MHz, CDCl3) 
144.6 (>C=CH-CH2-OH), 141.8 (-CH=CH2), 119.7 (>C=CH-CH2-OH), 113.7 (-
CH=CH2), 58.9 (4°), 50.7 (=CH-CH2-OH), 43.1 (3°), 42.6 (2°), 39.9 (2°), 29.6 
(2°), 26.6 (2°), 24.9 (2°), 23.3 (2°), 21.8 (2°); νmax (film) 3304, 2924, 2852, 1450, 
999, 909 cm-1; TOF-ESI+ m/z calculated for (C14H22O + H)+, 207.1743, found, 
207.1735; calculated for (C14H22O + Na)+, 229.1563, found, 229.1554. 
 
Methyl 2-(4a-vinyldecahydronaphthalen-1-yl)acetate (207) 
 
This was performed by adaptation of a literature procedure.72 A mixture of 205 
(67.5 mg, 0.288 mmol, 1.00 equiv) and dry MeOH (5 mL) under N2 atmosphere 
was stirred at rt for 3 h. the resulting mixture was quenched by careful addition 
of aq HCl (1.00 M, 10 mL) until excess Mg dissolved. The reaction mixture was 
extracted with ether (2 × 10 mL), and then the combined organic layers were 
washed with brine (2 × 10 mL), dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure to give a mixture of four inseparable 
diastereomers 207 (60.0 mg, 88%) as an oil; Rf 0.45 (5% EtOAc-petroleum 
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ether); TOF-ESI+ m/z calculated for (C15H24O2 + H)+, 259.1674, found, 
259.1648.  
 
1-(1,2,3,4,4a,5,6,7-Octahydronaphthalen-4a-yl)ethanone (232) 
 
This was performed by adaptation of a literature procedure.80 To a stirring 
solution of vinyl ether 176 (16.3 g, 91.3 mmol, 1.00 equiv) in DCM was added 
ethylene glycol (13.3 g, 215 mmol, 2.35 equiv) followed by a substoichiometric 
amount of p-TSA. The mixture was then refluxed for 15 h using a Dean–Stark 
trap. The reaction mixture was then washed with sat. aq. NaHCO3 solution (2 × 
25 mL), water (25 mL) and brine (25 mL). The organic layer was dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure to 
give the title product 232 (11.8 g, 66%) as a colourless oil; Rf 0.45 (10% EtOAc-
petroleum ether); δH (300 MHz, CDCl3) 6.57 (1H, dt, J 1.5, 1.0 Hz, =CH-), 2.21-
2.05 (2H, m), 2.06 (3H, m, -CH3), 1.98-1.85 (3H, m), 1.77-1.15 (9H, m); δC (75 
MHz, CDCl3) 212.4 (>C=O), 138.8 (>C=CH-), 122.7 (>C=CH-), 54.4 (4°), 36.6 
(2°), 34.6 (2°), 34.5 (2°), 27.7 (2°), 25.3 (2°), 25.1 (>CO-CH3), 23.6 (2°), 19.0 
(2°); νmax (film) 2926, 2855, 1701, 1662, 1445, 1349, 1150, 1090, 999, 809 cm-1; 
TOF-ESI+ m/z calculated for (C12H18O + H)+, 179.1435, found, 179.1438; 
calculated for (C12H18O + Na)+, 201.1255, found, 201.1260. 
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1,3-Bis(trimethylsilyloxy) propane (234) 
 
This was performed by adaptation of a literature procedure.159 To a solution of 
propane-1,3-diol (15.0 g, 0.197 mol, 1.00 equiv), and DMAP (2.40 g, 10 mol%) 
in DMF (250 mL) at 0 °C was added trimethylsilyl chloride (56.0 mL, 0.443 mol, 
2.25 equiv). The reaction mixture was stirred for 30 min. Then Et3N (110 mL, 
0.788 mol, 4.00 equiv) was added and the resulting reaction mixture was left to 
stir for 18 h. The reaction mixture was then washed with water (3 × 500 mL), 
extracted with DCM (3 × 150 mL), dried over MgSO4 and filtered. The filtrate 
was concentrated under reduced pressure and purified by distillation to afford 
the title compound 234 (34.7 g, 80%) as a colourless liquid; (b.pt. 36–38 °C at 
1.2 Torr). Analytical data were consistent with those previously reported:160 δH 
(300 MHz, CDCl3) 3.65 (4H, t, J 6.5 Hz, -CH2-CH2-OSi(CH3)3)), 1.73 (2H, d, J 
6.5 Hz, -CH2-CH2-OSi(CH3)3)), 0.10 (18H, s, -CH2-OSi(CH3)3)). δC (75 MHz, 
CDCl3) 59.1 (-CH2-CH2-O-Si(CH3)3)), 35.5 (-CH2-CH2-O-Si(CH3)3)), -0.5 (-CH2-
O-Si(CH3)3). 
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(1S*,4aR*,8aS*)-4a-Vinyldecahydronaphthalen-1-ol (248) 
 
This was performed by adaptation of a literature procedure.161 To a stirred 
solution of vinyl ketone 135 (0.580 g, 3.25 mmol, 1.00 equiv) in anhydrous THF 
(30 mL), was added 9-BBN (0.500 M in THF, 9.76 mL, 4.88 mmol, 1.50 equiv) 
dropwise at 0 °C and the resulting mixture was then stirred at rt for 4 h. H2O (1 
mL) was added followed by aq. NaOH (3.00 M, 8 mL) and aq. 30% H2O2 (6 
mL). The reaction mixture was heated to 60 °C and stirred for 2 h, then 
extracted with EtOAc (2 × 15 mL). The combined extracts were washed with 
water (2 × 15 mL) and brine (2 × 15 mL), dried over MgSO4 and filtered. The 
filtrate was concentrated under reduced pressure to give the crude product. 
Purification by column chromatography (25% EtOAc in petroleum ether) gave 
two diastereomers: 
The major diastereomer was alcohol 182 (210 mg, 35%) as colourless oil. 
Spectroscopic data correspond to those already reported (vide supra).  
The minor diastereomer was the title alcohol 248 (61.4 mg, 11%), a white solid; 
m.pt. 54–56 °C; Rf 0.46 (30% EtOAc in petroleum ether); δH (250 MHz, CDCl3) 
6.00 (1H, dd, J 18.0, 11.5 Hz, CH-CH2), 5.16 (1H, dd, Jcis 11.5, 0.5 Hz, -
CH=CH2), 5.01 (1H, dd, Jtrans 18.0, 1.0 Hz, -CH=CH2), 3.44 (1H, td, J 10.5, 4.5 
Hz, HO-CH<), 2.01-1.03 (16H, m); δC (62.5 MHz, CDCl3) 142.0 (-CH=CH2), 
114.1 (-CH=CH2), 70.4 (>CH-OH), 52.9 (2°), 41.6 (3°), 41.5 (4°), 40.0 (2°), 36.5 
(2°), 26.4 (2°), 22.8 (2°), 21.8 (2°), 20.3 (2°); νmax (film) 3416, 2925, 2849, 1629, 
1450, 1243, 1153, 927, 903 cm-1; TOF-ESI+ m/z calculated for (C12H20O + H)+, 
181.1592, found, 181.1583; (C12H20O + Na)+, 203.1411, found, 203.1398. 
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(4aR*,8aR*)-1-Methylene-4a-vinyldecahydronaphthalene (250) 
 
Procedure A 
This was performed by adaptation of a literature procedure.162 A solution of 
methyltriphenylphosphonium bromide (25.0 g, 70.1 mmol, 2.50 equiv) and 
potassium tert-butoxide (1.00 M in THF, 56.0 mL, 56.0 mmol, 2.00 equiv) in 
THF (150 mL) was stirred at reflux for 3 h. Vinyl ketone 135 (5.00 g, 28.0 mmol, 
1.00 equiv) in toluene (15 mL) was then added dropwise to the above solution 
and the resulting mixture was stirred at reflux for 16 h. The reaction was 
carefully quenched by the addition of acetone (100 mL) and stirred at 60 °C for 
30 min. The reaction mixture was then allowed to cool to rt and water (100 mL) 
was added. The reaction mixture was extracted with Et2O (3 × 120 mL) and the 
combined organic layers were washed with brine (2 × 150 mL), dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure to 
give the crude. Purification by column chromatography (100% hexane) gave the 
title alkene 250 (4.55 g, 92%) as a colourless liquid; b.pt. 233–235 °C at 760 
Torr; Rf 0.73 (100% pentane); δH (500 MHz, CDCl3) 5.86 (1H, dd, J 18.0, 11.0 
Hz, CH2=CH-), 5.13 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 5.01 (1H, dd, Jtrans 
18.0, 1.5 Hz, -CH=CH2), 4.76 (1H, q, J 1.5 Hz, >C=CH2), 4.52 (1H, q, J 1.5 Hz, 
>C=CH2), 2.37-2.28 (1H, m), 2.11-1.99 (1H, m), 1.86-1.74 (3H, m), 1.65-1.18 
(10H, m); δC (125 MHz, CDCl3) 150.6 (>C=CH2), 142.1 (-CH=CH2), 113.6 (-
CH=CH2), 106.1 (>C=CH2), 50.2 (4°), 42.7 (2°), 42.6 (3°), 39.6 (2°), 36.9 (2°), 
26.7 (2°), 25.1 (2°), 23.5 (2°), 21.9 (2°); νmax (film) 2926, 2845, 1644, 1145, 
1140, 1230, 1151, 997, 858, 785 cm-1; TOF-ESI+ m/z calculated for (C13H20 + 
H)+, 177.1638, found, 177.1634. 
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Procedure B 
This was performed in accordance with a literature procedure.163 To a stirred 
solution of methyltriphenylphosphonium bromide (15.5 g, 43.5 mmol, 2.25 
equiv) in dry THF (100 mL) at 0 °C, n-BuLi (1.41M, 20.5 mL, 29.0 mmol, 1.50 
equiv) was added dropwise. The reaction mixture was left to warm up to rt and 
stirred for 2.5 h. The mixture was then cooled to –78 °C and vinyl ketone 135 
(3.45 g, 19.3 mmol, 1.00 equiv) in THF (20 mL) was then added dropwise over 
15 min. The resulting solution was stirred at the same temperature for 1 h 
before being allowed to warm to rt and stirred for 18 h. The reaction was 
quenched by addition of aq. NH4Cl solution (100 mL). The reaction mixture was 
extracted with Et2O (3 × 120 mL); the combined organic layers were washed 
with brine (2 × 100 mL), dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure then purified by column chromatography 
(100% petroleum ether to 10% EtOAc in petroleum ether) to give the desired 
bis(alkene) 250 (2.46 g, 72%) as a colourless liquid. Spectroscopic data 
correspond to those reported in procedure A. 
 
((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methanol (249) 
 
This was performed by adaptation of a literature procedure.162 To a stirred 
solution of bis(alkene) 250 (2.35 g, 13.3 mmol, 1.00 equiv) in anhydrous THF 
(75 mL) was added 9-BBN (0.5 M THF solution, 39.9 mL, 20.0 mmol, 1.50 
equiv) dropwise at –15 °C and the resulting mixture was stirred for 15 min. The 
reaction mixture was allowed to warm up to rt and stirred for 120 h. Aq. NaOH 
(3.00 M, 30 mL) followed by aq. 30% H2O2 (30 mL) was added. The resulting 
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exothermic reaction was left to cool to rt with stirring over 3 h. The reaction 
mixture was then diluted with aq. NH4Cl (50 mL) and extracted with Et2O (2 × 
50 mL). The combined organic extracts were washed with water (50 mL) and 
brine (2 × 25 mL), dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure to give the crude. Purification by column 
chromatography (25% EtOAc in petroleum ether) gave the title alcohol 249 
(2.20 g, 85%) as a colourless oil; Rf 0.39 (25% EtOAc in petroleum ether); δH 
(250 MHz, CDCl3) 6.09 (1H, dd, J 16.5, 10.5 Hz, -CH-CH2), 5.05 (1H, dd, Jcis 
10.5, 1.5 Hz, -CH=CH2), 4.99 (1H, dd, Jtrans 16.5, 1.5 Hz, -CH=CH2), 3.66-3.56 
(2H, m, -CH2-OH), 1.93-1.01 (17H, m); δC (62.5 MHz, CDCl3) 142.6 (-CH=CH2), 
112.1 (-CH=CH2), 60.8 (>CH-CH2-OH), 48.2 (>CH-CH2-OH), 45.0 (>CH-CH-
CH2-OH), 43.1 (2°), 40.6 (4°), 38.5 (2°), 28.1 (2°), 27.5 (2°), 26.6 (2°), 22.1 (2°), 
17.5 (2°); νmax (film) 3311, 2923, 2859, 1631, 1448, 1410, 1223, 1149, 1069, 
1020, 995, 974, 847 cm-1; TOF-ESI+ m/z calculated for (C13H22O + H)+, 
195.1748, found, 195.1729. 
 
((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methyl 4-
nitrobenzoate (253) 
 
This was performed by adaptation of a literature procedure.164 To a stirred 
solution of alcohol 249 (40.0 mg, 0.208 mmol, 1.00 equiv) in anhydrous DCM 
(10 mL), were added 4-nitrobenzoyl chloride (38.1 mg, 0.208 mmol, 1.00 equiv), 
pyridine (32.0 mg, 33.0 µL, 0.411 mmol, 2.00 equiv), and catalytic amounts of 
DMAP (2.5 mg, 10 mol%). Resulting reaction mixture was stirred at rt for 6 h. 
After completion of reaction, the reaction mixture was quenched by addition of 
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aq. NaOH (0.500 M, 5 mL) and extracted with DCM (2 × 20 mL). The combined 
extracts were washed with water (2 × 15 mL) and brine (2 × 15 mL), dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure to 
give the crude. Purification by column chromatography (20% EtOAc in 
petroleum ether) gave the title ester 253 (40.6 mg, 58%) as pale yellow solid, 
m.pt. 69–71 °C; Rf 0.65 (25% EtOAc in petroleum ether); δH (250 MHz, CDCl3) 
8.20 (2H, d, J 9.0 Hz, Ar-H), 8.11 (2H, d, J 9.0 Hz, Ar-H) 6.22 (1H, dd, J 17.5, 
11.0 Hz, -CH=CH2), 5.15 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 5.08 (1H, dd, 
Jtrans 17.5, 1.5 Hz, -CH=CH2), 4.39 (2H, d, J 7.5 Hz, >CH-CH2-O-), 2.01-1.06 
(14H, m), 0.91-0.71 (2H, m); δC (62.5 MHz, CDCl3) 164.7 (>C=O), 150.4 (Ar-C-
NO2), 141.9 (-CH=CH2), 135.9 (Ar-C-CO2-), 130.5 (Ar-CH-), 123.4 (Ar-CH), 
112.9 (-CH=CH2), 64.8 (>CH-CH2-O-), 48.0 (3°), 45.0 (4°), 40.0 (2°), 39.2 (2°), 
38.1 (2°), 28.8 (2°), 27.5 (2°), 26.6 (2°), 22.0 (2°), 17.4 (2°); νmax (film) 2925, 
2853, 1721, 1608, 1527, 1449, 1345, 1270, 1116, 1014, 952, 913 cm-1; TOF-
ESI+ m/z calculated for (C20H25NO4 + H)+, 344.1854, found, 344.1843. 
 
((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methyl 4-
methylbenzenesulfonate (231) 
 
To a mixture of the alcohol 249 (215 mg, 1.10 mmol, 1.00 equiv) and DMAP 
(1.3 mg, 10 mol%) in anhydrous DCM (10 mL) was added p-
toluenesulfonylchloride (316 mg, 1.65 mmol, 1.50 equiv) and Et3N (0.610 mL, 
4.42 mmol, 4.00 equiv) at 0 °C. The resulting mixture was allowed to warm up 
to rt stirred for 16 h. The reaction mixture then was diluted with DCM (15 mL), 
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washed with water (2 × 20 mL), aq. NaHCO3 (2 × 15 mL), brine (2 × 20 mL). 
The combined organic layers were dried over MgSO4 and filtered. The filtrate 
was concentrated under reduced pressure, then purified by column 
chromatography (10 to 20% EtOAc in petroleum ether) to give the title product 
231 as pale yellow oil (244 mg, 68%); Rf 0.48 (15% EtOAc in petroleum ether); 
δH (300 MHz, CDCl3) 7.75 (2H, d, J 8.0 Hz, Ar-H), 7.32 (2H, d, J 8.0 Hz, Ar-H), 
5.98 (1H, dd, J 17.5, 11.0 Hz, -CH-CH2), 5.00 (1H, dd, Jcis 11.0, 1.0 Hz, -
CH=CH2), 4.92 (1H, dd, Jtrans 17.5, 1.5 Hz, -CH=CH2), 4.10-3.96 (2H, m, >CH-
CH2-O-), 2.43 (3H, s, -CH3), 1.87-0.64 (16 H, m); δC (75 MHz, CDCl3) 144.6 (Ar 
>C-SO2-), 141.5 (-CH=CH2), 133.1 (Ar >C-CH3), 129.6 (Ar -CH-), 127.8 (Ar -
CH-), 112.8 (-CH=CH2), 69.5 (>CH-CH2-O-), 47.6 (3°), 44.8 (2°), 39.7 (2°), 39.1 
(4°), 37.6 (3°), 28.0 (2°), 27.3 (2°), 26.2 (2°), 21.8 (2°), 21.5 (1°), 16.95 (2°); νmax 
(film) 2926, 2859, 1632, 1495, 1449, 1358, 1174, 1097, 950, 839, 812 cm-1; 
TOF-ESI+ m/z calculated for (C20H28SO3 + Na)+, 371.1656, found, 371.1644. 
 
9-(((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methyl)-9-
borabicyclo[3.3.1]nonane (265) 
 
This was performed by adaptation of a literature procedure.162 To a stirred 
solution of bis(alkene) 250 (3.95 g, 22.4 mmol, 1.00 equiv) in anhydrous THF 
(80 mL), 0.500 M THF solution of 9-BBN (67.2 mL, 33.6 mmol, 1.50 equiv) was 
added dropwise at 0 °C. The resulting mixture was allowed to warm up to rt and 
stirred for 72 h. Aq. NaOH (3.00 M, 25 mL) following by aq. 30% H2O2 (25 mL) 
was added, resulting in an exotherm. The reaction mixture was left to cool to rt 
Chapter 4  Experimental 
162 
with stirring over 1 h. The reaction mixture was then diluted with aq. NH4Cl (50 
mL) and extracted with Et2O (3 × 50 mL). The combined organic extracts were 
washed with water (50 mL) and brine (100 mL), dried over MgSO4 and filtered. 
The filtrate was concentrated under reduced pressure to give the crude. 
Purification by column chromatography (25% EtOAc in petroleum ether) gave 
two products: 
The major product was the alcohol 249 (2.98 g, 69%), a colourless oil. 
Spectroscopic data correspond to those already reported (vide supra). 
The minor product was the title borane 265 (0.96 g, 14%), a colourless oil; Rf 
0.65 (20% EtOAc in petroleum ether); δH (300 MHz, CDCl3) 6.27 (1H, dd, J 
17.5, 11.0 Hz, -CH-CH2), 5.01 (1H, dd, Jcis 11.0, 1.5 Hz, -CH=CH2), 4.96 (1H, 
dd, Jtrans 17.5, 1.5 Hz, -CH=CH2), 2.14-0.80 (31H, m); δC (75 MHz, CDCl3) 142.7 
(-CH=CH2), 111.4 (-CH=CH2), 75.6 (>CH-CH2-B<), 49.5 (2°), 44.4 (4°), 40.3 
(3°), 39.1 (2°), 38.4 (3°), 36.6 (3°), 35.8 (3°), 33.8 (2°), 32.8 (2°), 28.2 (2°), 28.2 
(2°), 27.3 (2°), 27.1 (2°), 24.8 (2°), 22.2 (2°), 22.2 (2°), 22.0 (2°), 17.6 (2°); νmax 
(film) 2918, 2850, 1632, 1447, 1380, 1215,1096, 1013, 957, 848, 754 cm-1; 
TOF-ESI+ m/z calculated for (C31H35B + H)+, 299.2904, found, 299.2899. 
 
(((1R*,4aS*)-Decahydro-1,4a-methanooxymethanonaphthalen-9-yl)methyl) 
iodide (262) 
 
Procedure A 
This was performed by adaptation of a literature procedure.91 To a solution of 
ethylenebis(diphenylphosphine) (1.01 g, 2.54 mmol, 1.10 equiv) in DCM (25 
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mL), 1,2-diiodoethane (1.43 g, 5.09 mmol, 2.20 equiv) was added in one portion 
at 0 °C and stirred. Reaction temperature was kept below 10 °C for 15 min. The 
solution of alcohol 249 (0.45 g, 2.31 mmol, 1.00 equiv) in DCM (10 mL) was 
then added dropwise to the yellow reagent mixture. After addition of all 
substrate, resulting reaction mixture was stirred at reflux for 16 h before 
concentrating it under reduced pressure. To this brown residue was added 
K2CO3 (1.25 g), diluted with Et2O (50 mL) and added water (25 drops). The 
mixture then was stirred at rt for 30 min. Additional K2CO3 was added to dry the 
solution. The solids were washed with ether (2 × 20 mL), combined organic 
layers were concentrated to give the crude. Purified by column chromatography 
(5% to 20% EtOAc in petroleum ether) to give the title product 262 (350 mg, 
47%) as a single isomer and colourless oil; Rf 0.36 (5% EtOAc in petroleum 
ether); δH (300 MHz, CDCl3) 4.16 (1H, m, >CH-CH2-I), 4.01 (1H, dt, J 11.0, 2.0 
Hz, >CH-CH2-O-CH<), 3.57 (1H, d, J 11.5 Hz, >CH-CH2-O-CH<), 2.33-2.17 
(1H, m, >CH-CH2-O-CH<), 1.99-1.55 (5H, m), 1.50-1.20 (8H, m), 1.08 (2H, d, J 
6.5 Hz, >CH-CH2-I), 0.91 (1H, tdd, J 13.5, 6.0, 1.5 Hz), 0.81-0.78 (1H, m); δC 
(75 MHz, CDCl3) 71.4 (>CH-CH2-I), 67.9 (>CH-CH2-O-CH<), 44.6 (>CH-CH<), 
37.0 (>CH-CH2-O-CH<), 36.9 (4°), 35.8 (2°), 35.0 (2°), 33.3 (2°), 26.8 (2°), 25.7 
(2°), 22.4 (2°), 21.7 (2°), 15.1 (>CH-CH2-I); νmax (film) 2924, 2854, 1460, 1377, 
1259, 1076, 1017, 798, 752, 606 cm-1; TOF-ESI+ m/z calculated for (C13H21IO + 
H)+, 321.0717, found, 321.0714. 
 
Procedure B 
This was performed by adaptation of a literature procedure.91 A solution of 
iodine (261 mg, 1.02 mmol, 2.00 equiv) in DCM (5 mL) was added dropwise to 
a stirred solution of ethylenebis(diphenylphosphine) (256 mg, 0.640 mmol, 1.25 
equiv) in DCM (5 mL) at 0 °C. Reaction temperature was kept below 10 °C for 
30 min. The solution of alcohol 249 (100 mg, 0.510 mmol, 1.00 equiv) in DCM 
(5 mL) was then added dropwise to the reagent mixture. After addition of all 
substrate, resulting reaction mixture was stirred at the rt for 16 h. Then reaction 
solvent was removed under reduced pressure, the residue was diluted with 
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Et2O (25 mL), washed with aq. solution of Na2S2O3 (2 × 15 mL). Combined 
organic extracts were then washed with brine (25 mL), dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure and purified by 
column chromatography to afford the title product 262 (30.0 mg, 18%) as a 
colourless oil. Spectroscopic data correspond to those reported in procedure A. 
 
((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methyl iodide (260) 
 
This was performed by adaptation of a literature procedure.91 A solution of 
iodine (520 mg, 2.05 mmol, 2.00 equiv) in DCM (10 mL) was added dropwise to 
a stirred solution of ethylenebis(diphenylphosphine) (1.23 g, 3.08 mmol, 3.00 
equiv) in DCM (5 mL) at 0 °C. Reaction temperature was kept below 10 °C for 
30 min. The solution of alcohol 249 (200 mg, 1.02 mmol, 1.00 equiv) in DCM (5 
mL) was then added dropwise to the reagent mixture within 20 min. After 
addition of all substrate, resulting reaction mixture was stirred at the rt for an 
additional hour before refluxing it for 18 h. Then reaction solvent was removed 
under reduced pressure, the residue was washed with pentane (3 × 15 mL). 
Combined filtrates were concentrated under reduced pressure and again 
washed with pentane. This washing procedure was repeated 5 times to give the 
title product 260 (190 mg, 61%) a colourless oil; δH (300 MHz, CDCl3) 5.54 (1H, 
dd, J 17.5, 10.5 Hz, CH=CH2), 5.12 (1H, dd, Jcis 10.5, 2.0 Hz, -CH=CH2), 4.79 
(1H, dd, Jtrans 17.5, 2.0 Hz, -CH=CH2), 2.54-2.46 (1H, m), 2.36-2.27 (1H, m), 
2.24-0.99 (16H, m); δC (75 MHz, CDCl3) 142.7 (-CH=CH2), 114.1 (-CH=CH2), 
49.5 (3°), 41.8 (4°), 40.6 (2°), 36.7 (2°), 34.0 (2°), 29.6 (2°), 26.6 (2°), 23.8 (2°), 
21.7 (2°), 21.0 (3°), 18.1 (>CH-CH2-I); νmax (film) 3311, 2923, 2859, 1631, 1448, 
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1410, 1223, 1149, 1069, 1020, 995, 974, 847 cm-1; TOF-ESI+ m/z calculated for 
(C13H21I - HI + H)+, 177.1638, found, 177.1634. 
 
1-Methyl-4a-vinyl-2,3,4,4a,5,6,7,8-octahydronaphthalene (261) 
 
Procedure A 
This was performed by adaptation of a literature procedure.165 To a solution of 
vinyl alcohol 249 (200 mg, 1.02 mmol, 1.00 equiv) in DCM (10 mL) was added 
PPh3 (539 mg, 2.05 mmol, 2.00 equiv) and CBr4 (683 mg, 2.05 mmol, 2.00 
equiv) at 0 °C and the mixture was stirred for 18 h. Sat. aq. NaHCO3 (15 mL) 
was added to the mixture followed by addition of EtOAc (30 mL). The organic 
layer was separated, and aqueous phase was further extracted with EtOAc (2 
×25 mL). The combined organic layers were washed with brine (20 mL), dried 
over MgSO4 and filtered. The filtrate was concentrated under reduced pressure, 
then purified by column chromatography (5% to 20% EtOAc in petroleum ether) 
to give the title product 261 (70.0 mg, 32%) as a colourless oil; Rf 0.76 (10% 
EtOAc-petroleum ether); δH (250 MHz, CDCl3) 5.54 (1H, dd, J 17.5, 10.5 Hz, -
CH=CH2), 5.11 (1H, dd, Jcis 10.5, 2.0 Hz, -CH=CH2), 4.79 (1H, dd, Jtrans 17.0, 
2.0 Hz, -CH=CH2), 2.53-2.45 (1H, m), 2.08-1.68 (5H, m), 1.65 (3H, s, -CH3), 
1.59-1.10 (8H, m); δC (62.5 MHz, CDCl3) 146.4 (-CH=CH2), 131.7 (4°), 126.9 
((=C(CH3)-), 4°), 115.2 (-CH=CH2), 43.1 (4°), 41.7 (2°), 37.8 (2°), 32.9 (2°), 27.8 
(2°), 25.9 (2°), 23.1 (2°), 19.1 (2°), 17.8 (1°); νmax (film) 2924, 2853, 1633, 1446, 
1401, 1148, 996, 914 cm-1; TOF-ESI+ m/z calculated for (C13H20 + H)+, 
177.1643, found, 177.1635. 
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Procedure B 
This was performed by adaptation of a literature procedure.166 To a solution 
containing of vinyl tosylate 231 (105 mg, 0.300 mmol, 1.00 equiv) in NaI sat. 
acetone (10 mL) was refluxed for 72 h. The cooled reaction mixture was diluted 
with Et2O (30 mL) washed with sat. aq. Na2S2O3 (20 mL), brine (2 × 20 mL), 
dried over MgSO4 and filtered. The filtrate was concentrated to give the crude 
product. Purification by column chromatography (5% to 10% EtOAc in 
petroleum ether) gave the title product 261 (28.2 mg, 53%) as a colourless oil. 
Spectroscopic data correspond to those reported in procedure A. 
 
2-Iodooxazole (264)94 
 
Procedure A  
This was performed in accordance with a literature procedure.94 n-BuLi (2.50 M 
in hexanes, 2.89 mL, 7.24 mmol, 1.00 equiv) was added to a solution of MgBr2 
(0.440 g, 2.39 mmol 0.33 equiv) in THF (5 mL) cooled to –10 °C. After stirring 
for 1 h, oxazole 213 (0.470 mL, 7.24 mmol, 1.00 equiv) was introduced. The 
reaction mixture allowed to warm up to rt and stirred for 2 h before solution of 
iodine (1.83 g, 7.24 mmol, 1.00 equiv) in THF (3 mL) was introduced. The 
reaction was stirred for 18 h, and then quenched by addition of sat. aq. Na2S2O3 
solution (25 mL) until no iodine colour persisted. The reaction mixture was 
extracted with chloroform (3 × 20 mL), and the combined organic layers were 
washed with brine (60 mL), dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure. The residue was dissolved in DCM (20 
mL) and filtered through a short pad of silica gel, then concentrated under 
reduced pressure to give 2-iodooxazole 264 (110 mg, 8%) as a pale yellow 
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solid. Analytical data were consistent with those previously reported:94 δH (300 
MHz, CDCl3) 7.77 (1H, s), 7.10 (1H, s); δC (75 MHz, CDCl3) 144.8, 129.8, 101.3. 
 
Procedure B  
This was performed by adaptation of a literature procedure.96 To a solution of 
oxazole 213 (500 mg, 0.470 mL, 7.24 mmol 1.00 equiv) in THF (20 mL) at –78 
°C was added n-BuLi (2.20 M in hexanes, 3.62 mL, 7.96 mmol, 1.10 equiv) 
dropwise over 15 min. Reaction mixture was stirred at the temperature for 1 h 
before a solution of 1,2-diiodoethane (2.24 g, 7.96 mmol, 1.10 equiv) in Et2O 
(10 mL) was added and resulting mixture allowed to warm up to rt. After 1 h, the 
reaction was quenched by addition of sat. aq. Na2S2O3 solution (30 mL), 
extracted with Et2O (3 × 20 mL) and combined organic layers were washed with 
brine (60 mL), dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure to give 2-iodooxazole 264 (660 mg, 47%) as a pale 
yellow solid. Spectroscopic data correspond to those reported in procedure A. 
 
Procedure C 
This was performed in accordance with a literature procedure.97 To a solution of 
oxazole 213 (500 mg, 0.470 mL, 7.24 mmol 1.00 equiv) in THF (10 mL) cooled 
to –78 °C was added n-BuLi (2.20 M in hexanes, 3.62 mL, 7.96 mmol, 1.10 
equiv) dropwise over 15 min. Reaction mixture was stirred at the temperature 
for 1 h. Then a solution of anhydrous ZnCl2 in Et2O (3.00 M, 8.00 mL, 24.2 
mmol, 6.00 equiv) was added dropwise over 5 min. The reaction mixture 
allowed to warm up to rt and stirred for 1 h before adding a solution of iodine 
(2.02 g, 7.96 mmol, 1.10 equiv) in THF (10 mL) in one portion. The resulting 
mixture was stirred for 30 min, quenched by addition of sat. aq. Na2S2O3 
solution (25 mL), diluted with Et2O (50 mL) and poured into aq. citric acid 
solution (10 wt%, 50 mL). The biphasic mixture was vigorously stirred for 15 min 
before clean separation of layers occurred and separated. The organic layer 
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was washed with brine (50 mL), dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure. The residue was dissolved in DCM (20 
mL) and filtered through a short pad of silica gel, then concentrated under 
reduced pressure to give 2-iodooxazole 264 (800 mg, 57%) as a pale yellow 
solid. Spectroscopic data correspond to those reported in procedure A. 
 
(1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalene-1-carbaldehyde (223) 
 
This was performed by adaptation of a literature procedure.156 To a stirred 
solution of oxalyl chloride (1.38 mL, 16.1 mmol, 1.10 equiv) in DCM (80 mL) at –
78 °C was added DMSO (2.23 mL, 31.5 mmol, 2.15 equiv). The solution was 
stirred for 20 min, and then alcohol 249 (2.85 g, 14.7 mmol, 1.00 equiv) in dry 
DCM (20 mL) was added. The reaction mixture was stirred at –78 °C under 
nitrogen for 2.5 h, and then Et3N (10.3 mL, 73.3 mmol, 5.00 equiv) was added 
at the same temperature. After 20 min the solution allowed to warm to rt over 30 
min, then water (100 mL) was added and the reaction mixture was extracted 
with Et2O (2 × 75 mL). The combined organic extracts were washed with brine 
(2 × 50 mL) and dried over MgSO4, then filtered. The filtrate was concentrated 
under reduced pressure and purified by column chromatography (10% EtOAc in 
petroleum ether) to give the title aldehyde 223 (2.45 g, 87%) as a pale yellow 
oil; Rf 0.64 (20% EtOAc-petroleum ether); δH (400 MHz, CDCl3) 9.89 (1H, s, -
CHO), 5.99 (1H, dd, J 17.5, 11.0 Hz, -CH=CH2), 5.14 (1H, d, Jcis 11.0 Hz, -
CH=CH2), 5.06 (1H, d, Jtrans 17.5 Hz, -CH=CH2), 2.23-2.19 (2H, m), 1.98-0.66 
(14H, m); δC (100 MHz, CDCl3) 204.7 (>CH-CHO), 140.2 (-CH=CH2), 115.1 (-
CH=CH2), 51.9 (3°), 48.2 (3°), 43.0 (2°), 40.6 (4°), 38.8 (2°), 27.5 (2°), 26.4 (2°), 
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26.0 (2°), 21.9 (2°), 18.6 (2°); νmax (film) 2923, 2854, 1723, 1448, 1236, 1074, 
911 cm-1; TOF-ESI+ m/z calculated for (C12H20O + H)+, 193.1593, found, 
193.1587; (C12H20O + Na)+, 215.1413, found, 215.1404. 
 
(S*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-
yl)methanol (266) 
(R*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-
yl)methanol (267) 
 
This was performed by adaptation of a literature procedure.88,167 To a solution of 
oxazole 213 (355 mg, 338 µL, 5.14 mmol, 1.00 equiv) in anhydrous THF (15 
ml), in a flame dried flask, BH3·THF complex (1.00 M in THF, 5.40 mL, 5.40 
mmol, 1.05 equiv) was added at rt. After being stirred at rt for 1 h, the colourless 
solution was cooled to –78 °C and n-BuLi in hexanes (1.50 M, 3.60 mL, 5.40 
mmol, 1.05 equiv) was added dropwise over 15 min. The resulting yellow 
solution was stirred at –78 °C for 90 min before a solution of aldehyde 223 
(0.990 g, 5.14 mmol, 1.00 equiv) in THF (15 mL) was added dropwise over 30 
min. The resulting yellow solution was stirred at –78 °C for 1.5 h and then 
quenched with 5% AcOH in ethanol (20 mL). The cooling bath was removed, 
and the reaction mixture was allowed to warm up to rt. After being stirred at rt 
for 16 h the colourless solution was concentrated under vacuum. The residue 
was dissolved in Et2O (20 mL), washed with sat. aq. NaHCO3 (2 × 30 mL), brine 
(50 mL). The combined organic layers were dried over MgSO4 and filtered. The 
filtrate was concentrated under reduced pressure, then purified by column 
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chromatography (10% to 25% EtOAc in petroleum ether) to give the title 
products 266 and 267 (0.704 g, 53%) as a solid mixture of 2 diastereomers in a 
ratio 1:1. Crystals of 266 suitable for X-ray diffraction were grown by slow 
diffusion of hexane vapour into a solution of 266 in chloroform; 
Title product 267, a white solid; m.pt. 90–92 °C; Rf 0.57 (40% EtOAc-petroleum 
ether); δH (400 MHz, CDCl3) 7.57 (1H, s, oxazole -CH=CH-), 7.04 (1H, s, 
oxazole -CH=CH-), 6.61 (1H, dd, J 18.0, 11.0 Hz, -CH=CH2), 5.33 (1H, d, J 11.0 
Hz, >CH-OH), 5.18 (1H, d, Jcis 12.5 Hz, -CH=CH2), 5.14 (1H, d, Jtrans 19.0 Hz, -
CH=CH2), 2.35 (1H, br s, >CH-OH), 2.27 (1H, qd, J 13.0, 3.5 Hz), 2.13-2.03 
(2H, m), 1.86-1.80 (1H, m), 1.67-1.06 (10H, m). 0.99-0.82 (2H, m); δC (75 MHz, 
CDCl3) 166.6 (oxazole 4°), 142.6 (-CH=CH2), 138.1 (oxazole 3°), 126.6 
(oxazole 3°), 112.3 (-CH=CH2), 68.8 (>CH-OH), 49.5 (3°), 46.3 (2°), 45.1 (3°), 
40.6 (4°), 38.1 (2°), 30.3 (2°), 28.8 (2°), 28.4 (2°), 22.4 (2°), 18.4 (2°); νmax (film) 
3239, 2917, 2849, 1567, 1460, 1238 cm-1; TOF-ESI+ m/z calculated for 
(C16H23NO2 + H)+, 262.1807, found, 262.1788; (C16H23NO2+ Na)+, 284.1626, 
found, 284.1602. 
Title product 266 as a white solid; Rf 0.50 (40% EtOAc-petroleum ether), m.pt. 
98–100 °C; δH (400 MHz, CDCl3) 7.57 (1H, s, oxazole -CH=CH-), 7.01 (1H, s, 
oxazole -CH=CH-), 6.34 (1H, dd, J 17.5, 11.0 Hz, -CH-CH2), 5.16 (1H, dd, Jcis 
11.0, 1.0 Hz, -CH=CH2), 5.08 (1H, d, J 7.5 Hz, >CH-OH), 5.04 (1H, dd, Jtrans 
17.5, 1.5 Hz, -CH=CH2), 3.45 (1H, br s, >CH-OH), 2.37-2.31 (1H, m), 2.26-2.21 
(1H, m), 2.05-1.99 (1H, m), 1.73-1.07 (11H, m), 0.91-0.85 (1H, m), 0.62 (1H, qd, 
J 13.0, 3.5 Hz); δC (100 MHz, CDCl3) 166.6 (oxazole 4°), 142.5 (-CH=CH2), 
138.0 (oxazole 3°), 126.6 (oxazole 3°), 112.4 (-CH=CH2), 64.6 (>CH-OH), 48.4 
(3°), 45.7 (2°), 43.8 (3°), 40.2 (4°), 38.1 (2°), 28.5 (2°), 27.9 (2°), 25.6 (2°), 21.9 
(2°), 17.9 (2°); νmax (film) 3239, 2917, 2849, 1567, 1460, 1238, 1071, 916, cm-1; 
TOF-ESI+ m/z calculated for (C16H23NO2 + H)+, 262.1807, found, 262.1787; 
(C16H23NO2 + Na)+, 284.1626, found, 284.1602.  
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2-((1R*,4aS*,8aR*,9S*,11S*)-9-Methyldecahydro-1,4a-
(methanooxymethano)naphthalen-11-yl)oxazole (269) 
 
This was performed by adaptation of a literature procedure.104 To a stirred TFA 
(10 mL) at rt was added sodium borohydride (468 mg, 12.4 mmol, 36.0 equiv) 
over a period of 10 min. To the viscous mixture, solution of 226 (90.0 mg, 0.344 
mmol, 1.00 equiv) in DCM (10 mL) was added and the resulting mixture was 
refluxed for 3 h. Then reaction mixture was allowed to cool down to rt, carefully 
poured into 25% aq. NaOH/ice slurry (150 mL) to adjust the pH to 11, then 
extracted with Et2O (2 × 25 mL). The organic extracts were combined, dried 
over MgSO4 and then filtered. The filtrate was concentrated under reduced 
pressure, then purified by column chromatography (30% EtOAc in petroleum 
ether) to give the product (60.4 mg, 67%) as an oily mixture of all four possible 
diastereomers. Only one of the four proved to be separable by column 
chromatography: 
Title product 269, Rf 0.36 (25% EtOAc-petroleum ether); δH (400 MHz, CDCl3) 
7.62 (1H, s, oxazole -CH=CH-), 7.09 (1H, s, oxazole -CH=CH-), 5.22 (1H, 
s,>CH-oxazole), 4.38 (1H, q, J 6.0 Hz, -O-CH(CH3)-), 2.39-2.08 (3H, m), 2.04-
1.92 (2H, m), 1.86-1.74 (1H, m, >CH-CH(Het)-O-), 1.65-1.24 (7H, m), 1.23 (3H, 
d, J 6.5 Hz, -O-CH(CH3)-), 1.13-0.88 (3H, m); δC (75 MHz, CDCl3) 164.0 
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(oxazole =C<), 138.3 (oxazole -CH=CH-), 126.8 (oxazole -CH=CH-), 72.9 
(>CH-oxazole), 72.2 (-O-CH(CH3)-), 45.4 (3°), 39.0 (3°), 36.8 (3°), 36.6 (2°) 
34.5 (2°), 29.2 (4°), 26.7 (2°), 25.5 (2°), 21.8 (2°), 21.6 (2°), 15.0 (1°); νmax (film) 
2925, 2853, 1571, 1523, 1450, 1374, 1301, 1167, 1133, 1072, 1014, 913 cm-1; 
TOF-ESI+ m/z calculated for (C16H23NO2 + H)+, 262.1807, found, 262.1817; 
(C16H23NO2 + Na)+, 284.1626, found, 284.1621. 
 
2-((1R*,4aS*,8aR*,9S*,11R*)-9-Methyldecahydro-1,4a-
(methanooxymethano)naphthalen-11-yl)oxazole (270) 
 
To a flask 275 (10.0 mg, 0.038 mmol, 1.00 equiv) was added zinc dust (50.4 
mg, 0.771 mmol, 20.00 equiv) and a mixture of HCl (conc.) and water (3:1, 3 
mL). The resulting mixture was refluxed for 30 min. Then reaction mixture was 
allowed to cool to rt andwas extracted with EtOAc (3 × 10 mL). The organic 
extracts were combined, washed with sat. aq. NaHCO3 (3 × 20 mL) dried over 
MgSO4 and filtered. The filtrate was concentrated under vacuum to give the 
crude. Purification by column chromatography (25% EtOAc in petroleum ether) 
gave the product as two diastereomers: 
The major diastereomer was the title product 270, (5.6 mg, 56%), a colourless 
oil; Rf 0.29 (25% EtOAc-petroleum ether); δH (500 MHz, CDCl3) 7.61 (1H, s, 
oxazole -CH=CH-), 7.11 (1H, s, -CH=CH-), 4.88 (1H, s,>CH-oxazole), 4.58 (1H, 
q, 6.0 Hz, -O-CH(CH3)-), 2.36-1.26 (2H, m), 2.04-1.93 (2H, m), 2.04-1.93 (1H, 
m), 1.57-1.50 (4H, m), 1.45-1.41 (1H, m, >CH-CH(Het)-O-), 1.35-1.24 (2H, m), 
1.22 (3H, d, J 6.5 Hz, -O-CH(CH3)-), 1.19-0.78 (4H, m); δC (125 MHz, CDCl3) 
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165.5 (oxazole =C<), 137.8 (oxazole -CH=CH-), 127.2 (oxazole -CH=CH-), 73.6 
(-O-CH(CH3)-), 68.8 (>CH-CH-CH(Het)-O-), 44.1 (>CH-CH-CH(Het)-O-), 37.7 
(>CH-CH-CH(Het)-O-), 37.0 (2°), 36.5 (2°) 34.7 (4°), 34.3 (2°), 27.0 (2°), 25.9 
(2°), 21.7 (2°), 21.4 (2°), 15.1 (1°); νmax (film) 2922, 2854,1453, 1380, 1170, 
1134, 1092, 911, 728 cm-1; TOF-ESI+ m/z calculated for (C16H23NO2 + Na)+, 
284.1626, found, 284.1647. 
The minor diastereomer was compound 269, (0.7 mg, 7%), a colourless oil; Rf 
0.36 (25% EtOAc-petroleum ether). Spectroscopic data corresponds to that 
reported for compound 269. 
 
 (S*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-yl)methyl 
4-nitrobenzoate (274) 
 
This was performed by adaptation of a literature procedure.164 To a stirred 
solution of alcohol 266 (30.0 mg, 0.114 mmol, 1.00 equiv) in anhydrous DCM (5 
mL), were added 4-nitrobenzoyl chloride (22.3 mg, 0.120 mmol, 1.05 equiv), 
pyridine (18.1 µL, 0.229 mmol, 2.00 equiv), and catalytic amounts of DMAP (1.3 
mg, 10 mol%). The resulting reaction mixture was stirred at rt for 16 h. After 
completion of reaction, the reaction mixture was quenched by addition of aq. 
0.5N NaOH (5 mL) and extracted with DCM (2 × 15 mL). The combined extracts 
were washed with water (2 × 15 mL) and brine (2 × 15 mL), dried over MgSO4 
and concentrated under reduced pressure to give the crude. Purified by column 
chromatography (25% EtOAc in petroleum ether) to give the title product 274 
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(16.4 mg, 35%) as pale yellow solid, m.pt. 79–81 °C; Rf 0.62 (25% EtOAc in 
petroleum ether); δH (250 MHz, CDCl3) 8.26 (2H, d, J 8.5 Hz, Ar-H), 8.19 (2H, d, 
J 8.5 Hz, Ar-H), 7.65 (1H, s, oxazole -CH-CH-), 7.14 (1H, s, oxazole -CH-CH-), 
6.62 (1H, d, J 11.0 Hz, >CH-O-CO-), 6.44 (1H, dd, J 17.5, 11.0 Hz, -CH-CH2), 
5.28 (1H, d, Jcis 11.0 Hz, -CH=CH2), 5.14 (1H, d, Jtrans 17.5 Hz, -CH=CH2), 2.70-
2.61 (1H, m, >CH-CH(Het)-), 2.13-0.61 (15H, m); δC (100 MHz, CDCl3) 163.4 
(>C=O), 162.1 (oxazole, 4°), 150.6 (Ar-C-NO2), 141.8 (-CH=CH2), 138.6 
(oxazole -CH-CH-), 135.1 (Ar-C-CO2-), 130.9 (Ar-CH), 127.7 (oxazole -CH-CH-
), 123.5 (Ar-CH), 113.1 (-CH=CH2), 68.2 (>CH(Het)-O-), 48.4 (3°), 45.8 (4°), 
42.2 (3°), 40.2 (2°), 37.9 (2°), 29.0 (2°), 27.9 (2°), 25.6 (2°), 21.9 (2°), 18.0 (2°); 
νmax (film) 2927, 2854, 1727, 1607, 1528, 1452, 1345, 1267, 1100, 1013, 913 
cm-1; TOF-ESI+ m/z calculated for (C23H26N2O5 + H)+, 411.1919, found, 
411.1944; (C23H26N2O5 + Na)+, 433.1739, found, 433.1768.  
 
(R*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-yl)methyl 
methanesulfonate (273)  
 
This was performed by adaptation of a literature procedure.168 To a mixture of 
the alcohol 267 (5.9 mg, 0.025 mmol, 1.00 equiv) and DMAP (0.3 mg, 10 mol%) 
in anhydrous DCM (5 mL) was added methanesulfonyl chloride (2.2 µL, 0.028 
mmol, 1.25 equiv) and Et3N (12.6 µL, 0.090 mmol, 4.00 equiv) at 0 °C. The 
resulting mixture was allowed to warm up to rt stirred for 6 h under N2 
atmosphere. The reaction mixture then was diluted with DCM (10 mL), washed 
with water (2 × 5 mL), aq. NaHCO3 (10 mL), brine (5 mL). The combined 
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organic layers were dried over MgSO4, and then filtered. The filtrate was 
concentrated under reduced pressure, then purified by column chromatography 
(25% EtOAc in petroleum ether) to give the title product 273 (1.0 mg, 18%) as a 
colourless oil, Rf 0.31 (25% EtOAc-petroleum ether); δH (250 MHz, CDCl3) 7.68 
(1H, s, oxazole -CH-CH-), 7.14 (1H, s, oxazole -CH-CH-), 6.65 (1H, dd, J 17.5, 
11.0 Hz, -CH=CH2), 6.22 (1H, d, J 11.0 Hz, -CH(OMs)-Het), 5.31 (1H, dd, Jcis 
11.0, 1.0 Hz, -CH=CH2), 5.17 (1H, dd, Jtrans 18.0, 1.5 Hz, -CH=CH2), 2.68 (3H, 
s, CH3-SO2-), 2.42-2.33 (1H, m), 2.27-1.99 (4H. m), 1.93-1.82 (2H, m), 1.74-
1.04 (7H, m), 0.94-0.82 (2H, m); δC (75 MHz, CDCl3) 161.0 (oxazole 4°), 141.5 
(-CH=CH2), 139.1 (oxazole -CH-CH-), 127.4 (oxazole -CH-CH-), 113.2 (-
CH=CH2), 76.3 (>CH(OMs)-Het), 48.8 (2°), 46.1 (2°), 42.9 (3°), 40.3 (4°), 38.6 
(1°), 37.4 (3°), 29.9 (2°), 28.3 (2°), 27.7 (2°), 22.1 (2°), 18.1 (2°); νmax (film) 
3367, 2921, 2852, 1652, 1452, 1362, 1175, 1044, 916, 850, 778 cm-1; TOF-
ESI+ m/z calculated for (C17H25NO4S + H)+, 340.1582, found, 340.1555; 
(C17H25NO4S + Na)+, 362.1401, found, 362.1371. 
 
(S*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-yl)methyl 
methanesulfonate (271) 
 
This was performed by adaptation of a literature procedure.168 To a mixture of 
the alcohol 266 (10 mg, 0.038 mmol, 1.00 equiv) and DMAP (0.5 mg, 10 mol%) 
in anhydrous DCM (10 mL) was added methanesulfonyl chloride (3.7 µL, 0.047 
mmol, 1.25 equiv) and Et3N (21.0 µL, 0.152 mmol, 4.00 equiv) at 0 °C. The 
resulting mixture was allowed to warm up to rt stirred for 16 h. The reaction 
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mixture was diluted with DCM (15 mL), washed with water (2 × 15 mL), aq. 
NaHCO3 (20 mL) and brine (20 mL). The combined organic layers were dried 
over MgSO4, and then filtered. The filtrate was concentrated under reduced 
pressure to give the crude. Purification by column chromatography (25% EtOAc 
in petroleum ether) gave the title product 271 (12.1 mg, 93%) as a colourless 
oil: Rf 0.29 (25% EtOAc-petroleum ether); δH (500 MHz, CDCl3) 7.71 (1H, s, 
oxazole -CH=CH-), 7.20 (1H, s, oxazole -CH=CH-), 6.33 (1H, dd, J 18.0, 11.0 
Hz, -CH=CH2), 6.12 (1H, d, J 12.0 Hz, -CH(OMs)-Het), 5.32 (1H, dd, Jcis 11.0, 
0.5 Hz, -CH=CH2), 5.19 (1H, dd, Jtrans 18.0, 1.0 Hz, -CH=CH2), 2.71 (3H, s, 
CH3-SO2-), 2.53-2.49 (1H, m), 2.33-2.22 (2H, m), 2.13-2.23 (2H, m), 1.86-1.07 
(7H, m), 0.98-0.66 (2H, m), 0.43 (1H, qd, J 13.0, 4.0 Hz); δC (125 MHz, CDCl3) 
160.9 (oxazole 4°), 141.6 (-CH=CH2), 139.7 (oxazole -CH=CH-), 127.9 (oxazole 
-CH=CH-), 113.5 (-CH=CH2), 74.5 (>CH(OMs)-Het), 48.2 (3°), 45.7 (2°), 42.4 
(2°), 40.2 (4°), 38.4 (1°), 37.8 (3°), 29.1 (2°), 27.9 (2°), 25.4 (2°), 21.8 (2°), 17.9 
(2°); νmax (film) 3408, 2921, 2852, 1634, 1452, 1362, 1175, 906 cm-1; TOF-ESI+ 
m/z calculated for (C17H25NO4S + H)+, 340.1582, found, 340.1555; (C17H25NO4S 
+ Na)+, 362.1401, found, 362.1371. 
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2-(((4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-ylidene)methyl)oxazole 
(272) 
 
Procedure A 
This was performed by adaptation of a literature procedure.106 To a mixture of 
mesylates 271 and 273 (33.0 mg, 0.097 mmol, 1.00 equiv) in 1.2-
dimethoxyethane (10 mL) sodium iodide (80.0 mg, 0.534 mmol, 5.50 equiv) and 
zinc dust (0.762 g, 11.7 mmol, 120 equiv) were added. The resulting mixture 
was heated in an oil bath at 120 °C for 16 h. The resulting mixture was cooled 
down to rt before dilution with water (15 mL) and filtration through a celite pad. 
The filtrate was extracted with Et2O (3 × 20 mL). The combined organic layers 
were washed with brine (50 mL), dried over MgSO4, then filtered. The filtrate 
was concentrated under reduced pressure, then purified by column 
chromatography (5 to 15% EtOAc in petroleum ether) to give the title product 
272 (15.0 mg, 64%) as a colourless oil, Rf 0.77 (25% EtOAc-petroleum ether); 
δH (250 MHz, CDCl3) 7.57 (1H, s, oxazole -CH=CH-), 7.16 (1H, s, oxazole -
CH=CH-), 5.96 (1H, br s >C=CH-Het), 5.82 (1H, dd, J 18.0, 11.0 Hz, -CH=CH2), 
5.12 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 5.02 (1H, dd, Jtrans 18.0, 1.5 Hz, -
CH=CH2), 3.93-3.88 (1H, m), 2.37-2.28 (1H, m), 2.17-0.70 (13 H, m); δC (75 
MHz, CDCl3) 154.6 (oxazole 4°), 141.4 (-CH=CH2), 137.9 (oxazole -CH=CH-), 
130.9 (>C=CH-Het), 127.4 (oxazole -CH=CH-), 114.3 (-CH=CH2), 107.6 
(>C=CH-Het), 52.6 (4°), 44.4 (2°), 42.6 (2°), 40.0 (3°), 31.2 (2°), 26.6 (2°), 25.2 
(2°), 23.4 (2°), 22.1 (2°); νmax (film) 2925, 2852, 1650, 1451, 1363, 1103, 908 
cm-1; TOF-ESI+ m/z calculated for (C16H21NO + H)+, 244.1701, found, 
244.1713. 
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Procedure B 
This was performed by adaptation of a literature procedure.168 To a mixture of 
the alcohol 267 (5.9 mg, 0.025 mmol, 1.00 equiv) and DMAP (0.3 mg, 10 mol%) 
in anhydrous DCM (5 mL) was added methanesulfonyl chloride (2.2 µL 0.028 
mmol, 1.25 equiv) and Et3N (12.7 µL, 0.090 mmol, 4.00 equiv) at 0 °C. The 
resulting mixture was allowed to warm up to rt stirred for 6 h under N2 
atmosphere. The reaction mixture was diluted with DCM (10 mL), washed with 
water (2 × 5 mL), aq. NaHCO3 (10 mL) and brine (5 mL). The combined organic 
layers were dried over MgSO4, and then filtered. The filtrate was concentrated 
under reduced pressure and purified by column chromatography (25% EtOAc in 
petroleum ether) to give the title product 272 (4.4 mg, 81%) as a colourless oil. 
Spectroscopic data correspond to those reported in procedure A. 
 
Oxazol-2-yl ((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-yl) ketone 
(275) 
 
This was performed by adaptation of a literature procedure.156 To a stirred 
solution of oxalyl chloride (53.3 mg, 36.0 µL, 0.420 mmol, 1.10 equiv) in DCM 
(10 mL) at –78 °C was added DMSO (64.2 mg, 58 µL, 0.820 mmol, 2.15 equiv). 
The solution was stirred for 25 min, and then alcohols 226 (100 mg, 0.38 mmol, 
1.00 equiv) in dry DCM (5 mL) was added. The reaction mixture was stirred at –
78 °C under nitrogen for 3 h, and then Et3N (194 mg, 270 µL, 1.91 mmol, 5.00 
equiv) was added at the same temperature. After 20 min the solution allowed to 
warm to rt over 30 min, then water (20 mL) was added and the reaction mixture 
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was extracted with EtOAc (3 × 15 mL). The combined organic extracts were 
washed with brine (50 mL) and dried over MgSO4, then filtered. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(10 to 25% EtOAc in petroleum ether) to give the title compound 275 (85.0 mg, 
86%) as a yellow colour oil; Rf 0.36 (20% EtOAc-petroleum ether); δH (250 MHz, 
CDCl3) 7.77 (1H, s, oxazole -CH=CH-), 7.27 (1H, s, oxazole -CH=CH-), 6.23 
(1H, dd, J 17.5, 11.0 Hz, -CH=CH2), 5.10 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 
4.98 (1H, dd, Jtrans 17.5, 1.5 Hz, -CH=CH2), 3.83 (1H, t, J 6.0 Hz, >CH-CO-Het), 
2.15-1.09 (15H, m); δC (62.5 MHz, CDCl3) 192.5 (>CH-CO-Het), 159.0 (oxazole 
4°), 141.7 (-CH=CH2), 141.1 (oxazole -CH=CH-), 128.4 (oxazole -CH=CH-), 
112.4 (-CH=CH2), 48.0 (3°), 45.8 (3°), 44.0 (2°), 40.5 (4°), 40.0 (2°), 29.0 (2°), 
27.6 (2°), 27.6 (2°), 21.8 (2°), 19.1 (2°); νmax (film) 2925, 2850, 1692, 1482, 
1449, 1353, 1247, 1150, 1105, 975, 923 cm-1; TOF-ESI+ m/z calculated for 
(C16H21NO2 + H)+, 260.1650, found, 260.1679; (C16H21NO2+ Na)+, 282.1469, 
found, 282.1459. 
 
O-((S*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-
yl)methyl) 1H-imidazole-1-carbothioate (276) 
 
This was performed by adaptation of a literature procedure.169 To a stirred 
solution of 266 (44.0 mg, 0.168 mmol, 1.00 equiv) in anhydrous DCM (10 mL) 
was added DMAP (2.5 mg, 10 mol%) followed by 1,1’-thiocarbonyldiimidazole 
(37.5 mg 0.210 mmol, 1.25 equiv). The reaction mixture was stirred for 16 h at 
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rt. Then solvent was removed under reduced pressure to give the crude. 
Purification by column chromatography (25 to 50% EtOAc in petroleum ether) 
gave the title product 276 (52.0 mg, 83%) as a pale yellow oil: Rf 0.24 (50% 
EtOAc-petroleum ether); δH (300 MHz, CDCl3) 8.30 (1H, s, -CH=N-CH=CH-), 
7.65 (1H, d, J 0.5 Hz, oxazole -CH=CH-), 7.60 (1H, s, -CH=N-CH=CH-), 7.15 
(1H, d, J 0.5 Hz, oxazole -CH=CH-), 7.07 (1H, d, J 10.5 Hz, >CH-CH(OHet)-CS-
), 6.99 (1H, s, -CH=N-CH=CH-), 6.40 (1H, ddd, J 17.5, 11.0, 1.0 Hz, -CH=CH2), 
5.30 (1H, dd, Jcis 11.0, 1.0 Hz, -CH=CH2), 5.12 (1H, dd, Jtrans 17.5, 1.5 Hz, -
CH=CH2), 2.75-2.67 (1H, m, >CH-CH(OHet)-CS-), 2.13-2.05 (1H, m), 2.00-1.92 
(1H, m), 1.78-1.49 (4H, m), 1.47-1.08 (6H, m), 1.01-0.83 (2H, m), 0.65 (1H, qd, 
J 13.0, 3.5 Hz); δC (75 MHz, CDCl3) 182.6 (-C(=S)-O), 160.6 (oxazole 4°), 141.2 
(-CH=CH2), 139.0 (oxazole -CH=CH-), 136.8 (-CH=N-CH=CH-N<), 130.8 (-
CH=N-CH=CH-N<), 127.8 (oxazole -CH=CH-), 118.0 (imidazole -CH=N-
CH=CH-N<), 113.2 (-CH=CH2), 75.9 (>CH(OHet)-CS-), 48.5 (3°), 45.6 (2°), 
42.4 (3°), 40.1 (4°), 37.7 (2°), 29.0 (2°), 27.9 (2°), 25.5 (2°), 21.8 (2°), 18.4 (2°); 
νmax (film) 2924, 2852, 1463, 1386, 1312, 1283, 1219, 1102, 968, 914, 855, 764 
cm-1; TOF-ESI+ m/z calculated for (C20H25N3O2S + H)+, 372.1745, found, 
372.1755; (C20H25N3O2S + Na)+, 394.1565, found, 394.1604. 
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O-((R*)-Oxazol-2-yl((1R*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-
yl)methyl) 1H-imidazole-1-carbothioate (277) 
 
This was performed by adaptation of a literature procedure.169 To a stirred 
solution of 267 (85.0 mg, 0.325 mmol, 1.00 equiv) in anhydrous DCM (10 mL) 
was added DMAP (4.0 mg, 10 mol%) followed by 1,1’-thiocarbonyldiimidazole 
(72.4 mg 0.406 mmol, 1.25 equiv). The corresponding reaction solution was 
stirred for 16 h at rt. Then solvent was removed under reduced pressure to give 
the crude. Purification by column chromatography (25 to 45% EtOAc in 
petroleum ether) gave the title product 277 (61.0 mg, 51%) as a pale yellow oil: 
Rf 0.10 (40% EtOAc-petroleum ether); δH (250 MHz, CDCl3) 8.37 (1H, s, -
CH=N-CH=CH-), 7.66 (1H, s, -CH=N-CH=CH-), 7.59 (1H, s, oxazole -CH=CH-), 
7.08 (1H, s, oxazole -CH=CH-), 7.03 (1H, s, -CH=N-CH=CH-), 6.92 (1H, d, J 
11.0 Hz, >CH-CH(OHet)-CS-), 6.31 (1H, dd, J 17.5, 11.0 Hz, -CH=CH2), 5.25 
(1H, dd, Jcis 11.5, 1.0 Hz, -CH=CH2), 5.18 (1H, dd, Jtrans 17.5, 1.0 Hz, -
CH=CH2), 2.60-2.52 (1H, m, >CH-CH(OHet)-CS-), 2.15-2.07 (1H, m), 1.83-0.83 
(14H, m); δC (75 MHz, CDCl3) 182.1 (-C(=S)-O), 160.9 (oxazole 4°), 141.4 (-
CH=CH2), 138.9 (-CH=N-CH=CH-N<), 138.7 (oxazole -CH=CH-), 130.9 (-
CH=N-CH=CH-N<), 127.4 (oxazole -CH=CH-), 118.2 (imidazole -CH=N-
CH=CH-N<), 113.5 (-CH=CH2), 78.8 (>CH(OHet)-CS-), 48.6 (3°), 45.8 (2°), 
42.4 (3°), 40.1 (4°), 37.3 (2°), 29.7 (2°), 28.3 (2°), 28.1 (2°), 21.9 (2°), 18.1 (2°); 
νmax (film) 2930, 2847, 1466, 1361, 1315, 1258, 1221, 1107, 971, 909 cm-1; 
TOF-ESI+ m/z calculated for (C20H25N3O2S + H)+, 372.1745, found, 372.1755; 
(C20H25N3O2S + Na)+, 394.1565, found, 394.1604. 
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2-((1R*,4aS*,8aR*)-6-Butyl-9-methyldecahydro-1,4a-ethanonaphthalen-10-
yl)oxazole (278) 
 
Procedure A 
This was performed by adaptation of a literature procedure.115 To a stirred 
solution of 276 (50.0 mg, 0.130 mmol, 1.00 equiv) in anhydrous benzene (10 
mL), was added n-Bu3SnH (79.8 mg, 73.7 µL, 0.270 mmol, 2.00 equiv) and the 
resulting mixture was heated under reflux for 30 min. After consumption of 276 
by monitoring on TLC, the mixture was concentrated under reduced pressure. 
The crude product was purified by column chromatography (10 to 20% EtOAc in 
petroleum ether) to give the title compound 278 (19.0 mg, 45%) as a single 
isomer and a colourless oil; Rf 0.26 (10% EtOAc in petroleum ether); δH (500 
MHz, CDCl3) 7.54 (1H, s, oxazole -CH=CH-), 7.01 (1H, s, oxazole -CH=CH-), 
2.81 (1H, pent, J 7.5 Hz), 2.74 (1H, d, J 7.5 Hz), 2.33 (1H, d, J 3.0 Hz), 1.71-
1.55 (8H, m), 1.48-1.24 (11H, m), 1.19-1.02 (3H, m), 1.07 (3H, d, J 7.0 Hz), 
0.91 (3H, t, J 7.0 Hz) ; δC (125 MHz, CDCl3) 169.3 (oxazole 4°), 137.8 (oxazole -
CH=CH-), 126.5 (oxazole -CH=CH-), 53.3 (3°), 47.7 (3°), 44.7 (3°), 44.4 (4°), 
38.2 (3°), 37.0 (2°), 33.1 (2°), 32.0 (2°), 27.8 (2°), 26.8 (2°), 26.4 (2°), 25.9 (2°), 
21.4 (2°), 19.8 (2°), 17.4 (2°), 13.5 (1°), 11.4 (1°); νmax (film) 2922, 2856, 1563, 
1451, 1377, 1133, 1101, 1075, 915, 740 cm-1; TOF-ESI+ m/z calculated for 
(C20H31NO + H)+, 302.2478, found, 302.2413. 
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Procedure B 
To a stirred solution of 276 (55.0 mg, 0.140 mmol, 1.00 equiv) in anhydrous 
toluene (5 mL), was added n-Bu3SnH (108 mg, 100 µL, 0.37 mmol, 2.50 equiv) 
and AIBN (2.4 mg, 0.01 mol, 10mol%), and the resulting mixture was heated 
under reflux for 1 h. After consumption of starting material by monitoring on 
TLC, the mixture was concentrated under reduced pressure. The crude product 
was purified by column chromatography (5 to 40% EtOAc in petroleum ether) to 
give the the title compound 278 (26.0 mg, 56%) a colourless oil. Spectroscopic 
data correspond to those reported in procedure A. 
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(6S*,6aR*,10aS*)-6,6a,7,8,9,10-Hexahydro-5H-6,10a-
propanobenzo[f]quinolin-2-ol (284) 
(6R*,6aR*,10aS*)-6,6a,7,8,9,10-Hexahydro-5H-6,10a-
propanobenzo[f]quinolin-5-one (285) 
(6R*,6aR*,10aS*)-2-Hydroxy-3,4,6,6a,7,8,9,10-octahydro-1H-6,10a-
propanobenzo[f]quinolin-5(2H)-one (286) 
(6R*,6aR*,10aS*)-5-(Hexahydropyrrolo[1,2-a]pyrimidin-1(2H)-yl)-
6,6a,7,8,9,10-hexahydro-5H-6,10a-propanobenzo[f]quinolin-2-ol (287) 
1-(3-(((5R*,6R*,6aR*,10aS*)-5-hydroxy-6,6a,7,8,9,10-hexahydro-5H-6,10a-
propanobenzo[f]quinolin-2-yl)amino)propyl)pyrrolidin-2-one (288) 
HO
N
HH
O
N
OH
N
O
NH
OH
N
NH
O
284 285 286
R*
R*
R*
H
H
H
H
226
N
O
N
NH
H
N
O
OH
inseparable mixture
ratio 287:288 = 4.3:1
287 288
 
To a microwave vial charged with a stirring bar, substrate 226 (260 mg, 0.994 
mmol, 1.00 equiv), anhydrous toluene (10 mL) and DBN (2.47 g, 2.45 mL, 19.9 
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mmol, 20.0 equiv) were added. The reaction mixture was degassed with argon 
and irradiated in microwave reactor at 200 °C for 90 min. After completion of 
reaction, the reaction solvent was removed under reduced pressure. The brown 
residue was diluted with EtOAc (20 mL) washed with water (2 × 15 mL) and 
brine (30 mL), dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure, then purified by column chromatography (elution 
gradient 0:0:80:20 to 5:10:100:0 (Et3N:MeOH:EtOAc:petrol)) to give the title 
products: 
Title product 284 (13 mg, 5%) as pale yellow oil; Rf 0.25 (100% EtOAc); δH (500 
MHz, CDCl3) 8.18 (1H, d, J 1.5 Hz, pyridine -N=CH-C(OH)=CH-), 7.22 (1H, d, J 
1.5 Hz, pyridine -N=CH-C(OH)=CH-), 3.14 (1H, dd, J 18.0, 7.0 Hz, Py-CH2-
CH<), 2.72 (1H, d, J 18.0 Hz, Py-CH2-CH<), 2.20 (1H, d, J 14.0 Hz, Py-4°C-
CHH-), 2.02-1.96 (2H, m, Py-CH2-CH< & one other alkyl H), 1.78-1.72 (2H, m), 
1.68-0.85 (13 H, m); δC (125 MHz, CDCl3) 153.4 (pyridine -N=CH-C(OH)=CH-), 
148.9 (pyridine 4°), 138.8 (pyridine 4°), 132.5 (pyridine -N=CH-C(OH)=CH-), 
122.7 (pyridine -N=CH-C(OH)=CH-), 44.4 (3°), 42.8 (3°), 39.3 (2°), 36.8 (2°), 
35.0 (2°), 33.3 (4°), 32.5 (2°), 28.2 (2°), 26.7 (2°), 22.1 (2°), 18.9 (2°); νmax (film) 
3423, 2936, 2885, 2831, 1527, 1453, 1343, 1301, 1268, 1204, 1123, 1019, 985, 
907 cm-1; TOF-ESI+ m/z calculated for (C16H21NO + Na)+, 266.1516, found, 
266.1515. 
Title product 285 (4 mg, 2%) as pale yellow oil; Rf 0.28 (100% EtOAc); δH (500 
MHz, CDCl3) 8.69 (1H, d, J 4.0 Hz, pyridine -N=CH-CH=CH-) 7.73 (1H, d, J 8.0 
Hz, pyridine -N=CH-CH=CH-), 7.48 (1H, dd, J 8.0, 4.5 Hz, pyridine -N=CH-
CH=CH-), 2.36 (1H, d, J 14.0 Hz), 2.17 (1H, app s), 1.89-1.78 (2H, m), 1.69-
0.83 (12 H, m); δC (125 MHz, CDCl3) 200.6 (>C=O), 150.2 (pyridine 4°), 148.1 
(pyridine -N=CH-CH=CH-), 142.7 (pyridine 4°), 135.3 (pyridine -N=CH-CH=CH-
), 127.9 (pyridine -N=CH-CH=CH-), 50.1 (3°), 47.4 (3°), 40.4 (2°), 40.1 (4°), 
36.7 (2°), 30.3 (2°), 29.6 (2°), 26.4 (2°), 21.6 (2°), 18.9 (2°); νmax (film) 2933, 
2881, 1701, 1542, 1473, 1389, 1325, 1277, 1215, 1157, 998, 911 cm-1; TOF-
ESI+ m/z calculated for (C16H19NO + H)+, 242.1544, found, 242.1539. 
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Title product 286 (30 mg, 12%) colourless oil; Rf 0.40 (100% EtOAc); δH (500 
MHz, CDCl3) 4.26 (1H, br s, -CH2-CH(OH)-CH2-), 4.20-4.14 (1H, m, -CH2-
CH(OH)-CH2-NH-) 3.20 (1H, dt, J 11.0, 3.0 Hz, -CH2-CH(OH)-CH2-NH-) 2.98 
(1H, dt, J 11.0, 1.5 Hz, -CH2-CH(OH)-CH2-NH-), 2.57 (1H, br s, -CH2-NH-), 2.37 
(1H, ddd, J 19.0, 4.0, 1.5 Hz, -CH2-CH(OH)-CH2-NH-), 2.31-2.27 (1H, m), 1.98 
(1H, dq, J 19.5, 2.0 Hz, -CH2-CH(OH)-CH2-NH-), 1.86-1.77 (2H, m), 1.73-0.83 
(13H, m); δC 62.5 MHz, CDCl3) 196.4 (>C=O), 138.4 (>C=C<), 124.4 (>C=C<), 
62.7 (>C(OH)<), 48.5 (>C(OH)-CH2-NH-), 48.1 (3°), 45.9 (3°), 39.6 (4°), 35.7 
(2°), 35.0 (2°), 31.6 (2°), 28.3 (2°), 27.8 (2°), 26.0 (2°), 23.1 (2°), 19.1 (2°); νmax 
(film) 3357, 3251, 2947, 2851, 1705, 1552, 1414, 1369, 1284, 1105, 1078, 999, 
911, 871 cm-1; TOF-ESI+ m/z calculated for (C16H23NO2 + Na)+, 284.1626, 
found, 284.1642. 
Title product 287 (41.9 mg, 11%) colourless oil; Rf 0.17 (1:5:100 
(Et3N:MeOH:EtOAc)); δH (500 MHz, CDCl3) 7.79 (1H, d, J 2.5 Hz, pyridine -
N=CH-C(OH)=CH-) 6.75 (1H, d, J 2.5 Hz, pyridine -N=CH-C(OH)=CH-), 4.18 
(1H, br s, -NH-), 3.37-3.33 (4H, m, Py-NH-CH2-CH2-CH2- and -C(O)N-CH2-CH2-
CH2-), 3.14-3.08 (2H, m, Py-NH-CH2-CH2-CH2-), 3.04 (1H, dd, J 18.0, 7.0 Hz, 
Py-CH2-CH<), 2.58 (1H, d, J 18.0 Hz, Py-CH2-CH<), 2.37 (2H, t, J 8.0 Hz, -CH2-
CH2-C(O)N-CH2-), 2.17-2.14 (1H, m, Py-C(4°)-CH2-), 2.02-1.96 (2H, m, -C(O)N-
CH2-CH2-CH2-), 1.93-1.91 (1 H, m, Py-CH2-CH<), 1.79-1.74 (2H, m, Py-NH-
CH2-CH2-CH2-), 1.73-0.99 (14H, m); δC (125 MHz, CDCl3) 175.3 (-C(O)N<), 
147.5 (pyridine 4°), 142.3 (pyridine -N=CH-C(NH-)=CH-), 136.4 (pyridine 4°), 
132.0 (pyridine -N=CH-C(NH-)=CH-), 117.4 (pyridine -N=CH-C(NH-)=CH-), 47.1 
(-C(O)N-CH2-) 44.7 (2°), 42.9 (3°), 40.4 (-NH-CH2-CH2-CH2-), 39.7 (-NH-CH2-
CH2-CH2-), 39.0 (4°), 36.8 (2°), 35.1 (2°), 34.3 (Py-CH2-CH<), 32.8 (Py-CH2-
CH<), 30.8 (-CH2-CH2-C(O)N-CH2-), 28.2 (2°), 26.8 (2°), 25.8 (-NH-CH2-CH2-
CH2-), 22.1 (2°), 19.0 (2°), 17.8 (-CH2-CH2-C(O)N-CH2-); νmax (film) 3321, 2981, 
2925, 2854, 1667, 1594, 1494, 1460, 1398, 1350, 1288, 1243, 1164, 1076, 
1031, 953, 745, 662 cm-1; TOF-ESI+ m/z calculated for (C23H33N3O + H)+, 
368.2796, found, 368.2859. 
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Title product 288 (12.6 mg, 3%) colourless oil; Rf 0.17 (1:5:100:0 
(Et3N:MeOH:EtOAc:petrol)); δH (500 MHz, CDCl3) 7.82 (1H, d, J 2.5 Hz, pyridine 
-N=CH-C(OH)=CH-) 6.70 (1H, d, J 2.5 Hz, pyridine -N=CH-C(OH)=CH-), 4.72 
(1H, d, J 7.0 Hz, Py-CH(OH)-CH<), 4.40 (1H, br s, -NH-), 3.37-0.99 (29H, m); δC 
(125 MHz, CDCl3) 175.4 (-CONH-), 148.5 (pyridine 4°), 143.5 (pyridine -N=CH-
C(NH-)=CH-), 135.9 (pyridine 4°), 131.9 (pyridine -N=CH-C(NH-)=CH-), 116.4 
(pyridine -N=CH-C(NH-)=CH-), 68.5 (Py-CH(OH)-CH<), 46.4, 43.4, 40.1, 39.7, 
39.6, 37.3, 36.8, 29.6, 29.5, 29.2, 28.1, 27.0, 26.9, 25.7, 22.3, 18.9; νmax (film) 
3670, 3321, 2981, 2925, 2854, 1667, 1594, 1494, 1460, 1398, 1350, 1288, 
1243, 1164, 1076, 1031, 953 cm-1; TOF-ESI+ m/z calculated for (C23H33N3O2 + 
H)+, 384.2646, found, 384.2706. 
 
(6S*,6aR*,10aS*)-6,6a,7,8,9,10-Hexahydro-5H-6,10a-
propanobenzo[f]quinolin-2-yl 4-nitrobenzoate (289) 
 
This was performed by adaptation of a literature procedure.164 To a stirred 
solution of alcohol 284 (17 mg, 0.069 mmol, 1.00 equiv) in anhydrous DCM (3 
mL), were added 4-nitrobenzoyl chloride (25.9 mg, 0.139 mmol, 2.00 equiv) and 
pyridine (27.6 mg, 28 µL, 0.349 mmol, 5.00 equiv). The reaction mixture was 
stirred  at rt for 16 h. After completion of reaction, the reaction mixture was 
quenched by addition of aq. NaOH (1.0 M, 5 mL) and extracted with DCM (3 × 
10 mL). The combined organic layers were washed with water (15 mL) and 
brine (30 mL), dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure, then purified by column chromatography (40 to 75% 
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EtOAc in petroleum ether) to give the title ester 289 (14 mg, 52%) as pale 
yellow solid, m.pt. 83–85 °C; Rf 0.47 (40% EtOAc in petroleum ether); δH (500 
MHz, CDCl3) 8.38 (2H, d, J 9.0 Hz, Ar-H), 8.36 (2H, d, J 9.0 Hz, Ar-H), 8.33 
(1H, d, J 2.0 Hz, pyridine -N=CH-C(OH)=CH-), 7.43 (1H, d, J 2.0 Hz, pyridine -
N=CH-C(OH)=CH-), 3.19 (1H, dd, J 18.5, 7.0 Hz, Py-CH2-CH<), 2.77 (1H, d, J 
18.5 Hz, Py-CH2-CH<), 2.21-2.16 (1H, m), 2.07-2.03 (1H, m), 1.83-1.77 (1H, 
m), 1.73-1.65 (2H, m), 1.63-1.58 (1H, m, Py-CH2-CH<), 1.56-1.50 (1H, m), 1.48-
1.03 (9H, m); δC (125 MHz, CDCl3) 163.1 (>C=O), 157.2 (pyridine 4°), 151.0 (Ar-
C-NO2), 145.7 (pyridine -N=CH-C(OPNB)=CH-), 139.1 (pyridine -N=CH-
C(OPNB)=CH-), 137.8 (pyridine 4°), 134.5 (Ar-C-CO2-), 131.3 (Ar-CH-), 126.2 
(pyridine -N=CH-C(OPNB)=CH-), 123.7 (Ar-CH-), 44.3 (3°), 42.9 (2°), 39.5 (4°), 
36.8 (2°), 35.1 (2°), 34.9 (2°), 32.6 (3°), 28.2 (2°), 26.7 (2°), 22.4 (2°), 18.9 (2°); 
νmax (film) 2926, 2855, 1742, 1608, 1528, 1448, 1348, 1258, 1210, 1107, 1014, 
907 cm-1; TOF-ESI+ m/z calculated for (C23H24N2O4 + Na)+, 415.1633, found, 
415.1633. 
 
(6R*,10aS*)-5-Oxo-2,3,4,5,6,6a,7,8,9,10-decahydro-1H-6,10a-
propanobenzo[f]quinolin-2-yl 4-nitrobenzoate (290) 
 
This was performed by adaptation of a literature procedure.164 To a solution of 
286 (30.0 mg, 0.114 mmol, 1.00 equiv) in anhydrous DCM (5 mL), were added 
4-nitrobenzoyl chloride (42.5 mg, 0.229 mmol, 1.00 equiv), pyridine (45.3 mg, 
46.3 µL, 0.573 mmol, 5.00 equiv), and catalytic amounts of DMAP (1.4 mg, 10 
mol%). Resulting reaction mixture was stirred at rt for 16 h. After completion of 
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reaction, the reaction mixture was quenched by addition of aq. NaOH (1.00 M, 
10 mL) and extracted with DCM (3 × 15 mL). The combined extracts were 
washed with water (15 mL) and brine (50 mL), dried over MgSO4 and filtered. 
The filtrate was concentrated under reduced pressure, then purified by column 
chromatography (40 to 75% EtOAc in petroleum ether) to give the title ester 290 
(63.6 mg, 83%) as pale yellow solid, m.pt. 92–94 °C; Rf 0.26 (75% EtOAc in 
petroleum ether); δH (300 MHz, CDCl3) 8.14 (2H, d, J 6.0 Hz, Ar-H), 7.71 (2H, d, 
J 6.0 Hz, Ar-H), 4.46-4.31 (1H, m, >CH-OH), 3.16 (1H, br s, >CH-OH) , 2.67 
(1H, dd, J 19.0, 5.0 Hz, -CH2-CH(OH)-CH2-N<), 2.22 (1H, d, J 19.0 Hz, -CH2-
CH(OH)-CH2-N<), 2.15-2.09 (1H, m, -CH2-CH(OH)-CH2-), 1.97-1.94 (1H, m, -
CH2-CH(OH)-CH2-), 1.78-1.44 (9H, m), 1.37-0.82 (7H, m); δC (75 MHz, CDCl3) 
192.7 (>C=O), 166.2 (-C(O)NPNB), 151.1 (Ar-C(4°)-NO2), 137.1 (>C=C<), 
134.7 (Ar-C(4°)-C(O)N<), 129.8 (Ar-CH-), 123.5 (>C=C<), 122.7 (Ar-CH), 65.9 
(-CH2-CH(OH)-CH2-), 49.2 (-CH(OH)-CH2-N<), 48.8 (3°), 46.7 (3°), 45.4 (2°), 
40.0 (2°), 39.7 (4°), 38.1 (-CH2-CH(OH)-CH2-N<), 33.8 (2°), 29.6 (2°), 26.6 (2°), 
22.1 (2°), 17.3 (2°); νmax (film) 3433, 2925, 2854, 1673, 1635, 1523, 1345, 1066, 
904, 723 cm-1; TOF-ESI+ m/z calculated for (C23H26N2O5 + H)+, 411.1919, 
found, 411.1937; (C23H26N2O5 + Na)+, 433.1739, found, 433.1737. 
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 (6R*,6aR*,10aS*)-5-(Hexahydropyrrolo[1,2-a]pyrimidin-1(2H)-yl)-
6,6a,7,8,9,10-hexahydro-5H-6,10a-propanobenzo[f]quinolin-2-yl 4-
nitrobenzoate (291) 
 
This was performed by adaptation of a literature procedure.164 To a stirred 
solution of alcohol 287 (54.5 mg, 0.148 mmol, 1.00 equiv) in anhydrous DCM (5 
mL), were added 4-nitrobenzoyl chloride (30.2 mg, 0.163 mmol, 1.10 equiv) and 
pyridine (23.4 mg, 24 µL, 0.296 mmol, 2.00 equiv. Resulting reaction mixture 
was stirred  at rt for 14 h. After completion of reaction, the reaction mixture was 
quenched by addition of aq. NaOH (1.0 M, 5 mL) and extracted with DCM (3 × 
10 mL). The combined extracts were washed with water (25 mL) and brine (40 
mL), dried over MgSO4 and filtered. The filtrate was concentrated under 
reduced pressure, then purified by column chromatography (40 to 85% EtOAc 
in petroleum ether) to give the title ester 291 (63.6 mg, 83%) as yellow oil; Rf 
0.18 (75% EtOAc in petroleum ether); δH (300 MHz, CDCl3) 8.14 (1H, d, J 2.0 
Hz, pyridine -N=CH-C(OH)=CH-), 7.87 (2H, d, J 8.5 Hz, Ar-H), 7.35 (2H, d, J 
8.5 Hz, Ar-H), 7.08 (1H, app s, pyridine -N=CH-C(OH)=CH-), 4.06-3.83 (2H, m), 
3.43-3.31 (4H, m, Py-NPNB-CH2-CH2-CH2- and -CH2-C(O)N-CH2-CH2-), 3.15-
3.05 (1H, m, -NPNB-CH2-CH2-CH2-), 3.01 (1H, d, J 18.0, 7.0 Hz, Py-CH2-CH<), 
2.59 (1H, d, J 19.0 Hz, Py-CH2-CH<), 2.36 (2H, t, J 8.0 Hz, -CH2-C(O)N-CH2-
CH2-), 2.07-1.82 (5H, m), 1.68-0.45 (14H, m); δC (75 MHz, CDCl3) 175.1 (-CH2-
C(O)N<), 168.3 (-C(O)NPNB), 158.8 (Ar-C-NO2), 147.8 (pyridine 4°), 144.2 
(pyridine -N=CH-C(NPNB)=CH-), 141.9 (pyridine 4°), 137.7 (pyridine -N=CH-
C(NPNB)=CH-), 136.3 (Ar-C-CO2-), 133.3 (pyridine -N=CH-C(NPNB)=CH-), 
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129.3 (Ar-CH-), 123.0 (Ar-CH-), 46.9 (2°), 46.7 (2°) 43.8 (3°), 42.8 (2°), 39.3 
(2°), 39.0 (4°), 36.2 (2°), 35.0 (2°), 34.5 (2°), 32.2 (3°), 30.8 (2°), 28.0 (2°), 26.4 
(2°), 25.2 (2°), 21.8 (2°), 18.5 (2°), 17.8 (2°); νmax (film) 2924, 2854, 1675, 1653, 
1601, 1523, 1455, 1346, 1313, 1292, 1107, 863, 851, 753 cm-1; TOF-ESI+ m/z 
calculated for (C30H36N4O4 + H)+, 517.2809, found, 517.2805. 
 
Oxazol-2-yl ((1S*,4aR*,8aR*)-4a-vinyldecahydronaphthalen-1-yl) ketone 
(296) 
 
This was performed by adaptation of a literature procedure.120 A mixture of 
ketone 275 (47.0 mg, 0.180 mmol, 1.00 equiv), DBN, (0.440 mL, 3.62 mmol, 
2.00 equiv), and o-xylene (20 mL) was heated to reflux for 16 h. The reaction 
mixture then was concentrated under reduced pressure to give a brown oil, 
which was purified by column chromatography (25 to 30% EtOAc in petroleum 
ether) to give the title product 296 (27.7 mg, 59%) as a colourless oil; Rf 0.26 
(30% EtOAc-petroleum ether); δH (250 MHz, CDCl3) 7.81 (1H, s, oxazole -
CH=CH-), 7.32 (1H, s, oxazole -CH=CH-), 6.20 (1H, dd, J 18.0, 11.0 Hz, -
CH=CH2), 5.21 (1H, d, Jcis 11.0 Hz, -CH=CH2), 5.10 (1H, dd, Jtrans 18.0, 1.5 Hz, 
-CH=CH2), 3.66 (1H, dt, J 11.0, 3.0 Hz, >CH-CO-Het), 1.93-1.17 (15H, m); δC 
(62.5 MHz, CDCl3) 192.7 (>CH-CO-Het), 158.3 (oxazole 4°), 141.7 (-CH=CH2), 
141.7 (oxazole -CH=CH-), 129.0 (oxazole -CH=CH-), 114.6 (-CH=CH2), 47.3 
(3°), 46.9 (3°), 41.4 (2°), 40.3 (4°), 40.3 (2°), 30.7 (2°), 26.5 (2°), 25.8 (2°), 21.8 
(2°), 21.1 (2°); νmax (film) 2925, 2857, 1694, 1537, 1481, 1448, 1387, 1269, 
1210, 1135, 981, 904 cm-1; TOF-ESI+ m/z calculated for (C16H21NO2 + Na)+, 
282.1469, found, 282.1476. 
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2-((S*)-Methoxy((1R*,4aR*,8aR*)-4a-Vinyldecahydronaphthalen-1-
yl)methyl)oxazole (312) 
 
This was performed by adaptation of a literature procedure.124 To a suspension 
of NaH (60% in mineral oil, 2.6 mg, 0.066 mmol, 1.25 equiv) in THF (3 mL), a 
solution of alcohol 266 (14.0 mg, 0.053 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise at 0 °C. The reaction mixture was stirred for 20 min, and then 
MeI (10.2 µL, 0.066 mmol, 1.25 equiv) was added dropwise. The reaction 
mixture was allowed to warm to rt and stirred for 14 h. The reaction mixture was 
quenched by addition of water and extracted with EtOAc (3 × 5 mL). The 
combined organic layers were washed with brine (20 mL), dried over MgSO4 
and filtered. The filtrate was concentrated Under reduced pressure, then 
purified by column chromatography (10% EtOAc in petrol) to give the title 
product 312 (12.0 mg, 81%) as pale yellow oil: Rf 0.23 (10% EtOAc-petroleum 
ether); δH (300 MHz, CDCl3) 7.64 (1H, s, oxazole -CH=CH-), 7.12 (1H, d, J 0.5 
Hz, oxazole -CH=CH-), 6.41 (1H, dd, J 18.0, 11.0 Hz, -CH=CH2), 5.23 (1H, dd, 
Jcis 11.0, 1.5 Hz, -CH=CH2), 5.09 (1H, dd, Jtrans 18.0, 1.5 Hz, -CH=CH2), 4.64 
(1H, d, J 11.0 Hz, -CH(OCH3)-Het), 3.15 (3H, s, -CH(OCH3)-), 2.38-2.24 (2H, 
m), 2.08-2.00 (1H, m), 1.84-0.98 (11H, m), 0.90-0.71 (2H, m), 0.65-0.51 (1H, 
m); δC (75 MHz, CDCl3) 164.2 (oxazole 4°), 143.0 (-CH=CH2), 138.6 (oxazole -
CH=CH-), 127.0 (oxazole -CH=CH-), 112.2 (-CH=CH2), 74.1 (>CH(OCH3)-Het), 
56.8 (>CH(OCH3)-Het), 48.4 (3°), 46.0 (2°), 43.1 (3°), 40.5 (4°), 38.5 (2°), 28.8 
(2°), 28.0 (2°), 25.5 (2°), 22.0 (2°), 17.9 (2°); νmax (film) 2924, 2853, 1566, 1450, 
1235, 1133, 1083, 1039, 912, 850, 795, 739 cm-1; TOF-ESI+ m/z calculated for 
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(C17H25NO2 + H)+, 276.1963, found, 276.1964; (C17H25NO2 + Na)+, 298.1782, 
found, 298.1800. 
 
4.3 Synthetic procedures for real system 
7-Methyl-1,2,3,4,5,6,7,8-octahydroquinolin-5-one (317) 
 
This was performed in accordance with a literature procedure.124 A solution of 
5-methylcyclohexane-1,3-dione 316 (1.20 g, 9.51 mmol, 1.00 equiv), 3-
bromopropylammonium bromide 315 (2.17 g, 9.89 mmol, 1.04 equiv) and 2,6-
lutidine (2.94 g, 3.2 mL, 27.5 mmol, 3.00 equiv) in EtOH (6 mL) was heated at 
130 °C for 20 min in a microwave reactor. The reaction mixture was quenched 
by addition of aq. NaOH solution (1.0 M, 50 mL) and extracted with DCM (3 × 
50 mL). The combined organic layers were washed with brine (150 mL), dried 
over MgSO4 and concentrated to 5 mL. Acetonitrile (2 × 30 mL) was added and 
the resulting solution was concentrated again to give the crude. Purified by 
column chromatography (100% EtOAc to 100:1:1 (EtOAc:Et3N:MeOH)) in 
petroleum ether) to give the title product 317 (1.52g, 97%) as beige solid; Rf 
0.17 (100% EtOAc in petroleum ether). Analytical data were consistent with 
those previously reported:124 m.pt. 173–174 °C; δH (400 MHz, CDCl3) 4.56 (1H, 
br s), 3.32-3.20 (2H, m), 2.41 (1H, dd, J 17.0, 3.0 Hz), 2.34 (1H, app t, J 6.0 
Hz,), 2.22-2.07 (3H, m), 2.02 (1H, dd, J 17.0, 11.0 Hz), 1.86-1.73 (2H, m), 1.04 
(3H, d, J 6.0, Hz, -CH(CH3)-); δC (100 MHz, CDCl3) 194.2 (>C=O), 158.6 (4°), 
104.2 (4°), 44.8 (2°), 41.5 (2°), 37.5 (2°), 29.0 (3°), 21.2 (2°), 21.1 (2°), 18.9 
(1°).  
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1-Benzyl-7-methyl-1,2,3,4,5,6,7,8-octahydroquinolin-5-one (337) 
 
This was performed by adaptation of a literature procedure.124 To a suspension 
of NaH (60% in mineral oil, 0.950 g, 23.8 mmol, 2.50 equiv) in THF (10 mL), a 
solution of vinylogous amide 317 (1.57 g, 9.50 mmol, 1.00 equiv) in THF (10 
mL) was added dropwise at 0 °C. The reaction mixture was stirred for 10 min, 
then benzyl bromide (2.82 mL, 23.7 mmol, 2.50 equiv) was added dropwise. 
Then reaction mixture was allowed to warm to rt and stirred for 16 h. The 
reaction mixture was quenched by addition of water and extracted with EtOAc 
(3 × 25 mL). The combined organic layers were washed with brine (75 mL), 
dried over MgSO4 and filtered. The filtrate was concentrated Under reduced 
pressure, then purified by column chromatography (75% EtOAc in petrol to 
100:1:5 (EtOAc:Et3N:MeOH)) to give the title product 337 (1.77 g, 73%) as 
brown oil: Rf 0.32 (100:1:5 (EtOAc:Et3N:MeOH));. δH (250 MHz, CDCl3) 7.46-
7.27 (3H, m, Ar-H), 7.20-7.06 (2H, m, Ar-H), 4.58 (1H, d, J 16.5 Hz, >N-CH2-
C6H5), 4.43 (1H, d, J 16.5 Hz, >N-CH2-C6H5), 3.20 (2H, t, J 5.5 Hz,-CH2-CH2-
N<), 2.60-1.72 (9H, m), 0.98 (3H, d, J 6.0 Hz, -CH(CH3)-); δC (62.5 MHz, CDCl3) 
193.8 (-(>N-)C=C-C(O)-), 158.8 (>N-)C=C-C(O-)-), 137.0 (Ar 4°), 128.4 (Ar CH), 
127.3 (Ar CH), 125.8 (Ar CH), 105.9 (-(>N-)C=C-C(O)-), 53.9 (>N-CH2-C6H5), 
49.4 (-CH2-CH2-CH2-N<), 43.9 (-CH2-CH2-CH2-N<), 34.7 (-CO-CH2-
CH(CH3)CH2-), 28.8 (-CH2-CH(CH3)CH2-), 21.2 (-CH2-CH(CH3)CH2-), 21.0 (-
CH2-CH2-CH2-N<), 19.7 (-CH2-CH(CH3)-CH2-); νmax (film) 2949, 2874, 1604, 
1538, 1432, 1394, 1347, 1309, 1242, 1203, 1143, 1078, 1001, 966. 909, 886, 
725, 696, 642 cm-1; TOF-ESI+ m/z calculated for (C17H21NO + Na)+, 278.1520, 
found, 278.1521. 
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(7R*,8aR*)-1-Benzyl-5,8a-diallyl-7-methyl-1,2,3,4,6,7,8,8a-
octahydroquinoline (339) 
1-Benzyl-5,5-diallyl-7-methyl-1,2,3,4,5,6,7,8-octahydroquinoline (340) 
 
This was performed by adaptation of a literature procedure.124 To a resealable 
pressure tube was added vinylogous amide 337 (324 mg, 1.27 mmol, 1.00 
equiv) and 2-iodopropane 336 (2.00 mL, 3.45 g, 20.3 mmol, 16.0 equiv). The 
reaction mixture was sealed and heated at 65 °C for 108 h, then diluted with 
benzene (2 × 6 mL), and concentrated to remove excess 2-iodopropane to give 
crude salt 337. To a solution of the residue (salt 337) in THF (9 mL) 
allylmagnesium bromide (0.320 M in Et2O, 7.14 mL, 2.29 mmol, 1.80 equiv) was 
added dropwise at 0 °C. The reaction mixture was stirred at the temperature for 
1 h before warming to the rt. After further 2 h reaction was quenched by addition 
of water and extracted with EtOAc (3 × 20 mL). The combined organic layers 
were washed with brine (60 mL), dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure, then purified by column chromatography 
(5 to 10% EtOAc in petrol) to give the title products: 
Title compound 339 (70.0 mg, 17%), a brown oil; Rf 0.57 (5% EtOAc in 
petroleum ether);. δH (300 MHz, CDCl3) 7.40-7.19 (5H, m, Ar-H), 5.92-5.71 (2H, 
m, 2 × -CH2-CH=CH2), 5.11-4.98 (4H, m, 2 × -CH2-CH=CH2), 4.16 (1H, d, J 
13.5 Hz, >N-CH2-C6H5), 3.24 (1H, d, J 13.5 Hz, >N-CH2-C6H5), 2.99-2.83 (2H, 
m), 2.78-2.44 (5H, m), 2.16-1.25 (8H, m), 0.92 (3H, d, J 6.0 Hz, -CH(CH3)-); δC 
(75 MHz, CDCl3) 136.9 (Ar 4°), 136.4 (-CH2-CH=CH2), 136.2 (-CH2-CH=CH2), 
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128.2 (Ar CH), 128.1 (Ar CH), 128.0 (Ar CH), 126.6 (>C=C<), 115.8 (-CH2-
CH=CH2), 114.6 (>C=C<), 114.4 (-CH2-CH=CH2), 53.9 (2°), 46.6 (2°), 44.8 (4°), 
39.2 (2°), 38.0 (2°), 36.5 (2°), 26.5 (2°), 25.5 (2°), 24.2 (2°), 22.4 (1°), 21.5 (3°); 
νmax (film) 3075, 2948, 2922, 2865, 2792, 1635, 1493, 1453, 1360, 1282, 1179, 
1089, 1027, 992, 906, 871, 803, 731, 696 cm-1; TOF-ESI+ m/z calculated for 
(C23H31N + H)+, 322.2529, found, 322.2548. 
Title compound 340 (22.0 mg, 5%), a light brown oil; Rf 0.40 (5% EtOAc in 
petroleum ether); δH (250 MHz, CDCl3) 7.36-7.21 (5H, m, Ar-H), 5.90-5.63 (2H, 
m, 2 × -CH2-CH=CH2), 5.17-4.96 (4H, m, 2 × -CH2-CH=CH2), 4.10 (2H, s, >N-
CH2-C6H5), 2.98-2.77 (2H, m), 2.33-0.94 (13H, m), 0.89 (3H, d, J 6.5 Hz, -
CH(CH3)-); δC (62.5 MHz, CDCl3) 140.5 (Ar 4°), 138.0 (>C=C<), 136.5 (-CH2-
CH=CH2), 136.4 (-CH2-CH=CH2), 128.2 (Ar CH), 127.4 (Ar CH), 126.5 (Ar CH), 
116.3 (-CH2-CH=CH2), 116.0 (-CH2-CH=CH2), 110.2 (>C=C<), 53.9 (2°), 48.5 
(2°), 44.4 (2°), 43.1 (2°), 41.2 (2°), 36.4 (2°), 29.6 (4°), 25.0 (2°), 22.3 (2°), 22.1 
(1°), 21.7 (3°); νmax (film) 3073, 2923, 2854, 1634, 1494, 1452, 1373, 1320, 
1183, 1108, 1072, 1028, 994, 966, 907, 730, 697 cm-1; TOF-ESI+ m/z 
calculated for (C23H31N + H)+, 322.2529, found, 322.2534. 
 
5-Methoxy-7-methyl-2,3,4,6,7,8-hexahydroquinolin-1-ium tetrafluoroborate 
(341) 
 
To a suspention of Meerwein’s salt 342 (560 mg, 3.81 mmol, 1.05 equiv) in 
DCM (15 mL) was added vinylogous amide 317 (600 mg, 3.63 mmol, 1.00 
equiv) in DCM (10 mL) dropwise at 0 °C. The reaction mixture was allowed to 
warm to rt and stirred for 16 h. The reaction solvent was removed under 
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reduced pressure to give crude product 341 (703 mg, 98%) as pale yellow oil of 
two rotamers: δH (250 MHz, CDCl3) 8.77 (1H, br s, >N+(H)=), 3.89 (3H, s, -
OCH3), 3.42-3.34 (2H, m, -CH2-N+(H)=), 2.77 (1H, dd, J 12.5, 4.5 Hz, 
>C(OCH3)-CH2-CH(CH3)-), 2.57 (1H, dd, J 12.5, 4.5 Hz, >C(OCH3)-CH2-
CH(CH3)-), 2.32-2.06 (5H, m), 1.78-1.70 (2H, m, -CH2-CH(CH3)-CH2-), 1.00 
(3H, d, J 5.5 Hz -CH2-CH(CH3)-); 
Major rotamer: δC (100 MHz, CDCl3) 180.2 (-N+(H)=C<), 174.0 (=C(OCH3)-CH2-
CH(CH3)-), 105.8 (>C=C(OCH3)-CH2-), 56.9 (=C(OCH3)-CH2-), 42.6 (-CH2-
N+(H)=), 36.1 (=C(OCH3)-CH2-), 32.7 (-CH2-CH(CH3)-), 27.7 (2°), 19.7 (1°), 18.7 
(2°), 17.8 (2°); 
Minor rotamer: δC (100 MHz, CDCl3) 178.2 (-N+(H)=C<), 174.7 (=C(OCH3)-CH2-
CH(CH3)-), 103.8 (>C=C(OCH3)-CH2-), 53.3 (=C(OCH3)-CH2-), 42.7 (-CH2-
N+(H)=), 36.8 (-CH2-CH(CH3)-), 36.5 (=C(OCH3)-CH2-), 27.8 (2°), 19.6 (2°), 18.7 
(1°), 17.5 (2°);  
νmax (film) 3250, 2988, 2885, 1651, 1483, 1383, 1314, 1273, 1183, 1140, 1005, 
946 cm-1; TOF-ESI+ m/z calculated for (C11H17NO + H)+, 180.1383, found, 
180.1520. 
 
1,7-Dimethyl-1,2,3,4,5,6,7,8-octahydroquinolin-5-one (323) 
 
This was performed in accordance with a literature procedure.124 To a 
suspension of NaH (60% in mineral oil, 330 mg, 8.32 mmol, 1.25 equiv) in THF 
(10 mL), a solution of vinylogous amide 317 (1.10 g, 6.66 mmol, 1.00 equiv) in 
THF (15 mL) was added dropwise at 0 °C. The reaction mixture was stirred for 
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20 min and MeI (1.53 mL, 9.99 mmol, 1.50 equiv) was added dropwise. Then 
reaction mixture was allowed to warm to rt and stirred for 14 h. The reaction 
mixture was quenched by addition of water and extracted with EtOAc (3 × 20 
mL). The combined organic layers were washed with brine (60 mL), dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure, then 
purified by column chromatography (100% EtOAc in petrol to 100:1:1 
(EtOAc:Et3N:MeOH)) to give the title product 323 (780 mg, 66%) as light yellow-
brown oil: Rf 0.12 (100:1:1 (EtOAc:Et3N:MeOH)). Analytical data were 
consistent with those previously reported:124 δH (400 MHz, CDCl3) 3.24-3.17 
(2H, m), 2.99 (3H, s), 2.55 (1H, dd, J 16.0, 4.0 Hz), 2.46-2.23 (3H, m), 2.16-1.94 
(3H, m), 1.80-1.71 (2H, m), 1.06 (3H, d, J 6.0, Hz); δC (100 MHz, CDCl3) 193.4 
(>C=O), 159.6 (4°), 105.6 (4°), 51.3 (2°), 43.9 (2°), 38.5 (1°), 35.1 (2°), 28.8 
(2°), 21.5 (2°), 21.1 (2°), 19.5 (1°).  
 
 (7S*,8aR*)-8a-Allyl-5-isopropoxy-1,7-dimethyl-1,2,3,4,6,7,8,8a-
octahydroquinoline (329) 
 
This was performed in accordance with a literature procedure.124 To a 
resealable pressure tube was added vinylogous amide 323 (788 mg, 4.39 
mmol, 1.00 equiv) and 2-iodopropane 336 (6.00 mL, 10.2 g, 60.1 mmol, 13.6 
equiv). The reaction mixture was sealed and heated at 65 °C for 108 h, diluted 
with benzene (2 × 12 mL), and concentrated to remove excess 2-iodopropane 
to give crude salt 326. To a solution of the residue (salt 326) in THF (25 mL) 
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allylmagnesium bromide (0.990 M in Et2O, 5.55 mL, 5.50 mmol, 1.25 equiv) was 
added dropwise at –78 °C. The reaction mixture was stirred at the temperature 
for 1 h before warming it up to the rt. After a further 2 h, the reaction mixture 
was quenched by addition of water and extracted with EtOAc (3 × 25 mL). The 
combined organic layers were washed with brine (75 mL), dried over MgSO4 
and filtered. The filtrate was concentrated under reduced pressure to give the 
crude product 329 (767 mg, 67%) as a brown oil; δH (250 MHz, CDCl3) 5.07-
5.53 (1H, m, -CH2-CH=CH2), 4.88 (1H, d, Jtrans 17.0 Hz, -CH2-CH=CH2), 4.81 
(1H, d, Jcis 10.0 Hz, -CH2-CH=CH2), 3.95 (1H, hept, J 6.0 Hz, -O-CH(CH3)2), 
2.98-2.46 (4H, m), 2.26-2.13 (1H, m), 2.19 (3H, s, >N-CH3), 1.97-1.43 (6H, m), 
1.30-1.13 (2H, m), 1.07 (3H, d, J 6.0 Hz, -O-CH(CH3)2), 1.03 (3H, d, J 6.0 Hz, -
O-CH(CH3)2), 0.79 (3H, d, J 6.0 Hz, -CH2-CH(CH3)-CH2-); δC (62.5 MHz, CDCl3) 
145.6 (>C=C(OCH(CH3)2)-), 136.2 (-CH2-CH=CH2), 119.5 (>C=C(OCH(CH3)2)-), 
115.5 (-CH2-CH=CH2), 77.2 (-O-CH(CH3)2), 68.2 (-CH2-N(CH3)-), 59.5 (>C-CH2-
CH(CH3)-), 50.3 (-CH2-CH(CH3)-CH2-), 44.5 (-CH2-CH(CH3)-CH2-), 37.6 (-CH2-
CH=CH2), 34.3 (2°), 33.9 (2°), 25.4 (2°), 22.7 (2°), 21.9 (-O-CH(CH3)2), 21.9 (-
O-CH(CH3)2), 20.4 (-CH2-CH(CH3)-CH2-); νmax (film) 2925, 2868, 2787, 1671, 
1604, 1555, 1453, 1370, 1307, 1279, 1149, 1114, 1057, 1001, 993, 916, 864, 
791, 743, 669 cm-1; TOF-ESI+ m/z calculated for (C17H29NO - (CH3)2CHOH + 
H2O + Na)+, 244.1677, found, 244.1686. 
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 (4aS*,7S*,8aR*)-8a-Allyl-1,7-dimethyldecahydroquinolin-5-one (350) 
(4aR*,7S*,8aR*)-8a-Allyl-1,7-dimethyldecahydroquinolin-5-one (351) 
 
This was performed in accordance with a literature procedure.124 To a solution 
of 329 (767 mg, 2.91 mmol, 1.00 equiv) in Et2O (20 mL) aq. H2SO4 (1.00 N, 20 
mL) was added and the resulting mixture was stirred at rt for 3 h. The ethereal 
layer was separated and the aqueous layer extracted with Et2O (2 × 15 mL). 
The combined organic layers were washed with sat. aq. NaHCO3 (2 × 30 mL) 
then brine (50 mL), dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure, then purified by column chromatography (25:75:0:0 to 
0:100:10:5 (Petrol:EtOAc:Et3N:MeOH)) to give the title products: 
Product 350 (66.0 mg, 7%), a light yellow-brown oil; Rf 0.47 (50:50:1:1 
(Petrol:EtOAc:Et3N:MeOH)); δH (500 MHz, CDCl3) 5.87-5.78 (1H, m, -CH2-
CH=CH2), 5.03-4.99 (2H, m, -CH2-CH=CH2), 2.81-2.74 (2H, m, -N(CH3)-CH2-
CH2-CH2-CH< and -CH2-CH=CH2), 2.61-2.58 (1H, m, -N(CH3)-CH2-CH2-CH2-
CH<), 2.45 (1H, dd, J 12.0, 3.0 Hz, >CH-C(O)-CH2-CH<), 2.42 (3H, s, >N-CH3), 
2.35-2.32 (1H, m), 2.25-2.22 (1H, m, >CH-C(O)-CH2-CH<), 2.03-1.97 (2H, m, 
>CH(CH3) and >CH-C(O)-CH2-CH<), 1.67-1.47 (5H, m), 1.38 (1H, t, J 12.0 Hz, 
>CH-C(O)-CH2-CH<), 1.02 (3H, d, J 6.0 Hz, -O-CH(CH3)2); δC (125 MHz, 
CDCl3) 211.3 (>CO), 134.5 (-CH2-CH=CH2), 117.4 (-CH2-CH=CH2), 61.6 (>C-
CH2-CH(CH3)-), 55.4 (>CH-C(O)-CH2-), 49.2 (-CH2-CH2-CH2-N(CH3)-), 49.0 
(>CH-C(O)-CH2-CH<), 42.2 (-CH2-CH(CH3)-CH2-C(O)-), 38.5 (>N-CH3), 30.6 (-
CH2-CH=CH2), 28.1 (-CH2-CH(CH3)-CH2-C(O)-), 23.0 (-CH2-CH2-CH2-N(CH3)-), 
22.6 (-CH(CH3)), 18.6 (-CH2-CH2-CH2-N(CH3)-); νmax (film) 2927, 2867, 2793, 
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1705, 1638, 1456, 1443, 1331, 1300, 1270, 1143, 1040, 991, 911 cm-1; TOF-
ESI+ m/z calculated for (C14H23NO + Na)+, 244.1677, found, 244.1686. 
Product 351 (95.0 mg, 10%), a light yellow-brown oil; Rf 0.16 (50:50:1:1 
(Petrol:EtOAc:Et3N:MeOH)); δH (500 MHz, CDCl3) 5.84 (1H, ddt, J 17.0, 10.0, 
7.0 Hz,-CH2-CH=CH2), 5.09 (1H, dd, Jcis 10.0, 1.0 Hz, -CH2-CH=CH2), 5.01 (1H, 
dd, Jtrans 17.0, 1.0 Hz, -CH2-CH=CH2), 2.63-2.53 (2H, m, -N(CH3)-CH2-CH2-
CH2-CH<), 2.47 (1H, dd, J 8.5, 7.5 Hz, >CH-C(O)-CH2-), 2.30-2.25 (1H, m, -
CH2-CH=CH2), 2.23 (3H, s, >N-CH3), 2.18 (1H, dd, J 14.5, 5.0 Hz, >CH-C(O)-
CH2-CH<), 2.09 (1H, dd, J 14.5, 12.0 Hz, >CH-C(O)-CH2-CH<), 1.99 (1H, dd, J 
15.0, 7.5 Hz, -CH2-CH=CH2), 1.90-1.81 (1H, m, -CH2-CH(CH3)-CH2-), 1.75 (1H, 
app t, J 13.0 Hz, -CH2-CH(CH3)-CH2-C(O)-), 1.65-1.60 (3H, m), 1.55-1.48 (2H, 
m), 1.03 (3H, d, J 6.0 Hz, -CH(CH3)); δC (125 MHz, CDCl3) 214.0 (>CO), 133.0 
(-CH2-CH=CH2), 117.8 (-CH2-CH=CH2), 59.4 (>C-CH2-CH(CH3)-), 53.7 (>CH-
C(O)-CH2-), 49.5 (-CH2-CH2-CH2-N(CH3)-), 45.2 (>CH-C(O)-CH2-CH<), 40.4 (-
CH2-CH=CH2), 37.0 (>N-CH3), 29.9 (-CH2-CH(CH3)-CH2-C(O)-), 27.1 (-CH2-
CH(CH3)-CH2-C(O)-), 25.8 (-CH2-CH2-CH2-N(CH3)-), 24.6 (-CH2-CH2-CH2-
N(CH3)-), 22.5 (-CH(CH3)); νmax (film) 2927, 2867, 2793, 1705, 1638, 1456, 
1443, 1331, 1300, 1270, 1143, 1040, 991, 911 cm-1; TOF-ESI+ m/z calculated 
for (C14H23NO + Na)+, 244.1677, found, 244.1686. 
 
(4aR*,7S*,8aR*)-8a-Allyl-7-methyldecahydroquinolin-5-one (361). 
 
A stirred solution of allyl ketone 351 (110 mg, 0.490 mmol 1.00 equiv) and TPP 
(7.0 mg, 2.5 mol%) in 5 mL of dry DCM in a microwave vial, was irradiated 
using 2 × 150 watt lamps, while oxygen was bubbled through the purple 
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solution. The progress of the reaction was monitored by 1H-NMR, after 2 h NMR 
indicated that the reaction was complete. The reaction mixture was transferred 
to a round bottom flask and solvent was removed under reduced pressure. The 
crude residue was purified by column chromatography (50% EtOAc in 
petroleum ether, then EtOAc:petroleum ether:MeOH:Et3N (50:50:1:1) to give 
the title compound 361 as a pale amber oil (35.0 mg, 34%); Rf 0.18 (50:50:1:1 
EtOAc:petroleum ether:MeOH:Et3N); δH (500 MHz, CDCl3) 5.78 (1H, ddt, J 17.0, 
9.5, 7.5 Hz,-CH2-CH=CH2),, 5.12 (1H, d, Jcis 10.0 Hz, -CH2-CH=CH2); 5.08 (1H, 
d, Jtrans 17.0, -CH2-CH=CH2), 2.92-2.83 (2H, m, -CH2-CH2-NH-), 2.18-2.08 (4H, 
m), 2.04-1.90 (4H, m), 1.77-1.63 (2H, m), 1.39-1.25 (3H, m), 1.02 (3H, d, J 6.0 
Hz, >CH-CH3); δC (125 MHz, CDCl3) 214.2 (>C=O), 132.0 (-CH2-CH=CH2), 
119.4 (-CH2-CH=CH2), 56.8 (-CH-C=O), 55.4 (N-C-CH2-CH=CH2), 44.9 (-CH2-
CH=CH2), 44.6 (-C(O)-CH2-CH(CH3)-), 40.1 (-CH2-CH2-NH-), 35.6 (2°), 27.2 (-
CH2-CH(CH3)-), 25.6 (2°), 25.5 (2°), 22.4 (-CH(CH3)-); νmax (film) 3333, 2925, 
2854, 1704, 1638, 1455, 1438, 1362, 1264, 1228, 1183, 999 cm-1; TOF-ESI+ 
m/z calculated for (C13H21NO + H)+, 208.1696, found, 208.1835. 
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.
41
22
.
40
28
.
42
28
.
83
30
.
39
38
.
18
40
.
64
45
.
11
46
.
30
49
.
50
68
.
87
11
2.
35
12
6.
60
13
8.
17
14
2.
66
16
6.
60
 
  Appendices 
236 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
88
84
1.
13
84
1.
22
48
1.
24
09
1.
24
92
1.
65
50
1.
74
59
1.
86
75
1.
92
97
2.
04
45
2.
08
65
2.
39
28
4.
36
34
4.
37
91
4.
39
53
4.
41
06
5.
22
88
7.
09
09
7.
62
14
3.
22
3.
16
7.
28
1.
18
2.
20
3.
05
1.
01
1.
00
1.
22
1.
17
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
15
.
07
38
21
.
68
85
21
.
80
45
25
.
52
42
26
.
76
75
29
.
28
16
34
.
59
56
36
.
67
14
36
.
86
50
39
.
00
43
45
.
45
24
72
.
26
82
72
.
90
40
12
6.
89
14
13
8.
31
50
16
4.
02
43
 
  Appendices 
237 
 
 
ppm
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
7
6
5
4
3
2
1
0
 
 
  Appendices 
238 
 
 
ppm
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
7
6
5
4
3
2
1
0
 
 
  Appendices 
239 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
0.
7
87
7
1.
19
15
1.
22
14
1.
23
33
1.
24
42
1.
35
76
1.
41
33
1.
45
41
1.
50
96
1.
57
94
1.
7
46
0
1.
81
84
1.
93
04
2.
04
34
2.
26
02
2.
36
30
4.
56
18
4.
57
42
4.
58
67
4.
59
93
4.
88
52
7.
11
26
7.
61
49
4.
29
3.
04
2.
23
1.
18
4.
09
1.
10
2.
14
2.
17
1.
00
1.
00
1.
03
1.
04
 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
15
.
15
21
.
49
21
.
71
25
.
94
27
.
01
34
.
39
34
.
70
36
.
57
37
.
08
37
.
73
44
.
10
68
.
85
73
.
64
12
7.
23
13
7.
87
16
5.
52
 
  Appendices 
240 
 
 
ppm
1.01.52.02.53.03.54.04.55.05.5 ppm
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
H
H
H
H
H
H
H
H
 
 
  Appendices 
241 
 
 
ppm
1.01.52.02.53.03.54.04.55.05.5 ppm
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
 
  Appendices 
242 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
82
67
0.
94
26
1.
04
91
1.
74
11
1.
82
25
1.
93
22
1.
99
48
2.
27
66
2.
33
36
2.
42
69
2.
68
88
5.
13
33
5.
13
89
5.
20
43
5.
20
99
5.
28
53
5.
28
97
5.
33
02
5.
33
46
6.
20
82
6.
25
12
6.
59
14
6.
63
75
6.
66
31
6.
70
79
7.
14
97
7.
68
12
2.
28
7.
34
2.
04
4.
14
1.
11
3.
16
1.
09
1.
12
1.
07
1.
00
1.
04
1.
04
 
R*
R*
R*
H
O
N
O
H
S
O
Me O
R*
273
 
2030405060708090100110120130140150160170180 ppm
18
.
19
22
.
14
27
.
76
28
.
36
29
.
91
37
.
49
38
.
62
40
.
34
42
.
90
46
.
13
48
.
88
7
6.
32
11
3.
27
12
7
.
48
13
9.
31
14
1.
51
16
1.
00
 
  Appendices 
243 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
1.
09
87
2.
15
82
3.
81
25
3.
83
68
3.
86
13
4.
94
94
4.
95
54
5.
02
01
5.
02
60
5.
08
09
5.
08
63
5.
12
56
5.
13
10
6.
18
09
6.
22
55
6.
25
16
6.
29
61
7.
27
10
7.
77
49
15
.
44
1.
14
1.
08
1.
19
1.
00
1.
02
1.
05
 
H
O
N
O
H
R*
R*
R* 275
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
19
.
13
21
.
80
27
.
63
27
.
67
29
.
00
40
.
01
40
.
51
44
.
01
45
.
86
48
.
02
11
2.
40
12
8.
48
14
1.
16
14
1.
79
15
9.
05
19
2.
54
 
  Appendices 
244 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
64
57
0.
67
53
0.
68
84
0.
71
90
0.
73
15
0.
83
68
1.
01
27
1.
08
05
1.
47
50
1.
49
77
1.
78
41
1.
92
48
2.
00
02
2.
05
30
2.
13
34
2.
67
87
2.
75
16
5.
10
09
5.
10
52
5.
15
98
5.
16
42
5.
28
41
5.
28
73
5.
32
11
5.
32
42
6.
35
14
6.
35
41
6.
38
83
6.
39
12
6.
41
03
6.
41
32
6.
44
74
6.
45
01
6.
99
05
6.
99
33
6.
99
61
6.
99
88
7.
06
04
7.
09
63
7.
15
19
7.
15
41
7.
59
74
7.
60
20
7.
60
72
7.
65
45
7.
65
61
8.
29
81
8.
30
11
8.
30
43
1.
07
2.
11
6.
44
4.
20
1.
01
1.
03
1.
06
1.
03
1.
03
1.
00
1.
00
1.
17
1.
03
1.
02
1.
00
1.
04
 
R*
R*
S*
R*
H
O
N
O
H
N S
N
276
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
18
.
46
21
.
84
25
.
55
27
.
90
29
.
07
37
.
76
40
.
10
42
.
48
45
.
61
48
.
52
75
.
92
11
3.
24
11
8.
08
12
7.
85
13
0.
80
13
6.
86
13
9.
01
14
1.
27
16
0.
61
18
2.
62
 
  Appendices 
245 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
64
57
0.
67
53
0.
68
84
0.
71
90
0.
73
15
0.
83
68
1.
01
27
1.
08
05
1.
47
50
1.
49
77
1.
78
41
1.
92
48
2.
00
02
2.
05
30
2.
13
34
2.
67
87
2.
75
16
5.
10
09
5.
10
52
5.
15
98
5.
16
42
5.
28
41
5.
28
73
5.
32
11
5.
32
42
6.
35
14
6.
35
41
6.
38
83
6.
39
12
6.
41
03
6.
41
32
6.
44
74
6.
45
01
6.
99
05
6.
99
33
6.
99
61
6.
99
88
7.
06
04
7.
09
63
7.
15
19
7.
15
41
7.
59
74
7.
60
20
7.
60
72
7.
65
45
7.
65
61
8.
29
81
8.
30
11
8.
30
43
1.
07
2.
11
6.
44
4.
20
1.
01
1.
03
1.
06
1.
03
1.
03
1.
00
1.
00
1.
17
1.
03
1.
02
1.
00
1.
04
 
R*
R*
S*
R*
H
O
N
O
H
N S
N
277
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
18
.
46
21
.
84
25
.
55
27
.
90
29
.
07
37
.
76
40
.
10
42
.
48
45
.
61
48
.
52
75
.
92
11
3.
24
11
8.
08
12
7.
85
13
0.
80
13
6.
86
13
9.
01
14
1.
27
16
0.
61
18
2.
62
 
  Appendices 
246 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
90
10
0.
91
56
0.
93
03
1.
02
31
1.
19
73
1.
24
23
1.
48
36
1.
55
74
1.
7
14
5
2.
33
46
2.
34
06
2.
7
38
9
2.
7
54
0
2.
7
87
1
2.
80
12
2.
81
52
2.
82
96
2.
84
40
7.
01
13
7.
54
30
3.
25
3.
20
3.
13
11
.
18
8.
21
1.
01
1.
01
1.
06
1.
04
1.
00
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
11
.
40
13
.
57
17
.
50
19
.
86
21
.
47
25
.
93
26
.
45
26
.
82
27
.
82
32
.
03
33
.
13
37
.
07
38
.
27
44
.
42
44
.
74
47
.
74
53
.
33
12
6.
56
13
7.
85
16
9.
33
 
  Appendices 
247 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
0.
85
61
1.
68
81
1.
72
58
1.
78
40
1.
96
89
2.
02
03
2.
19
19
2.
21
94
2.
70
38
2.
74
00
3.
11
99
3.
13
44
3.
15
63
3.
17
08
7.
22
72
7.
23
05
8.
18
53
8.
18
83
15
.
70
2.
12
2.
15
1.
02
1.
12
1.
01
1.
04
1.
00
 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
18
.
97
22
.
10
26
.
79
28
.
28
32
.
57
33
.
30
35
.
00
36
.
89
39
.
30
42
.
88
44
.
44
12
2.
7
5
13
2.
58
13
8.
84
14
8.
93
15
3.
43
 
  Appendices 
248 
1.01.52.02.53.03.54.04.55.05.56.06.57.0 ppm
1.
93
33
1.
94
24
1.
95
08
1.
95
99
2.
01
17
2.
01
95
2.
02
86
2.
03
70
2.
27
96
2.
31
72
2.
32
56
2.
33
28
2.
34
25
2.
35
09
2.
40
22
2.
41
06
2.
42
03
2.
42
75
2.
57
34
2.
94
80
2.
95
50
2.
96
15
2.
96
85
2.
99
34
3.
00
04
3.
00
64
3.
01
39
3.
17
22
3.
18
42
3.
19
72
3.
21
72
3.
22
97
3.
24
17
4.
14
33
4.
20
45
4.
26
80
13
.
06
2.
13
1.
11
1.
05
1.
11
1.
09
1.
00
1.
07
1.
00
0.
96
 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
19
.
18
23
.
18
26
.
08
27
.
83
28
.
39
31
.
68
35
.
05
35
.
73
39
.
62
45
.
93
48
.
12
48
.
58
62
.
73
12
4.
44
13
8.
45
19
6.
43
 
  Appendices 
249 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1.
73
82
1.
74
68
1.
00
12
1.
48
63
1.
57
16
1.
79
66
1.
89
68
1.
92
97
1.
96
25
2.
03
07
2.
14
46
2.
17
22
2.
35
82
2.
37
43
2.
38
97
2.
56
41
2.
59
95
3.
01
69
3.
03
21
3.
05
37
3.
06
78
3.
08
89
3.
14
40
3.
33
23
3.
37
66
4.
18
61
6.
75
44
6.
75
94
7.
79
60
7.
80
11
14
.
56
2.
17
1.
06
2.
31
1.
13
2.
24
1.
02
1.
09
2.
06
4.
26
0.
95
0.
98
1.
00
 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
17
.
85
19
.
01
22
.
15
25
.
89
26
.
82
28
.
22
30
.
86
32
.
80
34
.
35
35
.
14
36
.
85
39
.
02
39
.
74
40
.
43
42
.
99
44
.
74
47
.
16
11
7
.
45
13
2.
01
13
6.
48
14
2.
33
14
7
.
56
17
5.
32
 
  Appendices 
250 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
1.
03
38
1.
48
47
1.
50
32
1.
56
57
1.
58
88
1.
63
04
1.
65
59
1.
73
45
1.
77
61
1.
83
16
2.
03
28
2.
07
21
2.
16
47
2.
21
55
2.
76
11
2.
79
86
3.
17
62
3.
19
08
3.
21
37
3.
22
83
7.
42
7
8
7.
43
23
8.
33
06
8.
33
50
8.
35
65
8.
37
46
8.
39
80
9.
38
1.
18
1.
09
2.
21
1.
14
1.
09
1.
04
1.
02
1.
01
1.
00
1.
01
4.
02
 
N
O
O
NO2
H 289
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
18
.
88
22
.
04
26
.
75
28
.
21
32
.
65
34
.
99
35
.
14
36
.
86
39
.
53
42
.
92
44
.
35
12
3.
77
12
6.
29
13
1.
34
13
4.
54
13
7.
89
13
9.
13
14
5.
73
15
1.
00
15
7.
28
16
3.
10
 
  Appendices 
251 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
45
69
1.
68
97
1.
82
07
2.
07
27
2.
56
51
2.
62
84
3.
00
42
3.
02
84
3.
05
92
3.
15
00
3.
31
35
3.
43
34
3.
83
67
4.
06
93
7.
08
20
7.
34
72
7.
37
55
7.
95
20
7.
98
03
8.
14
48
8.
15
21
14
.
56
5.
31
2.
20
1.
15
1.
01
1.
01
4.
25
2.
17
1.
12
2.
27
2.
28
1.
00
 
 
2030405060708090100110120130140150160170180190 ppm
18
.
56
21
.
80
25
.
21
26
.
44
28
.
03
30
.
85
32
.
28
34
.
59
35
.
04
36
.
29
39
.
09
39
.
35
42
.
86
43
.
82
46
.
76
46
.
99
12
3.
01
12
9.
35
13
3.
35
13
6.
37
13
7.
73
14
1.
96
14
4.
27
14
7.
80
15
8.
84
16
8.
38
17
5.
11
 
  Appendices 
252 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1.
17
08
1.
93
12
3.
61
78
3.
63
08
3.
66
31
3.
67
69
3.
70
82
3.
72
34
5.
07
25
5.
07
80
5.
14
37
5.
14
92
5.
24
79
5.
29
26
6.
14
23
6.
18
72
6.
21
35
6.
25
84
7.
32
21
7.
81
42
15
.
39
1.
05
1.
03
1.
14
1.
03
1.
05
1.
09
 
S*
R*
R*
H
O
N
O
H
296
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
21
.
13
21
.
84
25
.
85
26
.
54
30
.
76
40
.
30
40
.
39
41
.
48
46
.
97
47
.
32
11
4.
69
12
9.
02
14
1.
72
14
1.
75
15
8.
39
19
2.
74
 
  Appendices 
253 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
78
49
0.
80
88
1.
02
66
1.
05
11
1.
06
27
1.
08
72
1.
13
82
1.
30
83
1.
43
79
1.
97
66
2.
13
86
2.
19
53
2.
26
42
2.
46
26
2.
89
60
3.
87
62
3.
90
14
3.
92
60
3.
95
07
3.
97
43
4.
00
00
4.
02
31
4.
79
16
4.
83
25
4.
85
83
4.
92
71
5.
54
00
5.
70
35
3.
09
3.
03
3.
11
2.
16
6.
33
4.
14
4.
06
1.
05
1.
03
1.
02
1.
00
 
Me
O
Me
Me
N
Me
329
 
30405060708090100110120130140150160170 ppm
20
.
40
21
.
90
21
.
95
22
.
70
25
.
46
33
.
90
34
.
37
37
.
61
44
.
50
50
.
30
59
.
59
68
.
26
77
.
21
11
5.
58
11
9.
59
13
6.
25
14
5.
68
 
  Appendices 
254 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1.
00
38
1.
02
68
1.
70
73
2.
67
43
3.
21
16
3.
23
70
3.
25
78
4.
39
80
4.
46
67
4.
55
47
4.
62
19
7.
06
88
7.
20
98
7.
27
47
7.
46
13
3.
05
9.
35
2.
05
1.
00
1.
06
2.
08
3.
27
 
N Me
O
337
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
19
.
75
21
.
03
21
.
29
28
.
89
34
.
70
43
.
98
49
.
47
53
.
94
10
5.
96
12
5.
86
12
7.
38
12
8.
84
13
7.
09
15
8.
86
19
3.
87
 
  Appendices 
255 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
0.
91
94
0.
94
05
1.
25
08
2.
16
46
2.
44
93
2.
78
63
2.
86
12
2.
99
60
3.
22
07
3.
26
57
4.
14
20
4.
19
45
4.
98
09
5.
11
57
5.
71
50
5.
92
47
7.
19
05
7.
40
77
3.
35
15
.
62
8.
32
2.
06
1.
00
1.
08
4.
46
2.
21
5.
54
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
21
.
52
22
.
40
24
.
28
25
.
56
26
.
54
36
.
54
38
.
03
39
.
21
44
.
83
46
.
67
53
.
97
11
4.
40
11
4.
62
11
5.
81
12
6.
36
12
8.
02
12
8.
10
12
8.
20
13
6.
27
13
6.
43
13
6.
92
 
  Appendices 
256 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
0.
88
57
0.
91
14
0.
94
69
2.
33
50
2.
77
94
2.
98
87
4.
10
01
4.
96
58
5.
17
95
5.
63
90
5.
90
98
7
.
21
7
1
7
.
36
32
3.
39
13
.
77
2.
24
2.
00
4.
73
2.
39
5.
63
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
21
.
7
1
22
.
21
22
.
35
25
.
06
29
.
68
36
.
46
41
.
27
43
.
11
44
.
44
48
.
54
53
.
95
11
0.
20
11
6.
02
11
6.
30
12
6.
55
12
7.
48
12
8.
22
13
6.
43
13
6.
55
13
8.
00
14
0.
53
 
  Appendices 
257 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.
99
48
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6.2 X-Ray Crystallography Data  
Table 6.1 Crystal data and structure refinement for 177. 
Identification code h09sel3 
Empirical formula C12H20O2 
Formula weight 196.28 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21/n 
Unit cell dimensions a = 7.0510(2)Å α = 90o 
 b = 13.9920(5)Å β = 91.091(2)o 
 
c = 11.0780(4)Å γ = 90o 
Volume 1092.73(6) Å3 
Z 4 
Density (calculated) 1.193 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 432 
Crystal size 0.35 x 0.35 x 0.30 mm 
Theta range for data collection 3.68 to 27.50 o. 
Index ranges -9<=h<=9; -18<=k<=18; -14<=l<=14 
Reflections collected 13960 
Independent reflections 2477 [R(int) = 0.0469] 
Reflections observed (>2σ) 2116 
Data Completeness 0.987 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2477 / 0 / 130 
Goodness-of-fit on F2 1.073 
Final R indices [I>2σ(I)] R1 = 0.0569   wR2 = 0.1642 
R indices (all data) R1 = 0.0653  wR2 = 0.1732 
Largest diff. peak and hole 0.783 and -0.258 eÅ-3 
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Table 6.2 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 177. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
Atom x y z U(eq) 
O(1) 9912(2) 3715(1) -485(1) 49(1) 
O(2) 7036(2) 2691(1) 324(1) 48(1) 
C(1) 8040(2) 2254(1) 1314(1) 36(1) 
C(2) 8918(2) 1302(1) 946(2) 39(1) 
C(3) 10719(2) 1432(1) 228(1) 34(1) 
C(4) 12193(2) 2010(1) 941(1) 30(1) 
C(5) 11442(2) 3014(1) 1281(1) 26(1) 
C(6) 12817(2) 3498(1) 2183(1) 33(1) 
C(7) 12094(2) 4467(1) 2605(2) 41(1) 
C(8) 10146(2) 4388(1) 3167(2) 47(1) 
C(9) 8744(2) 3881(1) 2313(2) 43(1) 
C(10) 9520(2) 2904(1) 1929(1) 30(1) 
C(11) 11358(2) 3586(1) 105(1) 31(1) 
C(12) 13186(2) 3977(1) -382(2) 46(1) 
 
 
Table 6.3 Bond lengths [Å] and angles [o] for 177. 
O(1)-C(11) 1.2139(18) O(2)-C(1) 1.4312(19) 
O(2)-H(2) 0.8400 C(1)-C(2) 1.528(2) 
C(1)-C(10) 1.5333(19) C(1)-H(1) 1.0000 
C(2)-C(3) 1.522(2) C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 C(3)-C(4) 1.525(2) 
C(3)-H(3A) 0.9900 C(3)-H(3B) 0.9900 
C(4)-C(5) 1.5498(18) C(4)-H(4A) 0.9900 
C(4)-H(4B) 0.9900 C(5)-C(11) 1.5285(19) 
C(5)-C(6) 1.5370(18) C(5)-C(10) 1.5538(18) 
C(6)-C(7) 1.525(2) C(6)-H(6A) 0.9900 
C(6)-H(6B) 0.9900 C(7)-C(8) 1.523(2) 
C(7)-H(7A) 0.9900 C(7)-H(7B) 0.9900 
C(8)-C(9) 1.530(2) C(8)-H(8A) 0.9900 
C(8)-H(8B) 0.9900 C(9)-C(10) 1.535(2) 
C(9)-H(9A) 0.9900 C(9)-H(9B) 0.9900 
C(10)-H(10) 1.0000 C(11)-C(12) 1.510(2) 
C(12)-H(12A) 0.9800 C(12)-H(12B) 0.9800 
C(12)-H(12C) 0.9800   
C(1)-O(2)-H(2) 109.5 O(2)-C(1)-C(2) 111.38(13) 
O(2)-C(1)-C(10) 114.19(13) C(2)-C(1)-C(10) 111.09(11) 
O(2)-C(1)-H(1) 106.6 C(2)-C(1)-H(1) 106.6 
C(10)-C(1)-H(1) 106.6 C(3)-C(2)-C(1) 112.41(12) 
C(3)-C(2)-H(2A) 109.1 C(1)-C(2)-H(2A) 109.1 
C(3)-C(2)-H(2B) 109.1 C(1)-C(2)-H(2B) 109.1 
H(2A)-C(2)-H(2B) 107.9 C(2)-C(3)-C(4) 111.10(12) 
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C(2)-C(3)-H(3A) 109.4 C(4)-C(3)-H(3A) 109.4 
C(2)-C(3)-H(3B) 109.4 C(4)-C(3)-H(3B) 109.4 
H(3A)-C(3)-H(3B) 108.0 C(3)-C(4)-C(5) 111.92(11) 
C(3)-C(4)-H(4A) 109.2 C(5)-C(4)-H(4A) 109.2 
C(3)-C(4)-H(4B) 109.2 C(5)-C(4)-H(4B) 109.2 
H(4A)-C(4)-H(4B) 107.9 C(11)-C(5)-C(6) 109.68(11) 
C(11)-C(5)-C(4) 106.00(11) C(6)-C(5)-C(4) 110.08(11) 
C(11)-C(5)-C(10) 115.19(11) C(6)-C(5)-C(10) 106.76(11) 
C(4)-C(5)-C(10) 109.11(11) C(7)-C(6)-C(5) 112.39(11) 
C(7)-C(6)-H(6A) 109.1 C(5)-C(6)-H(6A) 109.1 
C(7)-C(6)-H(6B) 109.1 C(5)-C(6)-H(6B) 109.1 
H(6A)-C(6)-H(6B) 107.9 C(8)-C(7)-C(6) 111.69(13) 
C(8)-C(7)-H(7A) 109.3 C(6)-C(7)-H(7A) 109.3 
C(8)-C(7)-H(7B) 109.3 C(6)-C(7)-H(7B) 109.3 
H(7A)-C(7)-H(7B) 107.9 C(7)-C(8)-C(9) 110.98(13) 
C(7)-C(8)-H(8A) 109.4 C(9)-C(8)-H(8A) 109.4 
C(7)-C(8)-H(8B) 109.4 C(9)-C(8)-H(8B) 109.4 
H(8A)-C(8)-H(8B) 108.0 C(8)-C(9)-C(10) 110.79(13) 
C(8)-C(9)-H(9A) 109.5 C(10)-C(9)-H(9A) 109.5 
C(8)-C(9)-H(9B) 109.5 C(10)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 108.1 C(1)-C(10)-C(9) 114.08(12) 
C(1)-C(10)-C(5) 116.46(11) C(9)-C(10)-C(5) 110.98(12) 
C(1)-C(10)-H(10) 104.6 C(9)-C(10)-H(10) 104.6 
C(5)-C(10)-H(10) 104.6 O(1)-C(11)-C(12) 117.85(14) 
O(1)-C(11)-C(5) 123.75(13) C(12)-C(11)-C(5) 118.34(12) 
C(11)-C(12)-H(12A) 109.5 C(11)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 C(11)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 H(12B)-C(12)-H(12C) 109.5 
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Table 6.4 Anisotropic displacement parameters (Å2 x 103) for 177. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U]. 
Atom U11 U22 U33 U23 U13 U12 
O(1) 45(1) 55(1) 47(1) 19(1) -13(1) -1(1) 
O(2) 29(1) 59(1) 56(1) -2(1) -9(1) 1(1) 
C(1) 25(1) 41(1) 42(1) -2(1) 1(1) -4(1) 
C(2) 35(1) 34(1) 47(1) -3(1) 0(1) -9(1) 
C(3) 37(1) 29(1) 38(1) -4(1) 0(1) 1(1) 
C(4) 26(1) 27(1) 37(1) 1(1) 0(1) 4(1) 
C(5) 22(1) 26(1) 30(1) 1(1) -2(1) 2(1) 
C(6) 27(1) 35(1) 37(1) -2(1) -6(1) -2(1) 
C(7) 43(1) 37(1) 43(1) -9(1) -5(1) -5(1) 
C(8) 47(1) 47(1) 47(1) -18(1) 2(1) 3(1) 
C(9) 33(1) 47(1) 49(1) -13(1) 3(1) 7(1) 
C(10) 25(1) 35(1) 31(1) -3(1) 1(1) 0(1) 
C(11) 34(1) 27(1) 33(1) 1(1) 0(1) 3(1) 
C(12) 45(1) 44(1) 49(1) 11(1) 13(1) 1(1) 
 
 
Table 6.5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 177. 
Atom x y z U(eq) 
H(2) 7803 2991 -106 58 
H(1) 7075 2104 1936 43 
H(2A) 9216 923 1680 47 
H(2B) 7982 937 453 47 
H(3A) 10409 1765 -539 41 
H(3B) 11252 798 30 41 
H(4A) 13346 2081 453 36 
H(4B) 12549 1659 1688 36 
H(6A) 13007 3077 2893 39 
H(6B) 14062 3585 1799 39 
H(7A) 13003 4738 3205 50 
H(7B) 12021 4910 1908 50 
H(8A) 9666 5035 3352 57 
H(8B) 10255 4027 3934 57 
H(9A) 8513 4281 1588 52 
H(9B) 7520 3792 2722 52 
H(10) 9850 2573 2705 36 
H(12A) 13032 4097 -1250 69 
H(12B) 14206 3511 -245 69 
H(12C) 13507 4576 32 69 
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Table 6.6 Dihedral angles [o] for 177. 
Atom1  -  Atom2  -  Atom3  -  Atom4 Dihedral 
O(2) - C(1) - C(2) - C(3) 77.57(16) 
C(10) - C(1) - C(2) - C(3) -50.94(18) 
C(1) - C(2) - C(3) - C(4) 57.60(17) 
C(2) - C(3) - C(4) - C(5) -59.08(16) 
C(3) - C(4) - C(5) - C(11) -71.58(14) 
C(3) - C(4) - C(5) - C(6) 169.87(11) 
C(3) - C(4) - C(5) - C(10) 53.02(15) 
C(11) - C(5) - C(6) - C(7) 66.97(15) 
C(4) - C(5) - C(6) - C(7) -176.77(12) 
C(10) - C(5) - C(6) - C(7) -58.47(15) 
C(5) - C(6) - C(7) - C(8) 56.85(17) 
C(6) - C(7) - C(8) - C(9) -53.31(19) 
C(7) - C(8) - C(9) - C(10) 54.7(2) 
O(2) - C(1) - C(10) - C(9) 52.36(17) 
C(2) - C(1) - C(10) - C(9) 179.35(13) 
O(2) - C(1) - C(10) - C(5) -78.98(15) 
C(2) - C(1) - C(10) - C(5) 48.01(17) 
C(8) - C(9) - C(10) - C(1) 166.80(14) 
C(8) - C(9) - C(10) - C(5) -59.25(17) 
C(11) - C(5) - C(10) - C(1) 70.32(16) 
C(6) - C(5) - C(10) - C(1) -167.65(12) 
C(4) - C(5) - C(10) - C(1) -48.72(15) 
C(11) - C(5) - C(10) - C(9) -62.44(15) 
C(6) - C(5) - C(10) - C(9) 59.59(15) 
C(4) - C(5) - C(10) - C(9) 178.52(11) 
C(6) - C(5) - C(11) - O(1) -141.19(15) 
C(4) - C(5) - C(11) - O(1) 100.00(16) 
C(10) - C(5) - C(11) - O(1) -20.7(2) 
C(6) - C(5) - C(11) - C(12) 41.60(17) 
C(4) - C(5) - C(11) - C(12) -77.21(15) 
C(10) - C(5) - C(11) - C(12) 162.04(13) 
 
 
Table 6.7 Crystal data and structure refinement for 193. 
Identification code k09sel2 
Empirical formula C12H22O2 
Formula weight 198.30 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 10.0480(2)Å α = 90o 
 b = 8.1890(1)Å β = 105.657(1)o 
 
c = 14.2080(3)Å γ = 90o 
Volume 1125.70(4) Å3 
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Z 4 
Density (calculated) 1.170 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 440 
Crystal size 0.6 x 0.5 x 0.15 mm 
Theta range for data collection 3.88 to 27.52o 
Index ranges -13<=h<=13; -10<=k<=10; -18<=l<=18 
Reflections collected 20728 
Independent reflections 2583 [R(int) = 0.0533] 
Reflections observed (>2σ) 2255 
Data Completeness 0.994 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.967 and 0.783 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2583 / 0 / 131 
Goodness-of-fit on F2 1.159 
Final R indices [I>2σ(I)] R1 = 0.0534   wR2 = 0.1344 
R indices (all data) R1 = 0.0601  wR2 = 0.1384 
Largest diff. peak and hole 0.265 and -0.272 eÅ-3 
 
 
Table 6.8 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 193. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
Atom x y z U(eq) 
O(1) 934(1) 2472(2) 7174(1) 29(1) 
O(2) 1023(1) 5149(1) 8191(1) 26(1) 
C(1) 2319(2) 5874(2) 8163(1) 23(1) 
C(2) 3484(2) 5026(2) 8912(1) 28(1) 
C(3) 3692(2) 3270(2) 8619(1) 28(1) 
C(4) 3934(2) 3199(2) 7598(1) 24(1) 
C(5) 2835(2) 4067(2) 6780(1) 20(1) 
C(6) 3454(2) 4383(2) 5908(1) 26(1) 
C(7) 2511(2) 5402(2) 5088(1) 31(1) 
C(8) 2112(2) 7023(2) 5473(1) 30(1) 
C(9) 1554(2) 6806(2) 6371(1) 25(1) 
C(10) 2575(2) 5800(2) 7151(1) 20(1) 
C(11) 1498(2) 3021(2) 6403(1) 23(1) 
C(12) 1682(2) 1492(2) 5846(1) 33(1) 
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Table 6.9 Bond lengths [Å] and angles [o] for 193. 
O(1)-C(11) 1.435(2) O(1)-H(1) 0.8400 
O(2)-C(1) 1.4417(19) O(2)-H(2) 0.8400 
C(1)-C(2) 1.520(2) C(1)-C(10) 1.529(2) 
C(1)-H(1A) 1.0000 C(2)-C(3) 1.527(3) 
C(2)-H(2A) 0.9900 C(2)-H(2B) 0.9900 
C(3)-C(4) 1.536(2) C(3)-H(3A) 0.9900 
C(3)-H(3B) 0.9900 C(4)-C(5) 1.544(2) 
C(4)-H(4A) 0.9900 C(4)-H(4B) 0.9900 
C(5)-C(6) 1.551(2) C(5)-C(10) 1.560(2) 
C(5)-C(11) 1.561(2) C(6)-C(7) 1.534(2) 
C(6)-H(6A) 0.9900 C(6)-H(6B) 0.9900 
C(7)-C(8) 1.530(3) C(7)-H(7A) 0.9900 
C(7)-H(7B) 0.9900 C(8)-C(9) 1.537(2) 
C(8)-H(8A) 0.9900 C(8)-H(8B) 0.9900 
C(9)-C(10) 1.531(2) C(9)-H(9A) 0.9900 
C(9)-H(9B) 0.9900 C(10)-H(10) 1.0000 
C(11)-C(12) 1.519(2) C(11)-H(11) 1.0000 
C(12)-H(12A) 0.9800 C(12)-H(12B) 0.9800 
C(12)-H(12C) 0.9800   
C(11)-O(1)-H(1) 109.5 C(1)-O(2)-H(2) 109.5 
O(2)-C(1)-C(2) 108.84(14) O(2)-C(1)-C(10) 113.09(13) 
C(2)-C(1)-C(10) 110.31(13) O(2)-C(1)-H(1A) 108.2 
C(2)-C(1)-H(1A) 108.2 C(10)-C(1)-H(1A) 108.2 
C(1)-C(2)-C(3) 112.04(14) C(1)-C(2)-H(2A) 109.2 
C(3)-C(2)-H(2A) 109.2 C(1)-C(2)-H(2B) 109.2 
C(3)-C(2)-H(2B) 109.2 H(2A)-C(2)-H(2B) 107.9 
C(2)-C(3)-C(4) 111.22(14) C(2)-C(3)-H(3A) 109.4 
C(4)-C(3)-H(3A) 109.4 C(2)-C(3)-H(3B) 109.4 
C(4)-C(3)-H(3B) 109.4 H(3A)-C(3)-H(3B) 108.0 
C(3)-C(4)-C(5) 115.46(13) C(3)-C(4)-H(4A) 108.4 
C(5)-C(4)-H(4A) 108.4 C(3)-C(4)-H(4B) 108.4 
C(5)-C(4)-H(4B) 108.4 H(4A)-C(4)-H(4B) 107.5 
C(4)-C(5)-C(6) 108.58(12) C(4)-C(5)-C(10) 108.40(13) 
C(6)-C(5)-C(10) 104.97(13) C(4)-C(5)-C(11) 112.35(13) 
C(6)-C(5)-C(11) 108.14(13) C(10)-C(5)-C(11) 114.03(12) 
C(7)-C(6)-C(5) 113.46(13) C(7)-C(6)-H(6A) 108.9 
C(5)-C(6)-H(6A) 108.9 C(7)-C(6)-H(6B) 108.9 
C(5)-C(6)-H(6B) 108.9 H(6A)-C(6)-H(6B) 107.7 
C(8)-C(7)-C(6) 111.63(15) C(8)-C(7)-H(7A) 109.3 
C(6)-C(7)-H(7A) 109.3 C(8)-C(7)-H(7B) 109.3 
C(6)-C(7)-H(7B) 109.3 H(7A)-C(7)-H(7B) 108.0 
C(7)-C(8)-C(9) 112.69(14) C(7)-C(8)-H(8A) 109.1 
C(9)-C(8)-H(8A) 109.1 C(7)-C(8)-H(8B) 109.1 
C(9)-C(8)-H(8B) 109.1 H(8A)-C(8)-H(8B) 107.8 
C(10)-C(9)-C(8) 109.85(13) C(10)-C(9)-H(9A) 109.7 
C(8)-C(9)-H(9A) 109.7 C(10)-C(9)-H(9B) 109.7 
C(8)-C(9)-H(9B) 109.7 H(9A)-C(9)-H(9B) 108.2 
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C(1)-C(10)-C(9) 114.14(13) C(1)-C(10)-C(5) 116.13(13) 
C(9)-C(10)-C(5) 112.69(13) C(1)-C(10)-H(10) 104.0 
C(9)-C(10)-H(10) 104.0 C(5)-C(10)-H(10) 104.0 
O(1)-C(11)-C(12) 105.55(14) O(1)-C(11)-C(5) 112.98(13) 
C(12)-C(11)-C(5) 114.57(14) O(1)-C(11)-H(11) 107.8 
C(12)-C(11)-H(11) 107.8 C(5)-C(11)-H(11) 107.8 
C(11)-C(12)-H(12A) 109.5 C(11)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 C(11)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 H(12B)-C(12)-H(12C) 109.5 
 
 
Table 6.10 Anisotropic displacement parameters (Å2 x 103) for 193. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U] 
Atom U11 U22 U33 U23 U13 U12 
O(1) 30(1) 24(1) 38(1) -6(1) 18(1) -8(1) 
O(2) 23(1) 23(1) 35(1) 1(1) 14(1) 4(1) 
C(1) 22(1) 20(1) 29(1) -3(1) 9(1) -1(1) 
C(2) 27(1) 34(1) 23(1) -1(1) 5(1) 1(1) 
C(3) 25(1) 31(1) 27(1) 6(1) 7(1) 7(1) 
C(4) 21(1) 25(1) 27(1) 3(1) 8(1) 6(1) 
C(5) 17(1) 18(1) 24(1) 1(1) 7(1) 1(1) 
C(6) 26(1) 25(1) 29(1) 1(1) 13(1) 1(1) 
C(7) 36(1) 34(1) 26(1) 5(1) 11(1) 0(1) 
C(8) 31(1) 27(1) 32(1) 10(1) 8(1) 1(1) 
C(9) 24(1) 19(1) 31(1) 3(1) 7(1) 2(1) 
C(10) 18(1) 17(1) 26(1) -1(1) 6(1) -2(1) 
C(11) 23(1) 20(1) 29(1) -1(1) 10(1) -2(1) 
C(12) 38(1) 25(1) 38(1) -9(1) 16(1) -6(1) 
 
 
Table 6.11 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 193. 
Atom x y z U(eq) 
H(1) 842 3271 7522 35 
H(2) 401 5865 8068 31 
H(1A) 2307 7048 8354 28 
H(2A) 3272 5025 9553 34 
H(2B) 4352 5646 8984 34 
H(3A) 2865 2615 8623 33 
H(3B) 4496 2789 9102 33 
H(4A) 3976 2038 7413 29 
H(4B) 4847 3691 7634 29 
H(6A) 4349 4956 6150 31 
H(6B) 3639 3321 5635 31 
H(7A) 2992 5621 4578 38 
H(7B) 1663 4771 4784 38 
H(8A) 1399 7566 4947 36 
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H(8B) 2933 7744 5648 36 
H(9A) 1419 7889 6641 29 
H(9B) 648 6244 6178 29 
H(10) 3477 6377 7237 24 
H(11) 786 3720 5953 28 
H(12A) 2480 874 6229 49 
H(12B) 1836 1801 5217 49 
H(12C) 850 815 5732 49 
 
 
Table 6.12 Dihedral angles [o] for 193. 
Atom1  -  Atom2  -  Atom3  -  Atom4 Dihedral 
O(2) - C(1) - C(2) - C(3) 69.28(17) 
C(10) - C(1) - C(2) - C(3) -55.33(18) 
C(1) - C(2) - C(3) - C(4) 55.37(19) 
C(2) - C(3) - C(4) - C(5) -53.0(2) 
C(3) - C(4) - C(5) - C(6) 161.48(14) 
C(3) - C(4) - C(5) - C(10) 47.97(18) 
C(3) - C(4) - C(5) - C(11) -78.97(18) 
C(4) - C(5) - C(6) - C(7) -174.01(14) 
C(10) - C(5) - C(6) - C(7) -58.25(17) 
C(11) - C(5) - C(6) - C(7) 63.83(18) 
C(5) - C(6) - C(7) - C(8) 55.1(2) 
C(6) - C(7) - C(8) - C(9) -50.4(2) 
C(7) - C(8) - C(9) - C(10) 52.46(19) 
O(2) - C(1) - C(10) - C(9) 65.18(17) 
C(2) - C(1) - C(10) - C(9) -172.67(14) 
O(2) - C(1) - C(10) - C(5) -68.50(17) 
C(2) - C(1) - C(10) - C(5) 53.65(18) 
C(8) - C(9) - C(10) - C(1) 165.10(14) 
C(8) - C(9) - C(10) - C(5) -59.63(17) 
C(4) - C(5) - C(10) - C(1) -48.81(17) 
C(6) - C(5) - C(10) - C(1) -164.69(13) 
C(11) - C(5) - C(10) - C(1) 77.14(17) 
C(4) - C(5) - C(10) - C(9) 176.86(13) 
C(6) - C(5) - C(10) - C(9) 60.98(16) 
C(11) - C(5) - C(10) - C(9) -57.19(17) 
C(4) - C(5) - C(11) - O(1) 52.51(17) 
C(6) - C(5) - C(11) - O(1) 172.32(13) 
C(10) - C(5) - C(11) - O(1) -71.35(17) 
C(4) - C(5) - C(11) - C(12) -68.44(18) 
C(6) - C(5) - C(11) - C(12) 51.37(18) 
C(10) - C(5) - C(11) - C(12) 167.71(14) 
 
Table 6.13 Crystal data and structure refinement for 266. 
Identification code p10sel2 
Empirical formula C32.75H46.75Cl2.25N2O4 
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Formula weight 612.23 
Temperature 150(2) K 
Wavelength 1.54184 Å 
Crystal system Monoclinic 
Space group P21/n 
Unit cell dimensions a = 14.8975(16)Å α = 90o 
 b = 7.3862(4)Å β = 97.729(8)o 
 
c = 30.776(3)Å γ = 90o 
Volume 3355.7(5) Å3 
Z 4 
Density (calculated) 1.212 Mg/m3 
Absorption coefficient 2.214 mm-1 
F(000) 1310 
Crystal size 0.35 x 0.10 x 0.06 mm 
Theta range for data collection 4.94 to 58.93o 
Index ranges -16<=h<=15; -6<=k<=8; -34<=l<=30 
Reflections collected 11535 
Independent reflections 4690 [R(int) = 0.1109] 
Reflections observed (>2σ) 3004 
Data Completeness 0.971 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.59444 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4690 / 10 / 390 
Goodness-of-fit on F2 1.108 
Final R indices [I>2σ(I)] R1 = 0.1043   wR2 = 0.2796 
R indices (all data) R1 = 0.1397  wR2 = 0.3348 
Largest diff. peak and hole 0.752 and -0.511 eÅ-3 
 
 
Table 6.14 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 266. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
Atom x y z U(eq) 
Cl(1) 7903(2) 2378(3) 1804(1) 71(1) 
Cl(3) 9010(2) -637(4) 1598(1) 58(1) 
Cl(2) 8030(3) -678(5) 2359(1) 76(1) 
O(1) 1602(2) 248(4) 1464(1) 39(1) 
O(2) 2027(2) -2654(4) 2088(1) 43(1) 
N(1) 2235(3) 1854(5) 2033(1) 36(1) 
C(1) 2192(3) 299(6) 1832(2) 32(1) 
C(2) 1609(4) 2924(7) 1763(2) 44(2) 
C(3) 1234(4) 1968(6) 1418(2) 40(1) 
C(4) 2693(3) -1407(6) 1980(2) 34(1) 
C(5) 3205(4) -2255(6) 1621(2) 42(1) 
C(6) 3654(4) -4040(6) 1795(2) 48(2) 
C(7) 4472(4) -3735(7) 2128(2) 50(2) 
C(8) 5157(4) -2561(7) 1945(2) 52(2) 
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C(9) 4775(4) -728(6) 1766(2) 45(2) 
C(10) 5489(4) 185(8) 1516(2) 56(2) 
C(11) 5150(4) 1876(8) 1262(2) 62(2) 
C(12) 4310(5) 1456(9) 948(2) 67(2) 
C(13) 3566(4) 624(7) 1180(2) 50(2) 
C(14) 3921(4) -1088(7) 1442(2) 44(1) 
C(15) 4608(4) 546(6) 2138(2) 45(2) 
C(16) 4990(5) 571(8) 2546(2) 64(2) 
C(17) 8525(7) 460(11) 1996(3) 81(3) 
O(1A) 53(2) 5221(4) 1057(1) 41(1) 
O(2A) 10(2) 2326(4) 424(1) 38(1) 
N(1A) -198(3) 6865(5) 449(2) 37(1) 
C(1A) -309(3) 5304(6) 632(2) 35(1) 
C(2A) 279(4) 7899(6) 788(2) 40(1) 
C(3A) 435(4) 6913(6) 1148(2) 41(1) 
C(4A) -709(3) 3612(6) 415(2) 34(1) 
C(5A) -1484(4) 2800(6) 634(2) 40(1) 
C(6A) -1765(4) 948(6) 429(2) 46(2) 
C(7A) -2288(4) 1163(7) -31(2) 48(2) 
C(8A) -3115(4) 2333(7) -23(2) 49(2) 
C(9A) -2894(4) 4223(6) 178(2) 44(1) 
C(10A) -3809(4) 5149(8) 239(2) 53(2) 
C(11A) -3684(4) 6903(8) 505(2) 58(2) 
C(12A) -3111(4) 6611(8) 947(2) 62(2) 
C(13A) -2198(4) 5756(7) 895(2) 47(2) 
C(14A) -2328(4) 3975(6) 633(2) 40(1) 
C(15A) -2414(4) 5422(7) -120(2) 45(2) 
C(16A) -2417(5) 5261(8) -547(2) 61(2) 
Cl(2A) 7901(8) -1533(15) 2118(4) 90(3) 
Cl(3A) 9380(9) 40(20) 1740(5) 113(5) 
 
 
Table 6.15 Bond lengths [Å] and angles [o] for 266. 
Cl(1)-C(17) 1.752(8) Cl(3)-C(17) 1.708(8) 
Cl(2)-C(17) 1.649(8) O(1)-C(1) 1.338(6) 
O(1)-C(3) 1.383(6) O(2)-C(4) 1.425(6) 
O(2)-H(2) 0.8400 N(1)-C(1) 1.302(6) 
N(1)-C(2) 1.405(7) C(1)-C(4) 1.503(6) 
C(2)-C(3) 1.335(8) C(2)-H(2C) 0.9500 
C(3)-H(3) 0.9500 C(4)-C(5) 1.557(8) 
C(4)-H(4) 1.0000 C(5)-C(14) 1.531(8) 
C(5)-C(6) 1.542(7) C(5)-H(5) 1.0000 
C(6)-C(7) 1.500(8) C(6)-H(6A) 0.9900 
C(6)-H(6B) 0.9900 C(7)-C(8) 1.504(8) 
C(7)-H(7A) 0.9900 C(7)-H(7B) 0.9900 
C(8)-C(9) 1.541(7) C(8)-H(8A) 0.9900 
C(8)-H(8B) 0.9900 C(9)-C(15) 1.527(8) 
C(9)-C(14) 1.532(8) C(9)-C(10) 1.550(8) 
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C(10)-C(11) 1.523(8) C(10)-H(10A) 0.9900 
C(10)-H(10B) 0.9900 C(11)-C(12) 1.506(10) 
C(11)-H(11A) 0.9900 C(11)-H(11B) 0.9900 
C(12)-C(13) 1.527(9) C(12)-H(12A) 0.9900 
C(12)-H(12B) 0.9900 C(13)-C(14) 1.553(7) 
C(13)-H(13A) 0.9900 C(13)-H(13B) 0.9900 
C(14)-H(14) 1.0000 C(15)-C(16) 1.308(8) 
C(15)-H(15) 0.9500 C(16)-H(16A) 0.9500 
C(16)-H(16B) 0.9500 C(17)-Cl(3A) 1.615(12) 
C(17)-Cl(2A) 1.808(12) C(17)-H(17) 1.0000 
O(1A)-C(1A) 1.349(6) O(1A)-C(3A) 1.386(6) 
O(2A)-C(4A) 1.430(5) O(2A)-H(2A) 0.8400 
N(1A)-C(1A) 1.303(6) N(1A)-C(2A) 1.406(7) 
C(1A)-C(4A) 1.501(6) C(2A)-C(3A) 1.321(8) 
C(2A)-H(2B) 0.9500 C(3A)-H(3A) 0.9500 
C(4A)-C(5A) 1.535(8) C(4A)-H(4A) 1.0000 
C(5A)-C(14A) 1.527(7) C(5A)-C(6A) 1.540(7) 
C(5A)-H(5A) 1.0000 C(6A)-C(7A) 1.532(8) 
C(6A)-H(6A1) 0.9900 C(6A)-H(6A2) 0.9900 
C(7A)-C(8A) 1.508(8) C(7A)-H(7A1) 0.9900 
C(7A)-H(7A2) 0.9900 C(8A)-C(9A) 1.544(7) 
C(8A)-H(8A1) 0.9900 C(8A)-H(8A2) 0.9900 
C(9A)-C(15A) 1.521(8) C(9A)-C(14A) 1.546(8) 
C(9A)-C(10A) 1.559(8) C(10A)-C(11A) 1.530(8) 
C(10A)-H(10C) 0.9900 C(10A)-H(10D) 0.9900 
C(11A)-C(12A) 1.520(10) C(11A)-H(11C) 0.9900 
C(11A)-H(11D) 0.9900 C(12A)-C(13A) 1.528(8) 
C(12A)-H(12C) 0.9900 C(12A)-H(12D) 0.9900 
C(13A)-C(14A) 1.541(7) C(13A)-H(13C) 0.9900 
C(13A)-H(13D) 0.9900 C(14A)-H(14A) 1.0000 
C(15A)-C(16A) 1.320(8) C(15A)-H(15A) 0.9500 
C(16A)-H(16C) 0.9500 C(16A)-H(16D) 0.9500 
C(1)-O(1)-C(3) 105.5(4) C(4)-O(2)-H(2) 109.5 
C(1)-N(1)-C(2) 103.3(4) N(1)-C(1)-O(1) 114.3(4) 
N(1)-C(1)-C(4) 127.3(4) O(1)-C(1)-C(4) 118.4(4) 
C(3)-C(2)-N(1) 110.3(4) C(3)-C(2)-H(2C) 124.9 
N(1)-C(2)-H(2C) 124.9 C(2)-C(3)-O(1) 106.6(4) 
C(2)-C(3)-H(3) 126.7 O(1)-C(3)-H(3) 126.7 
O(2)-C(4)-C(1) 106.3(4) O(2)-C(4)-C(5) 109.2(4) 
C(1)-C(4)-C(5) 113.1(4) O(2)-C(4)-H(4) 109.4 
C(1)-C(4)-H(4) 109.4 C(5)-C(4)-H(4) 109.4 
C(14)-C(5)-C(6) 108.4(4) C(14)-C(5)-C(4) 117.5(4) 
C(6)-C(5)-C(4) 109.2(5) C(14)-C(5)-H(5) 107.1 
C(6)-C(5)-H(5) 107.1 C(4)-C(5)-H(5) 107.1 
C(7)-C(6)-C(5) 112.5(4) C(7)-C(6)-H(6A) 109.1 
C(5)-C(6)-H(6A) 109.1 C(7)-C(6)-H(6B) 109.1 
C(5)-C(6)-H(6B) 109.1 H(6A)-C(6)-H(6B) 107.8 
C(6)-C(7)-C(8) 111.2(5) C(6)-C(7)-H(7A) 109.4 
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C(8)-C(7)-H(7A) 109.4 C(6)-C(7)-H(7B) 109.4 
C(8)-C(7)-H(7B) 109.4 H(7A)-C(7)-H(7B) 108.0 
C(7)-C(8)-C(9) 113.8(5) C(7)-C(8)-H(8A) 108.8 
C(9)-C(8)-H(8A) 108.8 C(7)-C(8)-H(8B) 108.8 
C(9)-C(8)-H(8B) 108.8 H(8A)-C(8)-H(8B) 107.7 
C(15)-C(9)-C(14) 113.0(5) C(15)-C(9)-C(8) 111.3(5) 
C(14)-C(9)-C(8) 108.3(4) C(15)-C(9)-C(10) 107.3(4) 
C(14)-C(9)-C(10) 108.4(5) C(8)-C(9)-C(10) 108.4(4) 
C(11)-C(10)-C(9) 114.2(5) C(11)-C(10)-H(10A) 108.7 
C(9)-C(10)-H(10A) 108.7 C(11)-C(10)-H(10B) 108.7 
C(9)-C(10)-H(10B) 108.7 H(10A)-C(10)-H(10B) 107.6 
C(12)-C(11)-C(10) 110.5(5) C(12)-C(11)-H(11A) 109.6 
C(10)-C(11)-H(11A) 109.6 C(12)-C(11)-H(11B) 109.6 
C(10)-C(11)-H(11B) 109.6 H(11A)-C(11)-H(11B) 108.1 
C(11)-C(12)-C(13) 112.0(6) C(11)-C(12)-H(12A) 109.2 
C(13)-C(12)-H(12A) 109.2 C(11)-C(12)-H(12B) 109.2 
C(13)-C(12)-H(12B) 109.2 H(12A)-C(12)-H(12B) 107.9 
C(12)-C(13)-C(14) 110.6(5) C(12)-C(13)-H(13A) 109.5 
C(14)-C(13)-H(13A) 109.5 C(12)-C(13)-H(13B) 109.5 
C(14)-C(13)-H(13B) 109.5 H(13A)-C(13)-H(13B) 108.1 
C(5)-C(14)-C(9) 114.9(5) C(5)-C(14)-C(13) 116.1(4) 
C(9)-C(14)-C(13) 113.0(4) C(5)-C(14)-H(14) 103.6 
C(9)-C(14)-H(14) 103.6 C(13)-C(14)-H(14) 103.6 
C(16)-C(15)-C(9) 129.4(5) C(16)-C(15)-H(15) 115.3 
C(9)-C(15)-H(15) 115.3 C(15)-C(16)-H(16A) 120.0 
C(15)-C(16)-H(16B) 120.0 H(16A)-C(16)-H(16B) 120.0 
Cl(3A)-C(17)-Cl(2) 133.4(7) Cl(3A)-C(17)-Cl(3) 28.6(6) 
Cl(2)-C(17)-Cl(3) 121.0(5) Cl(3A)-C(17)-Cl(1) 114.0(7) 
Cl(2)-C(17)-Cl(1) 112.1(5) Cl(3)-C(17)-Cl(1) 113.4(5) 
Cl(3A)-C(17)-Cl(2A) 114.0(8) Cl(2)-C(17)-Cl(2A) 32.3(4) 
Cl(3)-C(17)-Cl(2A) 92.4(6) Cl(1)-C(17)-Cl(2A) 117.7(7) 
Cl(3A)-C(17)-H(17) 74.4 Cl(2)-C(17)-H(17) 102.4 
Cl(3)-C(17)-H(17) 102.4 Cl(1)-C(17)-H(17) 102.4 
Cl(2A)-C(17)-H(17) 127.0 C(1A)-O(1A)-C(3A) 104.8(4) 
C(4A)-O(2A)-H(2A) 109.5 C(1A)-N(1A)-C(2A) 104.0(4) 
N(1A)-C(1A)-O(1A) 113.7(4) N(1A)-C(1A)-C(4A) 127.7(5) 
O(1A)-C(1A)-C(4A) 118.4(4) C(3A)-C(2A)-N(1A) 109.7(4) 
C(3A)-C(2A)-H(2B) 125.1 N(1A)-C(2A)-H(2B) 125.1 
C(2A)-C(3A)-O(1A) 107.8(5) C(2A)-C(3A)-H(3A) 126.1 
O(1A)-C(3A)-H(3A) 126.1 O(2A)-C(4A)-C(1A) 107.1(4) 
O(2A)-C(4A)-C(5A) 109.8(4) C(1A)-C(4A)-C(5A) 114.0(4) 
O(2A)-C(4A)-H(4A) 108.6 C(1A)-C(4A)-H(4A) 108.6 
C(5A)-C(4A)-H(4A) 108.6 C(14A)-C(5A)-C(4A) 116.4(4) 
C(14A)-C(5A)-C(6A) 109.0(4) C(4A)-C(5A)-C(6A) 110.3(5) 
C(14A)-C(5A)-H(5A) 106.9 C(4A)-C(5A)-H(5A) 106.9 
C(6A)-C(5A)-H(5A) 106.9 C(7A)-C(6A)-C(5A) 111.3(4) 
C(7A)-C(6A)-H(6A1) 109.4 C(5A)-C(6A)-H(6A1) 109.4 
C(7A)-C(6A)-H(6A2) 109.4 C(5A)-C(6A)-H(6A2) 109.4 
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H(6A1)-C(6A)-H(6A2) 108.0 C(8A)-C(7A)-C(6A) 111.0(5) 
C(8A)-C(7A)-H(7A1) 109.4 C(6A)-C(7A)-H(7A1) 109.4 
C(8A)-C(7A)-H(7A2) 109.4 C(6A)-C(7A)-H(7A2) 109.4 
H(7A1)-C(7A)-H(7A2) 108.0 C(7A)-C(8A)-C(9A) 113.2(5) 
C(7A)-C(8A)-H(8A1) 108.9 C(9A)-C(8A)-H(8A1) 108.9 
C(7A)-C(8A)-H(8A2) 108.9 C(9A)-C(8A)-H(8A2) 108.9 
H(8A1)-C(8A)-H(8A2) 107.7 C(15A)-C(9A)-C(8A) 112.2(5) 
C(15A)-C(9A)-C(14A) 111.8(4) C(8A)-C(9A)-C(14A) 108.5(4) 
C(15A)-C(9A)-C(10A) 107.9(4) C(8A)-C(9A)-C(10A) 107.6(4) 
C(14A)-C(9A)-C(10A) 108.8(5) C(11A)-C(10A)-C(9A) 113.0(5) 
C(11A)-C(10A)-H(10C) 109.0 C(9A)-C(10A)-H(10C) 109.0 
C(11A)-C(10A)-H(10D) 109.0 C(9A)-C(10A)-H(10D) 109.0 
H(10C)-C(10A)-H(10D) 107.8 C(12A)-C(11A)-C(10A) 111.8(5) 
C(12A)-C(11A)-H(11C) 109.3 C(10A)-C(11A)-H(11C) 109.3 
C(12A)-C(11A)-H(11D) 109.3 C(10A)-C(11A)-H(11D) 109.3 
H(11C)-C(11A)-H(11D) 107.9 C(11A)-C(12A)-C(13A) 111.4(6) 
C(11A)-C(12A)-H(12C) 109.3 C(13A)-C(12A)-H(12C) 109.3 
C(11A)-C(12A)-H(12D) 109.3 C(13A)-C(12A)-H(12D) 109.3 
H(12C)-C(12A)-H(12D) 108.0 C(12A)-C(13A)-C(14A) 110.9(5) 
C(12A)-C(13A)-H(13C) 109.5 C(14A)-C(13A)-H(13C) 109.5 
C(12A)-C(13A)-H(13D) 109.5 C(14A)-C(13A)-H(13D) 109.5 
H(13C)-C(13A)-H(13D) 108.0 C(5A)-C(14A)-C(13A) 116.1(4) 
C(5A)-C(14A)-C(9A) 114.7(5) C(13A)-C(14A)-C(9A) 112.8(4) 
C(5A)-C(14A)-H(14A) 103.8 C(13A)-C(14A)-H(14A) 103.8 
C(9A)-C(14A)-H(14A) 103.8 C(16A)-C(15A)-C(9A) 127.5(5) 
C(16A)-C(15A)-H(15A) 116.2 C(9A)-C(15A)-H(15A) 116.2 
C(15A)-C(16A)-H(16C) 120.0 C(15A)-C(16A)-H(16D) 120.0 
H(16C)-C(16A)-H(16D) 120.0   
 
 
Table 6.16 Anisotropic displacement parameters (Å2 x 103) for 266. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U]. 
Atom U11 U22 U33 U23 U13 U12 
Cl(1) 78(2) 61(1) 76(2) 9(1) 14(1) 19(1) 
Cl(3) 85(2) 38(1) 48(2) -2(1) 1(2) 12(1) 
Cl(2) 84(2) 73(2) 72(2) 34(2) 12(2) -6(2) 
O(1) 48(2) 18(2) 47(2) -2(2) -13(2) 4(1) 
O(2) 54(2) 25(2) 45(2) 7(2) -13(2) -10(2) 
N(1) 43(3) 20(2) 43(3) -2(2) -6(2) 5(2) 
C(1) 27(3) 27(3) 37(3) 0(2) -9(2) 0(2) 
C(2) 50(3) 26(3) 50(4) 0(2) -14(3) 3(2) 
C(3) 47(3) 23(3) 45(3) 3(2) -10(3) 4(2) 
C(4) 45(3) 15(2) 38(3) -1(2) -14(2) -3(2) 
C(5) 47(3) 24(3) 48(4) -4(2) -17(3) 2(2) 
C(6) 51(4) 23(3) 67(4) -5(3) -8(3) 6(2) 
C(7) 56(4) 23(3) 66(4) 8(3) -12(3) 7(2) 
C(8) 48(4) 35(3) 68(5) 0(3) -8(3) 8(2) 
C(9) 41(3) 27(3) 64(4) -1(2) -6(3) 5(2) 
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C(10) 49(4) 46(3) 74(5) 1(3) 7(3) 5(3) 
C(11) 65(4) 49(4) 76(5) 19(3) 23(4) 9(3) 
C(12) 67(5) 64(4) 72(5) 25(4) 18(4) 14(3) 
C(13) 59(4) 40(3) 48(4) 1(3) -2(3) 8(3) 
C(14) 48(3) 33(3) 47(4) -6(2) -3(3) 11(2) 
C(15) 42(3) 29(3) 60(4) 1(3) -6(3) -1(2) 
C(16) 68(5) 53(4) 64(5) -12(3) -15(4) 7(3) 
C(17) 94(8) 90(7) 59(7) 9(5) 15(6) 16(6) 
O(1A) 48(2) 22(2) 46(2) 1(2) -15(2) -3(2) 
O(2A) 41(2) 26(2) 44(2) 2(2) -4(2) 8(1) 
N(1A) 45(3) 21(2) 43(3) 3(2) -6(2) -1(2) 
C(1A) 33(3) 26(3) 43(3) 1(2) -2(2) 2(2) 
C(2A) 42(3) 19(2) 55(4) 2(2) -7(3) 0(2) 
C(3A) 50(3) 22(3) 45(4) -5(2) -14(3) -4(2) 
C(4A) 40(3) 15(2) 40(3) -2(2) -13(2) 5(2) 
C(5A) 45(3) 25(2) 44(3) 3(2) -13(3) -6(2) 
C(6A) 55(4) 18(2) 60(4) -1(2) -12(3) -5(2) 
C(7A) 55(4) 26(3) 59(4) -10(3) -8(3) -6(2) 
C(8A) 54(4) 34(3) 52(4) 5(3) -19(3) -8(3) 
C(9A) 39(3) 27(3) 61(4) 5(2) -10(3) -1(2) 
C(10A) 44(4) 44(3) 68(4) -1(3) -3(3) -4(3) 
C(11A) 46(4) 43(3) 86(5) 0(3) 14(3) 6(3) 
C(12A) 57(4) 49(4) 82(5) -17(3) 12(4) 7(3) 
C(13A) 40(3) 34(3) 64(4) -5(3) 0(3) 1(2) 
C(14A) 44(3) 26(3) 48(3) -1(2) 3(3) -2(2) 
C(15A) 46(3) 29(3) 52(4) 9(2) -16(3) 6(2) 
C(16A) 71(5) 51(4) 54(4) 10(3) -13(3) 1(3) 
 
 
Table 6.17 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 266. 
Atom x y z U(eq) 
H(2) 2145 -2950 2353 52 
H(2C) 1472 4151 1819 53 
H(3) 800 2388 1185 48 
H(4) 3133 -1147 2247 41 
H(5) 2740 -2572 1367 50 
H(6A) 3207 -4771 1929 58 
H(6B) 3834 -4739 1546 58 
H(7A) 4752 -4915 2218 60 
H(7B) 4285 -3148 2391 60 
H(8A) 5396 -3225 1706 63 
H(8B) 5670 -2334 2179 63 
H(10A) 6023 512 1728 68 
H(10B) 5690 -704 1308 68 
H(11A) 5013 2829 1469 75 
H(11B) 5628 2340 1097 75 
H(12A) 4467 605 721 80 
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H(12B) 4081 2585 799 80 
H(13A) 3043 294 961 60 
H(13B) 3358 1524 1383 60 
H(14) 4143 -1878 1214 52 
H(15) 4163 1453 2061 54 
H(16A) 5442 -296 2646 77 
H(16B) 4815 1455 2743 77 
H(17) 9062 1002 2181 97 
H(2A) 289 2499 208 45 
H(2B) 462 9121 761 48 
H(3A) 753 7295 1421 50 
H(4A) -942 3894 102 40 
H(5A) -1239 2573 948 48 
H(6A1) -1217 206 414 56 
H(6A2) -2149 306 619 56 
H(7A1) -1888 1717 -227 58 
H(7A2) -2475 -45 -151 58 
H(8A1) -3539 1709 149 59 
H(8A2) -3424 2482 -326 59 
H(10C) -4147 5419 -53 63 
H(10D) -4177 4296 389 63 
H(11C) -3389 7819 337 70 
H(11D) -4285 7378 552 70 
H(12C) -3442 5814 1130 75 
H(12D) -3010 7788 1099 75 
H(13C) -1859 5512 1188 56 
H(13D) -1838 6612 741 56 
H(14A) -2729 3238 800 47 
H(15A) -2071 6400 18 53 
H(16C) -2748 4308 -702 73 
H(16D) -2089 6097 -699 73 
 
 
Table 6.18 Dihedral angles [o] for 266. 
Atom1  -  Atom2  -  Atom3  -  Atom4 Dihedral 
C(2) - N(1) - C(1) - O(1) -0.3(6) 
C(2) - N(1) - C(1) - C(4) -177.4(5) 
C(3) - O(1) - C(1) - N(1) 1.1(6) 
C(3) - O(1) - C(1) - C(4) 178.4(4) 
C(1) - N(1) - C(2) - C(3) -0.6(6) 
N(1) - C(2) - C(3) - O(1) 1.2(6) 
C(1) - O(1) - C(3) - C(2) -1.3(6) 
N(1) - C(1) - C(4) - O(2) 111.7(5) 
O(1) - C(1) - C(4) - O(2) -65.3(6) 
N(1) - C(1) - C(4) - C(5) -128.6(5) 
O(1) - C(1) - C(4) - C(5) 54.5(6) 
O(2) - C(4) - C(5) - C(14) 177.0(4) 
C(1) - C(4) - C(5) - C(14) 58.9(6) 
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O(2) - C(4) - C(5) - C(6) -59.1(5) 
C(1) - C(4) - C(5) - C(6) -177.1(4) 
C(14) - C(5) - C(6) - C(7) 55.1(7) 
C(4) - C(5) - C(6) - C(7) -74.0(6) 
C(5) - C(6) - C(7) - C(8) -56.3(7) 
C(6) - C(7) - C(8) - C(9) 55.4(7) 
C(7) - C(8) - C(9) - C(15) 72.4(6) 
C(7) - C(8) - C(9) - C(14) -52.5(7) 
C(7) - C(8) - C(9) - C(10) -169.9(5) 
C(15) - C(9) - C(10) - C(11) -68.5(7) 
C(14) - C(9) - C(10) - C(11) 53.9(6) 
C(8) - C(9) - C(10) - C(11) 171.2(5) 
C(9) - C(10) - C(11) - C(12) -55.9(7) 
C(10) - C(11) - C(12) - C(13) 55.7(7) 
C(11) - C(12) - C(13) - C(14) -55.5(7) 
C(6) - C(5) - C(14) - C(9) -54.9(6) 
C(4) - C(5) - C(14) - C(9) 69.4(6) 
C(6) - C(5) - C(14) - C(13) 170.1(5) 
C(4) - C(5) - C(14) - C(13) -65.6(6) 
C(15) - C(9) - C(14) - C(5) -70.5(6) 
C(8) - C(9) - C(14) - C(5) 53.3(6) 
C(10) - C(9) - C(14) - C(5) 170.7(4) 
C(15) - C(9) - C(14) - C(13) 65.9(6) 
C(8) - C(9) - C(14) - C(13) -170.3(5) 
C(10) - C(9) - C(14) - C(13) -52.9(6) 
C(12) - C(13) - C(14) - C(5) -169.1(5) 
C(12) - C(13) - C(14) - C(9) 55.0(7) 
C(14) - C(9) - C(15) - C(16) 147.0(6) 
C(8) - C(9) - C(15) - C(16) 24.8(8) 
C(10) - C(9) - C(15) - C(16) -93.6(7) 
C(2A) - N(1A) - C(1A) - O(1A) -0.2(6) 
C(2A) - N(1A) - C(1A) - C(4A) -174.4(5) 
C(3A) - O(1A) - C(1A) - N(1A) -0.3(6) 
C(3A) - O(1A) - C(1A) - C(4A) 174.5(4) 
C(1A) - N(1A) - C(2A) - C(3A) 0.7(6) 
N(1A) - C(2A) - C(3A) - O(1A) -0.9(6) 
C(1A) - O(1A) - C(3A) - C(2A) 0.7(6) 
N(1A) - C(1A) - C(4A) - O(2A) 111.5(6) 
O(1A) - C(1A) - C(4A) - O(2A) -62.4(6) 
N(1A) - C(1A) - C(4A) - C(5A) -126.8(6) 
O(1A) - C(1A) - C(4A) - C(5A) 59.2(6) 
O(2A) - C(4A) - C(5A) - C(14A) -177.3(4) 
C(1A) - C(4A) - C(5A) - C(14A) 62.6(6) 
O(2A) - C(4A) - C(5A) - C(6A) -52.4(5) 
C(1A) - C(4A) - C(5A) - C(6A) -172.6(4) 
C(14A) - C(5A) - C(6A) - C(7A) 55.8(6) 
C(4A) - C(5A) - C(6A) - C(7A) -73.1(6) 
C(5A) - C(6A) - C(7A) - C(8A) -57.4(6) 
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C(6A) - C(7A) - C(8A) - C(9A) 56.5(6) 
C(7A) - C(8A) - C(9A) - C(15A) 71.0(6) 
C(7A) - C(8A) - C(9A) - C(14A) -53.0(7) 
C(7A) - C(8A) - C(9A) - C(10A) -170.5(5) 
C(15A) - C(9A) - C(10A) - C(11A) -68.3(7) 
C(8A) - C(9A) - C(10A) - C(11A) 170.5(5) 
C(14A) - C(9A) - C(10A) - C(11A) 53.2(6) 
C(9A) - C(10A) - C(11A) - C(12A) -54.7(7) 
C(10A) - C(11A) - C(12A) - C(13A) 55.0(7) 
C(11A) - C(12A) - C(13A) - C(14A) -55.5(7) 
C(4A) - C(5A) - C(14A) - C(13A) -64.3(7) 
C(6A) - C(5A) - C(14A) - C(13A) 170.2(5) 
C(4A) - C(5A) - C(14A) - C(9A) 70.0(6) 
C(6A) - C(5A) - C(14A) - C(9A) -55.5(6) 
C(12A) - C(13A) - C(14A) - C(5A) -168.5(5) 
C(12A) - C(13A) - C(14A) - C(9A) 56.3(7) 
C(15A) - C(9A) - C(14A) - C(5A) -70.8(5) 
C(8A) - C(9A) - C(14A) - C(5A) 53.4(6) 
C(10A) - C(9A) - C(14A) - C(5A) 170.1(4) 
C(15A) - C(9A) - C(14A) - C(13A) 65.0(6) 
C(8A) - C(9A) - C(14A) - C(13A) -170.8(5) 
C(10A) - C(9A) - C(14A) - C(13A) -54.1(6) 
C(8A) - C(9A) - C(15A) - C(16A) 21.7(8) 
C(14A) - C(9A) - C(15A) - C(16A) 143.8(6) 
C(10A) - C(9A) - C(15A) - C(16A) -96.6(7) 
 
